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Summary
Hyaluronan (HA), a high molecular weight glycoaminoglycan, is widely distributed 
throughout the human body. It is implicated in a variety of biological processes 
ranging from cellular proliferation and wound healing to tumour invasion and organ 
fibrosis. In the kidney, HA is weakly expressed in the cortical region; however, its 
expression is greatly altered during the process of renal inflammation and fibrosis. 
Renal proximal tubule cells produce HA via the action of two hyaluronan synthase 
(HAS) isoforms: HAS2 and HAS3. The aim of this work was to investigate the 
regulation and function of HA in the proximal tubule cell which is the most common 
cell type in the renal cortex.
This work has demonstrated that:
i. HK-2 cells, a proximal tubule cell line, produce two distinct extracellular HA 
structures, namely: peri-cellular HA coats and HA cables. HA cables can mediate 
monocyte binding and prevent access to potential inflammatory receptors as ICAM-1.
n. BMP-7, a known renal protective cytokine, has a role in HA regulation in the 
proximal tubule cells. BMP-7 increased the formation of HA cables. This increase in 
HA cables resulted in increased monocyte binding which was CD44-dependent. This 
novel anti-inflammatory mechanism of BMP-7 is partially due to its alteration of the 
dynamics of HA metabolism (synthesis and degradation). IL-lp, a known pro- 
inflammatory cytokine, did not stimulate HA cable formation although it stimulated 
HA synthesis.
iii. Hyaluronan synthase 2 (HAS2) over-expression resulted in increased HA 
production by HK-2 cells. This resulted in the formation of big peri-cellular HA coats 
and increased intracellular HA. HA cable formation, however, was reduced. 
Functionally, the peri-cellular coats were shown to be important in cell migration and 
inhibition of HA coat formation resulted in reduction of the enhanced cell migration. 
The reduction in HA cables was associated with a reduction in monocyte binding.
iv. Hyaluronan synthase 3 (HAS3) over-expression also resulted in increased HA 
production. Although HAS3 is known to be the constitutive HAS isoform in HK-2 
cells (unlike the inducible HAS2), over-expression of HAS3 resulted in increased HA 
cable formation in addition to increased peri-cellular HA coats. Functionally, HAS3 
over-expression resulted in enhanced cell migration and increased monocyte binding.
v. HA binding proteins (Hyaladherins) differentially affected extracellular HA 
structures. Inter-alpha-trypsin inhibitor (Ial) is important in the formation of HA 
coats as well as HA cables. Tumour necrosis factor-stimulated gene-6 (TSG-6) is seen 
to be crucial to the formation of HA coats but not HA cables, while the role of 
versican in either structures is not fully determined yet although it is thought to be 
more crucial to the formation of HA cables.
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Chapter I 
General introduction
1.1 The kidney: Functional anatomy and basic physiology
Adult human kidneys are 11-14 cm (about 3 vertebral bodies) in length, and 
are located retroperitoneally on either side of the aorta and inferior vena cava in the 
upper dorsal region of the abdominal cavity. The right kidney is usually a few 
centimetres lower because the liver lies above it. Both kidneys rise and descend 
several centimetres with respiration. Each kidney contains approximately 1 million 
nephrons (functional units; figure 1.1) and weighs approximately 15 g. There is a rich 
blood supply, 20-25% of cardiac output, although there is considerable physiological 
variation in this. Intralobular branches of the renal artery give rise to the glomerular 
afferent arterioles.
Renal functions can be broadly classified into four categories: (z). 
Maintenance of homeostasis via regulation of extracellular fluid volume and 
composition, and acid-base balance. (zz). Hormonogenesis: as the production of renin 
which is important in regulating renal blood pressure, and erythropoietin which 
increases the number of circulating erythrocytes, (iii). Vitamin D3 activation; A 
function performed by the proximal tubule cells, and (zv). Gluconeogenesis: This is 
acquired by the kidney only in unusual circumstances such as prolonged starvation 
and confers the ability to synthesize and secrete glucose produced from non­
carbohydrate sources (such as amino acids) (reviewed in [1]).
The functional unit in the kidney is the “nephron”. Each nephron is composed 
of one glomerulus, a proximal convoluted tubule, a loop of Henle, a distal convoluted 
tubule and a collecting duct. The structure of the nephron is illustrated in figure 1.1B.
The basement membrane around the glomerular capillaries and the cells lying 
on either side of it form the filtration barrier. This allows free passage of water and 
small solutes; cells and large molecules are retained in the glomerular capillaries. 
Variations in the calibre of the afferent and efferent arterioles control the filtration 
pressure at the glomerular basement membrane (GBM). This is normally tightly 
regulated in order to maintain a constant glomerular filtration rate (GFR) despite 
varying systemic blood pressure and renal perfusion pressure. In response to a 
reduction in perfusion pressure, constriction of the efferent arteriole restores filtration
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pressure. This response of the efferent arteriole is dependent on angiotensin II 
production. After leaving the glomerulus, the efferent arteriole goes on to supply the 
distal nephron and medulla [1].
The glomerulus contains three main cell types: endothelial, epithelial and 
mesangial cells. The GBM is produced by fusion of the basement membranes of the 
endothelial and epithelial cells. Both of these cells are specialised in structure and 
function. The glomerular endothelial cells contain pores (fenestrae) which allow 
access of circulating molecules to the underlying GBM. On the other side of the 
GBM, glomerular epithelial cells (podocytes) put out multiple long foot processes 
which interdigitate with those of adjacent epithelial cells. These are non-dividing cells 
whose integrity is critical to the structure and function of the glomerulus. The death of 
the podocytes may lead to adhesion of the underlying GBM to Bowman’s capsule, 
followed by the formation of a focal glomerular scar. The normal filtration barrier 
requires integrity of the junctions between the epithelial cells and the epithelial slit 
diaphragm apparatus as well as the GBM itself. The filtration barrier at the 
glomerulus is normally absolute to proteins the size of albumin (67 kDa) or larger, 
with those of 20 kDa or less able to filter freely. Between these sizes there is a 
gradient of clearance, the behaviour of individual molecules being influenced by their 
shape and charge. Anionic proteins are relatively less freely filtered than cationic 
proteins. Little lipid is filtered. Mesangial cells lie in the central region of the 
glomerulus. They have similarities to vascular smooth muscle cells (e.g. contractility), 
but also some macrophage-like properties. In health, bone marrow-derived 
macrophages are occasionally found in glomeruli and in the interstitium. Tubular cells 
(discussed below) are polarised, with a brush border (proximal tubule), lying on their 
own basement membrane at their base (figure 1.1C and D). Interstitial cells between 
tubules can be classified into two main types. Fibroblast-like cells in the cortex are 
capable of producing erythropoietin in response to hypoxia in addition to its 
production of the ECM components while lipid-laden interstitial cells are believed to 
be important in prostaglandin production and are mostly found in the inner medulla 
[1].
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1.2 Renal proximal tubule cells (PTCs)
1.2.1 Histology
The renal proximal tubule extends from the glomerulus to the thin limb of the 
loop of Henle. Its average length is 15 mm and its diameter approximates 60-70 pm. 
PTCs are the most abundant cell type in the cortex. Cells of the proximal tubule are 
continuous with parietal epithelial cells of the glomerulus (podocytes) while the 
tubular lumen is continuous with the urinary space. In vivo, the proximal tubule is 
lined by a single layer of polarized columnar epithelial cells with characteristic 
features such as (figure 1.1C and D): (i) The presence of tight junctions between cells. 
(ii) Extensive lateral inter-digitations making it difficult to see the outlines of 
individual cells between adjacent cells, (iii) Irregularly-spaced nuclei, (iv) Clear 
vesicles in the apical pole beneath the brush border reflecting extensive apical 
endosomal system and (v) Large numbers of mitochondria, which provide the energy 
source for fluid and electrolyte reabsorption. The apical aspect of the PTCs has a 
special feature of brush borders, which result in a 40-fold increase in the surface area 
of the cells [1].
1.2.2 Function in health and disease
The polarized structure of PTCs is important to maintain their unique function 
in electrolyte, acid-base and solute balance. PTCs also contribute to tubular basement 
membrane formation as they can secrete collagen type IV and laminin.
PTCs are antigen-presenting cells and contribute to the body's ability to 
distinguish its own cells from foreign bodies. PTCs express several key immune 
surface molecules known to assist in the presentation of antigens and to coordinate the 
T-cell response to infection. Examples of these molecules are human leukocyte alleles 
(HLA) class II antigens and adhesion molecules (mainly inter-cellular adhesion 
molecule-1; ICAM-1) (reviewed in [2]). Through a series of soluble and cell-based 
cytokines and cytokine receptors as well as other molecules the blood cell-derived 
immune system and the PTCs communicate and interact with each other. It is 
interesting that PTCs are derived from the same embryonic compartment as bone 
marrow cells, which give rise to the body's blood and immune system. Moreover,
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circulating bone marrow stem cells are capable of engrafting into the kidney and of 
differentiating into renal tubular cells in animal models of acute renal failure [3].
PTCs also have the capacity to acquire a myofibroblastic phenotype during 
renal injury. Transforming growth factor-pl (TGF-pi) is thought to play an important 
role in the regulation of epithelial-mesenchymal transdifferentiation (EMT). Addition 
of TGF-pi resulted in de novo expression of fibroblasts-specific protein-1 (Fsp-1) in 
cultured rat PTCs with the acquisition of fibroblastic markers (such as vimentin and 
a-smooth muscle actin) and loss of epithelial markers (such as cytokeratin) [4].
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1.3 Chronic Renal Failure and End-Stage Renal Disease
Definition, causes and consequences
Chronic renal failure (CRF) is a progressive irreversible loss in renal function 
which classically develops over a period of years. Initially, it is manifested only as a 
biochemical abnormality. Eventually, loss of the excretory, metabolic and endocrine 
functions of the kidney leads to the development of the clinical symptoms and signs 
of renal failure, which are referred to as uraemia. End-stage renal disease (ESRD; 
with glomerular filtration rate [GFR] < 5 ml/min) is the final stage of CRF which is 
incompatible with life without renal replacement therapy.
CRF may be caused by any condition which destroys the normal structure and 
function of the kidney. In about 75% of cases (UK renal registry report 2004), the 
causes are established as: congenital diseases (e.g. polycystic kidney disease 6.1%), 
renal vascular diseases (7.7%; e.g. renal artery stenosis), hypertension (5.1%), 
glomerular disease (9.4%; with IgA nephropathy being the most common in this 
group), pyelonephritis (7.6%), systemic diseases (e.g. diabetes mellitus which is the 
most common specific cause [17.9%] and systemic lupus erythematosus) and 
malignancies (such as myeloma).
The social and economic consequences of CRF are considerable. In Britain, 
about 104 new patients per million of the adult population are accepted for long-term 
dialysis treatment each year. In spite of the availability of dialysis and transplantation 
as treatments, ESRD reduces the life quality and span dramatically with an annual 
mortality in dialysis patients ranging between 10-20% [5].
The incidence of CRF is increasing and currently in Britain the prevalence of 
stages 3-5 CRF (with GFR<60 ml/min/1.73m2) in the general population is estimated 
as 5.1% (UK renal registry report 2004). The progression of CRF can be retarded and 
currently aggressive treatment of hypertension and blockade of angiotensin II by 
angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor 
antagonists in patients with proteinuria are the preferred guidelines. The search for 
other treatment modalities is greatly needed but it requires more understanding of the 
pathogenesis of CRF.
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1.4 'Ribulointerstitial fibrosis
Fibrosis is defined as expansion of stromal elements at the expense of highly 
differentiated parenchymal cells within the tissue. In renal disease, the expansion of 
stromal elements disrupts the kidney architecture and impairs fluid and solute 
exchange. The pathological changes associated with CRF and ESRD are progressive 
expansion of the tubulointerstitial space and subsequent fibrosis. The expansion of the 
interstitial volume is the result of proliferation of fibroblasts within the interstitium, 
infiltration of monocytes and the excessive production of matrix within the 
interstitium by all these cells and by the tubule epithelial cells.
1.4.1 Association with renalfunction
Previous structural-functional studies have shown that pathological changes in 
the tubulointerstitium are more related to deterioration of renal function than other 
histological markers (like glomerular changes) in the kidney [6, 7]. This correlation 
are reported in different renal diseases including diabetic nephropathy [8-10], chronic 
sclerosing interstitial nephritis, mesangioproliferative GN, membranoproliferative GN 
[11, 12] and renal amyloidosis [13]. Furthermore, in experimental models of renal 
disease, treatments that improved renal function appeared to reduce interstitial 
fibrosis. For example, prednisolone administration leads to a reduction in the 
interstitial infiltrate and increment in GFR but had no effect on glomerular sclerosis in 
experimental focal glomerular sclerosis [14] while the response in diabetic 
nephropathy to angiotensin II antagonist treatment is reflected by resolution of 
tubulointerstitial fibrosis and not of glomerulosclerosis [15],
1.4.2 Pathogenesis o f tubulointerstitialfibrosis
Recent studies have focused on the molecular basis of interstitial fibrosis due 
to the strong correlation between the degree of interstitial fibrosis and loss of renal 
function. While glomerulosclerosis often occurs in parallel and may share some 
pathogenetic features, there are likely to be events that are unique to each region of 
the kidney as well. Few growth factors and vasoactive molecules initiate responses 
that culminate in fibrosis while many other factors trigger events that contribute 
indirectly to fibrosis. Observations from in vivo and in vitro experiments in this field
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point to the fact that it is unlikely that any single molecule acting in isolation will be 
able to trigger the full spectrum of fibrotic events. The fibrogenic cascade has been 
arbitrarily divided into 4 sequential phases [16]: Cellular activation and injury phase, 
the fibrogenic signalling phase, the fibrogenic phase and finally, the destructive phase.
L Cellular activation & injury phase: subdivided into:
A. Tubular cell activation
In response to various injurious stimuli, tubular cells begin to produce 
molecules that propagate renal injury, facilitate interstitial inflammation and/or 
directly contribute to fibrosis (figure 1.2). PTCs are capable of producing various 
cytokines including: TGF-pl [17], ET-1 [18], TNF-a [19], PDGF-B and IL-6 [20], 
MCP-1 [21] and IL-8 [22]. In addition, PTCs express receptors for a number of these 
molecules [19, 23-26]. The tubular cells may be exposed to bioactive molecules that 
originate in the plasma or inflamed glomeruli and appear in the glomerular ultra­
filtrate (apical activation) [27]. In some diseases such as diabetes, PTCs may be 
exposed to conditions of elevated glucose either apically as a result of glycosuria, or 
basally as a result of elevated interstitial tissue concentrations of glucose. Regarding 
diabetes, in vitro studies have shown that high glucose conditions applied apically or 
basolaterally produced the same incremental effect on fibronectin secretion that was 
detected in the basolateral compartment only [28] while TGF-pl production is only 
triggered by basolateral exposure to glucose. In addition, high glucose conditions 
induced type IV collagen secretion and reduced net gelatinolytic activity [29]. Tubular 
activation may also be modulated in response to other events that occur during the 
course of chronic renal disease including increased filtration of other urinary proteins 
(chemoattractants, complement proteins and cytokines), increased ammoniogenesis, 
ischaemia, lipiduria, tubular hypermetabolism and tubulointerstitial crystal deposition 
[30].
B. Inflammatory cell infiltration
Regardless of aetiology, progressive renal disease is characterized 
histologically by an interstitial infiltrate of mononuclear cells. Circulating leukocytes 
migrate from blood vessels into tissues under both normal and pathological 
conditions. In inflammation, their capture and subsequent migration is a multi-step 
process involving rolling, activation and firm adhesion to the endothelial cells
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followed by transmigration into the underlying tissue. This process is characterized by 
the sequential activation of adhesion molecules and their ligands on both leukocytes 
and endothelial cells following a co-ordinated response to inflammatory mediators 
[31,32].
Leukocyte adhesion molecules such as selectins, leukocyte integrins and 
members of the immunoglobulin super family (ICAMs and VCAMs play a vital role 
in the process of leukocyte recruitment (discussed below). Each of these adhesion 
molecules has its own mode of action that facilitates the co-ordinated sequence of 
events which results in the presentation of leukocytes to the inflammatory site. In 
chronic renal disease, the tubules have been noted to express de novo or to up-regulate 
their expression of several leukocyte adhesion molecules as ICAM-1, VCAM-1 and 
osteopontin that may facilitate mononuclear cell recruitment [33-36].
As a source of several profibrotic molecules, monocytes and macrophages in 
particular are thought to directly contribute to the fibrogenic process [37]. Although 
most of these cells have migrated from the circulation through the peritubular 
capillary endothelium into the interstitial space, some may originate from in situ 
proliferation of resident interstitial macrophages and in anti-GBM GN, local 
macrophage proliferation represents the major mechanism of macrophage 
accumulation during the progression of the disease [38]. Chemotactic cytokines 
(chemokines) such as MCP-1 are believed to play an important role in monocyte 
recruitment. PTCs increase MCP-1 production when stimulated with 
pathophysiologically relevant concentrations of albumin through NF-kB activation 
[39]. MCP-1 production has been reported in vivo in both human disease [40] and in 
animal models of chronic renal disease [35, 41, 42]. Other potent monocyte 
chemoattractants that have been implicated in the pathogenesis of tubulointerstitial 
disease include: 1. Complement proteins (such as C3a and C5a) which are activated 
by tubular cells via the alternative complement pathway [43] and may also be 
produced (C3 mainly) by PTCs when they are stimulated with serum proteins [44]. 2. 
Macrophage-stimulating protein (MSP): a member of the plasminogen-related growth 
factors which is produced in the kidney solely by the tubular cells and leads to the 
induction of growth, migration, invasion and IL-6 synthesis in mesangial cells [45] in
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addition to its known macrophage-stimulating effects [46, 47]. 3. Albumin binding 
neutral lipid [48]. 4. Oxidized low-density lipoproteins [49].
C. Appearance o f interstitial myofibroblasts and the activation o f interstitial 
fibroblasts
This event is also considered as a prerequisite for renal fibrosis. Studies of 
human renal biopsies indicate that the presence of interstitial myofibroblasts 
correlates with the risk of progressive renal disease [50-52]. Myofibroblasts are 
characterized by their expression of a-smooth muscle actin and ED-A fibronectin 
[53], which are not expressed by normal fibroblasts. In addition to their unique 
phenotype, myofibroblasts are considerably more profibrotic than resident interstitial 
fibroblasts although their origin is a subject of controversy. Theories include 
differentiation and/or proliferation of resident fibroblasts [54], migration of 
perivascular cells and/or transdifferentiation and migration of tubular cells [55]. The 
transformation of the phenotype, function and number of tubular interstitial cells sets 
the stage for subsequent events. At this early phase, renal damage may be repaired 
and kidney function restored to normal levels. However, if renal injury persists passed 
this point, changes in tubular cells and ongoing interstitial inflammation will result in 
destructive renal scarring [16].
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Figure 1.2: Cellular activation and injury phase.
The initial renal insult may have tubular effects that lead to the production and release 
of proinflammatory and injurious molecules, triggering interstitial inflammation and 
ongoing tubulointerstitial damage. Activation of peritubular capillary endothelial cells 
may facilitate the recruitment of interstitial mononuclear cells. Left unchecked, these 
cellular changes lead to the activation of interstitial fibroblasts and the appearance of 
interstitial myofibroblasts. Modified from Eddy et al. [16].
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2, Fibrogenic signalling phase
Coincident with, or as a consequence of the cellular events, a series of 
molecules are elaborated and their cognate receptors expressed by tubular interstitial 
cells to result in matrix accumulation along tubular basement membranes and within 
the interstitial space. These include TGF-P [30], connective tissue growth factor 
(CTGF)[56, 57], angiotensin II [58, 59], ET-1 [60], PDGF [61-63], fibroblast growth 
factor (FGF) [64,65], TNF-a [66] and interleukin-1 (IL-1) [67].
One of the fundamental pathways to fibrogenesis is dominated by TGF-p [16]. 
This is known to be an important regulator of interstitial matrix production and its 
over-production has been associated with renal fibrosis [16]. Three mammalian 
isoforms have been identified although only TGF-p 1 has been extensively 
investigated with regards to renal fibrosis. Both resident kidney cells and infiltrating 
leukocytes may be stimulated to produce latent TGF-p. It may also be filtered from 
the plasma during proteinuria [68]. Numerous factors are known to stimulate its 
production including angiotensin II, ET-1, ischaemia, high glucose and insulin [69- 
72]. It may also induce its own expression [30].
Activation of TGF-p triggers several events that promote fibrosis. This 
includes the transcription of matrix-encoding genes, inhibitors of matrix degrading 
enzymes, inhibition of matrix binding integrin receptors, transformation of fibroblasts 
into myofibroblasts, transdifferentiation of tubular epithelial cells into myofibroblasts 
and chemotaxis of fibroblasts and monocytes [30]. Up-regulated expression of TGF-P 
is a feature of all human and experimental models of renal fibrosis. For example, 
transgenic mice over-expressing TGF-p develop glomerular and interstitial fibrosis 
[73, 74]. In addition, treatment of rats with replication-defective adenoviral vectors 
that express the soluble TGF-p type II receptor attenuates interstitial collagen 
accumulation in models of proteinuria and ureteral obstruction [75].
Antifibrotic factors
While the kidney is producing cytokines and growth factors that promote 
fibrosis, it is possible that other factors may be released to counteract these effects. 
Examples of these antifibrotic factors include: interferon gamma (IF-y), hepatocyte
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growth factor (HGF), insulin-like growth factor-1 (IGF-1) and BMP-7 [16]. IFN-y 
significantly decreases interstitial collagen accumulation when infused directly into 
the kidney [66]. HGF treatment of nephritic mice has been reported to inhibit 
tubulointerstitial fibrosis via a significant reduction in renal production of PDGF and 
TGF-P and interstitial myofibroblast formation [76]. TGF-p is also known to inhibit 
HGF formation, illustrating reciprocal interactions between these pro- and antifibrotic 
growth factors [68]. However, the discovery that HGF-over-expressing mice develop 
cystic renal disease and glomeruloscekosis [77] illustrates the need for further studies 
to clarify the role of HGF in renal fibrosis. IGF-1 has been shown to significantly 
reduce interstitial collagen accumulation in neonatal rats with obstructive uropathy 
[78] while in a different setting, IGF-1 may promote fibrotic effects [79]. The anti­
fibrotic effects of BMP-7 will be discussed in detail below.
3. Fibrogenic phase
The synthesis, secretion and activation of one or more of the fibrogenic 
molecules by tubulointerstitial cells results in the activation of a new group of genes 
that lead to the accumulation of ECM proteins within the interstitial space. Generally, 
2 processes can lead to excessive accumulation of matrix proteins which causes 
progressive renal scarring: a. increased synthesis and b. decreased degradation [16].
Excessive ECMproduction
Evidence for increased matrix protein synthesis includes increased matrix 
gene mRNA levels in the kidney, noting that transcription is the rate-limiting step of 
protein expression for most matrix molecules, and the de novo appearance of proteins 
that are not normally present in the renal interstitium [16]. The interstitial scar 
consists of several molecules and the unique functional role of each constituent 
remains unclear. These include normal interstitial matrix proteins (collagens I, III, V, 
VII, XV and fibronectin) and matrix proteins that are usually restricted to tubular 
basement membranes (collagen IV and laminin) (reviewed in [30]). Limited in situ 
hybridization studies indicate that interstitial myofibroblasts are the primary source of 
these proteins although tubular cells and other interstitial cells may contribute as well 
[80]. Novel proteins include splice variants of fibronectin and novel chains of laminin
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and type IV collagen that are produced by damaged kidneys. In addition to providing 
structural support, these matrix proteins also interact with cellular receptors especially 
of the integrin family. As a consequence, the nature of the interstitial matrix may 
significantly influence the behaviour of the neighbouring cells. Fibronectin also has 
chemotactic properties that may perpetuate interstitial inflammation [16].
The interstitial scar can be viewed as a dynamic scaffold that changes as the 
renal disease progresses. Initially, the scaffold is relatively unstable and susceptible to 
degradation. With time, cross-linking bridges add stability and confer relative 
resistance to proteases. This maturing process is poorly understood but may involve 
enzymatic modification by glycosylation, oxidation or transglutamination [81]. 
Changes in matrix composition such as the ratio of collagen I to collagen III may also 
contribute to the stabilizing process.
Another class of molecules that plays an essential role in the composition of 
the interstitium are secreted proteoglycans, whose core protein is covalently bound to 
high molecular weight glycosaminoglycans such as chondroitin and heparin sulphate. 
Proteoglycans may act as a potential reservoir for growth factors such as bFGF and 
TGF-p. These sequestered growth factors are generally inactive but represent a 
reserve that could be readily mobilized. Decorin and biglycan are small proteoglycans 
that have the ability to bind and inhibit TGF-p. They too may accumulate in the 
kidney during progressive scarring [82-84].
Impaired matrix remodelling and decreased ECM degradation
Matrix remodelling is the result of multiple concurrent processes that vary 
according to the initiating stimulus. The processes during renal fibrosis not only 
involve changes that stabilize the scaffold, but events that may also break down and 
degrade some of the proteins [16]. A key step during the initiation of renal fibrosis is 
the production of protease inhibitors. At exactly the same time that matrix synthesis is 
accelerated, the enzymatic machinery that regulates this process by degradative 
remodelling is inactivated. The potential power of this process should not be 
underestimated considering that early renal fibrotic lesions can be completely 
reversed, presumably by matrix-degrading protease activity, if the primary process is
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halted. As examples, reversible tubulointerstitial fibrosis has been demonstrated in 
rats with acute nephrotic syndrome [85] and in humans with diabetic nephropathy 
[86]. It is possible that some types of progressive renal disease are caused by 
impairment of renal collagenolytic activity alone with little or no change in the rate of 
collagen synthesis. This has been demonstrated in rats that develop renal fibrosis after 
ligation of a renal vein or ureter [87]. Several matrix-degrading proteases are 
synthesized by normal kidney cells and are thought to help maintain normal renal 
architecture. The most prominent proteases are members of the matrix 
metalloproteinase (MMP) family although the serine proteinases (plasmin and 
cathepsin G) and the lysosomal cysteine proteases (cathepsin B, H and L) may also be 
active in the kidney [16]. Based on their perceived specificity for matrix proteins, 
MMPs have been sub-divided into four groups: collagenases, gelatinases, 
stromelysins and matrilysins. However, the high degree of overlap among MMP 
substrate specificities and the notion that MMPs can cleave a growing list of 
substrates that are not part of the ECM [88, 89] render this nomenclature imprecise. In 
addition to their matrix-degrading activity, MMPs are reported to have a wide range 
of cellular effects such as stimulating activation and proliferation (Table 1.1).
The major contributory role of tubular epithelial cells to MMP production has 
been emphasized by the study of Zaoui et al. [90] in which sequential assessment of 
MMP-2 and -9 in cortical, glomerular, tubular and urinary extracts showed increasing 
release of gelatinases (MMP-2 and -9) along the nephron segments in fructose-fed rats 
(a Diabetes Mellitus type II model) compared to control rats. In addition, areas of 
glomeruloscelrosis and tubular atrophy were concurrently stained with anti-MMP-9 
antibody along with a-smooth muscle actin (a marker of myofibroblastic 
differentiation).
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Table 1.1: Biological activities generated by MMP-mediated cleavage.
Modified from Visse et al. [91].
Biological Effect Responsible MMPs Substrate Cleaved
Keratinocyte migration and re- 
epithelialization
MMP-1 Type I collagen
Osteoclast activation MMP-13 Type I collagen
Neurite outgrowth MMP-2 Chondroitin sulphate 
proteoglycan
Adipocyte differentiation MMP-7 Fibronectin
Cell migration MMP-1,- 2, -3 
MT1-MMP
Fibronectin
CD44
Mammary epithelial cell 
apoptosis
MMP-3 Basement membrane
Epithelial-mesenchymal 
conversion (mammary epithelial 
cells)
MMP-3 E-cadherin
Mesenchymal cell differentiation 
with inflammatory phenotype
MMP-2 Not identified
Generation of angiostatin-like 
fragment
MMP-3,-7, -9 & -12 Plasminogen
Generation of endostatin-like 
fragment
MMPs Type XVIII collagen
Enhanced collagen affinity MMP-2, -3, -7, -9, - 
13 (but not MMP-1)
BM-40
(SPARC/osteonectin)
Kidney tubulogenesis MT1-MMP Type I collagen
Increased bioavailability of IGF 1 
and cell proliferation
MMP-1, -2, -3 
MMPs 
MMP-11
IGFBP-3
IGFBP-5
IGFBP-1
Activation of VEGF MMPs CTGF
Epithelial cell migration MMP-2, MT1-MMP Laminin 5y2 chain
Apoptosis (amnion epithelial 
cells)
Collagenase Type I collagen
Pro-inflammatory MMP-1,-3, -9 Processing IL-1B from 
the precursor
Tumor cell resistance MMP-9 ICAM-1
Anti-inflammatory MMP-1, -2, -9 
MMP-1,-2, -3,-13,- 
14
IL-lp degradation 
MCP-3
Increased bioavailability of 
TGF-3
MMP-2, -3, -7 Decorin
Disrupted cell aggregation and 
increased cell invasion
MMP-3, MMP-7 E-cadherin
Reduced cell adhesion and 
spreading
MT1-MMP, MT2- 
MMP, MT3-MMP
Cell surface tissue 
transglutaminase
Fas receptor-mediated apoptosis MMP-7 Fas ligand
Reduced IL-2 response MMP-9 IL-2Ra
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4. The destructive phase
As matrix proteins continue to accumulate within and expand the interstitial 
space, they begin to have destructive effects on kidney structures and subsequently 
function [16]. The increasing interstitial matrix isolates tubules from their oxygen 
supply (post-glomerular peritubular capillaries) in addition to its destructive effect on 
the capillaries themselves. Therefore, two main histological features are noted here: 
loss of renal tubules and loss of peritubular capillaries [92]. While the tubules 
atrophy, sometimes the glomeruli remain unaffected or slightly affected. Glomeruli 
that lack their distal nephron segment (i.e. atubular) are non-functional [93]. The 
hypoxic impulse is thought to have an important role in this phase as tubular cells 
exposed to hypoxic conditions in vitro show decreased MMP activity and increased 
synthesis of collagen [94].
Although it is evident now that the process of renal fibrosis is very 
complicated with many players at the cellular and molecular level, new studies have 
begun to identify possible targets for therapeutic interventions with a view of slowing, 
preventing and in some cases even reversing renal scar formation.
1.5 Bone Morphogenic Protein-7 (BMP-7)
1.5.1 Bone Morphogenic Proteins
Over the past 20 years, members of one subgroup of the transforming growth 
factor-p subfamily, named generically bone morphogenic proteins (BMPs), have been 
recognized as critical in controlling organogenesis (reviewed in [95]). Comprising an 
ever-growing number of identified homologs, the BMPs represent almost one third of 
the TGF-p subfamily, with more than 30 members already described. Individually, the 
members of this subfamily of secreted molecules are termed either BMPs, osteogenic 
proteins (OPs), cartilage-derived morphogenic proteins (CDMPs), or growth and 
differentiation factors (GDFs). They have been classified into several subgroups 
according to their structural similarities (table 1.2). The molecular cloning of many 
BMP-encoding genes and their identification as TGF-p relatives enhanced the interest 
in these molecules and allowed expression and functional studies to be performed. 
Unexpectedly, given the nature of the assay that led to the identification of these
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proteins, it became rapidly evident that their patterns of expression, as well as then- 
physiological functions, were not restricted to skeleton development. Other functions 
of BMPs include cell proliferation and differentiation, apoptosis, morphogenesis, 
patterning of various organs, including the kidney and the skeleton and general 
organogenesis.
2.5.2 BMP-7: nature and expression
BMP-7 (also called osteogenic protein-1; OP-1) is a homodimeric member of 
the BMP subfamily whose broad expression has been extensively studied [96, 97]. As 
other members of the family, BMP-7 is synthesized as large precursor proteins that 
undergo proteolytic processing at RXXR sites to yield mature active dimers of 
disulfide-linked monomers [98]. The three-dimensional structure of the protein was 
reported in 1996 by Griffith et al. [99].
BMP-7 starts to be expressed during early gastrulation, localizing in the 
ectoderm at the periphery of the embryo. At 8.5 and 9.5 days post-coitum (dpc), 
BMP-7 is strongly expressed in the surface ectoderm and the notochord, in the 
neuroepithelium extending toward the prospective forebrain, and in die developing 
gut [96]. BMP-7 is also expressed in the atrial and ventricular chambers of the heart. 
This expression in the heart continues throughout development. During eye 
development, BMP-7 expression is detected in the surface ectoderm, the lens placode, 
and the optic vesicle [96]. In the developing skeleton, BMP-7 is expressed in the 
developing limb, in the mesenchymal cells localized between the developing digits, 
and in the chondrogenic zones. In many cells of the developing kidney, BMP-7 plays 
a critical role. At 9.5 dpc, BMP-7 transcripts are detected in the Wolffian ducts, which 
give rise to the ureteric buds. At 12.5 dpc, BMP-7 is expressed, predominantly, in the 
ureteric bud epithelium but weaker expression is also detected in the surrounding 
condensed mesenchymal cells. Later on, its transcripts are present in the same 
structures but also in the peritubular aggregates and the podocytes of the glomeruli 
[100, 101]. BMP-7 can also promote nephrogenesis by isolated metanephric 
mesenchyme [102], and act as a survival factor for the nephrogenic mesenchyme by 
preventing apoptosis and expanding the progenitor cell population in conjunction with 
basic fibroblast growth factor (bFGF) [103]. Also worth noting is that BMP-7 is the
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only member of the BMPs for which expression is not overlapped in the metanephric 
mesenchyme, suggesting the possibility of a unique role for BMP-7 in metanephric 
development.
Consistent with their wide pattern of expression, mutations in BMP-encoding 
genes can affect many organogenetic processes. Some of these mutations cause early 
embryonic lethality precluding, for now, the analysis of the role of these proteins 
during skeleton development. The deletion of the gene encoding BMP-7 causes a 
perinatal lethality in mice caused by uraemia. In the absence of BMP-7 there is a 
failure of kidney morphogenesis, the deficient mice exhibiting small dysgenic kidneys 
that have less than 3 glomeruli per histological section compared with approximately 
100 in normal mice. This defect was tracked down to an epithelial-mesenchymal 
interaction occurring between 12.0 and 12.5 dpc and leading to cell death of the 
metanephric mesenchymal cells [100, 101]. A series of molecular analyses suggest 
that BMP-7 is one of the earliest glomerular inducers.
In the adult animal, BMP-7 expression subsides in other organs but remains 
high in the kidney. BMP-7 RNA expression in the normal kidney is largely confined 
to the medullary tubules (tentatively identified as collecting tubules), peripheral 
glomerular cells (presumptive podocytes) and renal artery adventitial cells [104,105]. 
The study by Gould et al. confirmed the previous reports and showed that BMP-7 
expression is detectable in mouse collecting duct, thick ascending limb, distal 
convoluted tubule and podocytes within glomeruli with no expression in the proximal 
tubule cells [106]. Nevertheless, PTCs expressed mRNA for known BMP receptors 
including: ActR-I, BMPR-IA, ActR-II, ActR-IIB and BMPR-II [106]. However, the 
physiological functions of BMP-7 in the adult kidney, unlike the pathophysiological 
effects, remain unclear.
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Table 1.2: Bone morphogenic protein superfamily.
Modified from von Bubnoff et al. [95].
BMP Major tissue of 
expression
Other names Mammalian cDNA 
sequenced
BMP-2 Cartilage, bone BMP-2a Bovine, human, mouse, rat, 
reindeer
BMP-3 Cartilage, bone, 
ovary
Osteogenin Bovine, human, rat
BMP-3b Muscle, bone, 
brain, lung
GDF-10 Human, rat, mouse, 
reindeer
BMP-4 Cartilage, bone, 
prostate
BMP-2b Human, mouse, reindeer
BMP-5 Bone Bovine, human
BMP-6 Cartilage Vgr-1 Bovine, human, mouse, rat
BMP-7 Bone, kidney OP-1 Bovine, human, mouse, rat
BMP-8a,b Testis, placenta OP-2, OP-3 Human, mouse
BMP-9 Liver GDF-2 Human
BMP-10 Bone, heart Human, mouse
BMP-11 Neurogenesis Human, mouse
BMP-12 Cartilage GDF-7,
CDMB-3
Human, mouse
BMP-13 Cartilage GDF-6,
CDMB-2
Human, mouse, bovine
BMP-14 Cartilage GDF-5,
CDMB-1
Bovine, mouse, human
BMP-15 Oocytes GDF-9 Human, mouse
1.5.3 BMP-7 in renal diseases
It is known now that during renal injury, BMP-7 expression in the kidney is 
decreased as well as BMP-7 serum levels [107]. Recent studies have shown that 
BMP-7 prevents kidney damage in vivo in numerous animal models of disease. In 
models of renal ischaemia, administration of BMP-7 reduces severity of renal injury 
and suppresses inflammation by down-regulation of intercellular adhesion molecules 
[104]. Interstitial inflammation and fibrogenesis associated with unilateral ureteral 
obstruction (UUO) are also prevented in vivo by administration of BMP-7 [108]. This 
is consistent with in vivo studies demonstrating counteraction of TGF-p 1-induced 
epithelial-to-mesenchymal transition and reversal of chronic renal injury in the 
nephrotoxic serum nephritis model by BMP-7 [109]. In the streptozocin model of 
diabetic nephropathy, BMP-7 therapy markedly ameliorated glomerular pathology, 
decreased tubulointerstitial volume and reduced proteinuria [110].
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In vitro studies shed some further light on the mechanistic basis of the mode of 
action of BMP-7. In mesangial cells, BMP-7 reduces TGF-p 1-induced ECM effects 
[111]. Specific membrane-bound, high affinity BMP-7 receptors have also been 
characterised on adult rat kidney tubular cells [112]. BMP-7 also antagonises TNFa- 
stimulated increases in expression of pro-inflammatory cytokines and chemokines in 
PTCs [106]. This is of particular significance as it is clear that progression of renal 
disease best correlates with the degree of interstitial fibrosis [10, 113-115]. Recent in 
vitro studies suggest that BMP-7 counteracts TGF-p 1 mediated changes in PTC 
phenotype, favouring retention of an epithelial cell phenotype, and inhibiting the 
epithelial-to-mesenchymal transition [109]. This resulted from a direct Smad- 
dependent counteraction of the TGF-p 1 signalling pathway by BMP-7, which 
reversed chronic renal injury. Interestingly although these data suggest that BMP-7 
may modify PTC response to TGF-pi, at least in vitro, BMP-7 does not directly affect 
expression of TGF-p 1 [116].
1.6 Leukocyte adhesion molecules
The infiltration of leukocytes to sites of injury is a highly complex but well- 
orchestrated event. When injury occurs, a number of relatively small proteins (like 
cytokines, chemokines and products of infectious agents) are released from the site of 
damage. These in turn up-regulate a variety of carbohydrate-rich protein molecules, 
on the endothelial cell surfaces of the blood vessels in the area, that are capable of 
slowing down, selecting and firmly capturing leukocytes [117]. The class of 
leukocytes captured initially depends on the array of adhesion molecules on the 
endothelium. The major steps of adhesion, described primarily for neutrophils, have 
included a primary event, during which leukocytes are engaged by the vessel wall and 
then retarded by a repeated transient interaction, followed by release. This results in a 
stuttered traversing of the length of the vessel known as “rolling”, which is followed 
by a secondary firm adhesion of the rolling cells and subsequent transmigration [31, 
32], Primary adhesion is attributed in many systems to the interaction between the 
lectin domain of members of the selectin family and their carbohydrate ligands on 
endothelial cells, whereas secondary adhesion is due to heterodimeric P2 integrins
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interacting with their endothelial cell ligands (members of the immunoglobulin 
superfamily) (reviewed in [118]).
1.6.1 The immunoglobulin superfamUy (IgSF)
Since the concept of the immunoglobulin superfamily was proposed in 1982 
[119], it has been expanded to embrace over 70 members, including both single- and 
multi-gene representatives. The IgSF represent a group of structurally heterogeneous 
proteins that contain at least one extracellular Ig domain and all cells of the body 
express members of this IgSF.
ICAM-1 (CD54) is a transmembrane glycoprotein of 505 amino acids with a 
molecular weight ranging between 80-114 kDa depending on cell type (due to 
differences in the degree of glycosylation). ICAM-1 expression can be detected in a 
number of cell types, including monocytes and endothelial cells. Its expression, 
however, is widely inducible in many cells including B and T lymphocytes, 
thymocytes, dendritic cells, endothelial cells, fibroblasts, keratinocytes, chondrocytes 
and epithelial cells [120]. In the kidney, unstimulated PTCs show little ICAM-1 
expression which is inducible by TNF-a or IF-y [121]. Ligands for ICAM-1 are: 
LFA-1 (CD18/CDlla) [122], which is highly expressed by monocytes [123], Mac-1 
(CD18/CDllb) [124] and CD43 [125].
VCAM-1 (CD 106) is another member of the IgSF consisting of 720 amino 
acids with a molecular weight of about 25 kDa. It is mainly a cytokine-induced (IL-1, 
TNF-a) molecule that is found in endothelial cells [126], mesenchymal cells [127, 
128]. Normally, PTCs don’t express VCAM-1 but expression is up-regulated when 
PTCs are stimulated with TNF-a or IF-y [121]. The preferred ligand for VCAM-1 is 
VLA-4 (a4pl integrin) [129] although it can bind to other integrins such as a4p7 
[130].
Although the IgSF contains many members, only ICAM-1 and VCAM-1 are 
known to mediate leukocyte adhesion to non-endothelial cells such as fibroblasts and 
epithelial cells [131]. Therefore, they are the most likely members of the IgSF to 
participate in leukocyte accumulation in extravascular tissue.
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1.6,2 The integrin family
The integrins are a family of heterodimeric membrane glycoproteins expressed 
on diverse cell types which function as the major receptors for ECM and as cell-cell 
adhesion molecules. All integrins consist of two-covalently associated subunits, a  and 
p. As adhesion molecules, the integrins play an important role in numerous biological 
processes such as platelet aggregation, inflammation, immune function, wound 
healing, tumour metastasis and tissue migration during embryogenesis [132]. The 
main “leukocyte-borne” integrins are: LFA-1, Mac-1, VLA-4 and a4p7.
Lymphocyte-function associate molecule-1 (LFA-1 or CD 11 a/CD 18) is aLp2 
integrin that is restricted to the haematopoietic tissue. LFA-1 is mainly constitutively 
expressed on most leukocyte populations, being especially abundant on lymphocytes 
and monocytes, but it is also up-regulated in activated T-cells [133]. LFA-1 has a key 
role in mediating leukocyte adhesion to endothelium during inflammatory responses 
through binding to ICAM-1. It is also involved in most immune phenomena involving 
T lymphocytes such as adhesion of cytotoxic T cells to their target cells, mixed 
lymphocyte reactions, antigen-specific and ConA-induced T cell proliferation, and T 
cell-dependent antibody response (reviewed in [134]). More recently in vitro 
experiments showed that interaction between monocytic LFA-1 and PTCs ICAM-1 
results in activation of PTCs and increased generation of TGF-pl [135].
Leukocyte adhesion receptor Mol (Mac-1 or CD 1 lb/CD 18) is another P2 
integrin (aMp2) that requires activation to engage in its reaction to ICAM-1. It is 
present on blood monocytes, macrophages and granulocytes. Mac-1 mediates PMN 
and monocyte adherence to endothelium and subsequently PMN extravasation to sites 
of inflammation [136, 137]. Mac-1 also binds complement fragment iC3b, which 
stimulates chemotaxis, phagocytosis and apoptosis by the leukocytes [138]. 
Additionally, fibrinogen, microbial products and denatured proteins may bind to this 
aM-type integrin [138].
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1.6.3 The selectin family
Despite the diminutive size of the family (three members) and the fact that 
protein sequences were obtained in 1989, there is already an extensive literature on 
the selectins. The reason behind this productivity is the strong evidence that E-, P- and 
L-selectins are involved in the inflammatory response and therefore represent novel 
therapeutic targets. All the selectins are structurally similar and recognise the same 
carbohydrate moieties sialyl Lewis* and sialyl Lewis8 and other sulphate-modified 
forms and their interactions are Ca+2-dependent [132]. L- and P-selectins (but not E- 
selectin) are also reported to bind versican through its CS chains [139]. E-selectin 
(also termed CD62E and endothelial leukocyte adhesion molecule-1; ELAM-1) is 
expressed mainly on the endothelium. P-selectin (CD62P) is expressed on platelets, 
endothelial cells and megakaryocytes, while L-selectin (leukocyte adhesion molecule- 
1; LAM-1) is expressed exclusively on haematopoietic cells like neutrophils and 
leukocytes [140, 141]. In terms of functionality, all the selectins are involved in 
mediating PMN, lymphocyte and monocyte “rolling” on the endothelial cells at 
inflammatory sites [132], which is considered a key early step in the cascade of events 
required for leukocyte egress from the blood vessel. It is worth noting here that not all 
primary “rolling” interactions are mediated by the selectin adhesion molecules, in 
clonal lymphoid B and T cells as well as activated normal lymphocytes this 
interaction is primarily mediated by CD44/HA interaction [142].
1.7 Hyaluronan (HA)
1.7.1 History and nature
HA {synonymous hyaluronic acid, hyaluronate; from Greek hyaloid [vitreous] 
and uronic acid) was discovered in the vitreous humour and characterized as a 
polysaccharide by Meyer & Palmer in 1934 [143]. Its exact chemical structure was 
elucidated 20 years after its discovery [144]. Since its discovery, HA has been 
detected in all vertebrate organs and fluids studied with the highest concentrations 
found in loose connective tissues. For a long time HA was regarded as an inert filling 
material between the cells and hence attracted little attention. About forty years after 
its discovery, HA was used as therapeutic agent to treat the joints of track horses 
[145] and in the 1980s, HA became an established aid in ophthalmic surgery [146,
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147]. Nowadays, HA has many different clinical applications which will be discussed 
below.
HA belongs to the glycoaminoglycan (GAG) family (formerly known as acid 
mucopolysaccharides) and is made of a repeated sequence of D-glucuronic acid and 
D-N-acetylglucosamine residues that are linked together via alternating p-1,4 and p-
1,3 glycosidic bonds [144]. This disaccharide structure (figure 1.3) is then repeated to 
form a hyaluronan molecule or HA chain.
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Figure 1.3: Chemical structure of HA: The repeating disaccharide unit is made of 
D-glucuronic acid (GlcUA) and D-N-acetylglucosamine (GlcNAc) linked via 
alternating p-1,4 and p-1,3 glycosidic bonds.
HA differs from other GAGs in many aspects. All GAGs, apart from HA, 
contain sulphate groups and their polysaccharide chains are relatively short (<50 kDa, 
commonly between 15-20 kDa), while the number of repeat disaccharides in a 
completed HA chain can approach 30,000 units in some tissues. It can, therefore, have 
a molecular mass of up to 10 x 106 Da and an extended length of more than 15 pm if 
straightened (figure 1.4) (reviewed in [148]). In addition, HA, unlike other GAGs, is 
not associated with a core protein and it is considered as the sole GAG that’s 
produced by both mammalian cells and bacteria. In free solution under physiological 
conditions of pH and strength, HA forms a stiffened and expanded random coil due to 
hydrogen bonding of adjacent sugar units and mutual repulsion between carboxyl 
groups. In dilute solution it occupies a very large solvent domain but as the 
concentration increases, individual molecules entangle and form a continuous
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network. Its conformation can also be modified by interaction with numerous specific 
binding proteins (discussed later).
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Figure 1.4: Electron micrograph of intertwined HA cables: deposited on a flat 
surface and rotary shadowed with heavy metal for contrast (taken from [149]).
1.7.2 HA distribution in mammalian organs and tissues
A painstaking analysis of the body of the rat by Reed et al. [150] should be 
broadly applicable to other mammals. About 56% of total HA was recovered from 
skin and -27% from the skeleton and joints. The remaining HA was from muscles 
and internal viscera. Comparative studies in other mammals showed that the highest 
HA concentration is found in typical connective tissues such as umbilical cord, 
synovial fluid, skin and vitreous body [151, 152]. Notable amounts are also present in 
the kidney, lung and brain but very little in the liver. The lowest concentration is 
found in blood serum [153]. Regarding HA distribution in normal kidney, most of the 
HA is concentrated in the renal papillae with minimal amount in the cortex [154].
1.7.3 HA biosynthesis
Before conclusive reports from 2 laboratories confirmed that HA synthesis 
occurred at the inner surface of the plasma membrane [155, 156], HA was thought to 
be synthesised in the Golgi apparatus (like most GAGs) as based on electron 
microscopic autoradiography of cells labelled with 3H-glucosamine [157]. However, 
metabolic labelling with 3H-glucosamine is not a reliable marker for HA, since it will
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be incorporated into many other GAGs. Other reports raised more doubts about the 
direct involvement of the Golgi apparatus in HA synthesis: HA synthesis was not 
inhibited by monensin, which interferes with secretion in trans-Golgi vesicles [158]. 
HA synthesis did not require a protein primer [159] or lipid intermediates [160] and it 
was not inhibited by cycloheximide [161], xylosides [162] or tunicamycin [163]. 
Adding to the controversy, Goldberg et al hypothesised that synthesis at the plasma 
membrane represents an “alternative” synthetic pathway as their findings showed that 
the ionophore monensin inhibits extracellular accumulation of HA in rat fibrosarcoma 
cells but not in human articular chondrocytes or rat chondrosarcoma cells [164]. This 
is due, as speculated by Philipson et a l [155], to the interruption of transport of the 
HA synthase to the cell surface.
HA is synthesized in the plasma membrane by a membrane-bound protein 
(termed HA synthase or HAS; figure 1.5) whose genetic code was determined in 
bacteria, mouse and human before the end of the last century. Four cDNAs have been 
identified and cloned in humans, and are numbered in the order they were discovered; 
HAS1 [165], HAS2 [166] and HAS3 (two isoforms) [167]. The chromosomal 
locations for the human HAS genes have also been elucidated, with HAS1 at 19ql3.3- 
13.4, HAS2 at 8q24.12 and HAS3 at 16q22.1 [167]. The HAS enzyme adds sugar 
units from nucleotide precursors to the chain on the cytoplasmic aspect of the 
membrane and translocates the growing chain to the pericellular space and unlike the 
synthesis of other GAGs, HA synthesis occurs at the reducing end of the chain [168]. 
It is worth noting here that to date more than 20 HA synthases have been recognized 
in a variety of organisms, all these but one (isolated from Pasteurella multocida) 
comprise a family of proteins with shared structural and mechanistic features 
(reviewed by Weigel et a l [169]).
Although it is widely accepted that HA synthesis occurs at the plasma 
membrane as mentioned above, recent reports suggest intracellular HA synthesis. 
Majors et al suggested that a “dormant” HAS isoform is present on/close to the 
endoplasmic reticulum (ER) and is activated when the ER is stressed [170]. Also, 
work from the Cleveland group showed that HAS2 is closely situated to the nucleus 
of colonic smooth muscle cells that were stimulated with viral-mimic RNA (De La 
Motte, CA and Hascall, VC -  personal communication).
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Figure 1.5: Proposed membrane topology for the HAS family: Very similar 
hydropathy plots and primary structure (28-71% identity) among all the HAS 
isozymes suggest that they are similarly organized within the membrane. The scheme 
depicts the N and C termini and the large central domain, between MD2 (Membrane 
Domain) and MD3, inside the cell (where HA synthesis occur). The larger eukaryotic 
HASs (thick line with 7 MDs) have additional amino acids in all regions compared 
with the bacterial HASs (thin line with 5 MDs), except for the highly conserved 
carboxyl 178 residues of the central domain and MD1-MD5. The conserved Cys is 
indicated by the circled C. MD5 can be modelled as an amphipathic helix, which 
would orient the C terminus of all HAS members inside the cell (adapted from Weigel 
etal. [171]).
1.7,4 Mechanism of HA synthesis by the HAS proteins
Virtually all known enzymes catalyse a reaction that uses one or two (or more 
rarely, three) substrates to produce one or two products. The HAS enzymes are an 
exception to this rule. HA synthase has two different enzymatic activities within the 
same enzyme [172]. The HA product after each sugar addition becomes a substrate 
for the next sugar addition. The overall reaction for the synthesis of one HA 
disaccharide unit is shown in the formula below:
UDP-GlcA + UDP-GlcNAc + (HA)„ ------------► (HA)n+i + 2UDP
One HA disaccharide unit is added to the HA chain using the substrates 
uridine diphosphate glucuronic acid (UDP-GlcA) and uridine diphosphate N- 
acetylglucosamine (UDP-GlcNAc). Although the synthase is only adding one HA 
disaccharide unit, it must exhibit six different functions to achieve this process. It 
requires two specific binding sites for the UDP-GlcA and UDP-GlcNAc sugar 
precursors and two different glycosyltransferase activities for the addition of the 
substrates to the HA chain by P-1,3 and p-1,4 linkages. It also requires a binding site 
that anchors the growing HA polymer to the enzyme and a ratchet-like transfer
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reaction that moves the growing polymer one sugar at a time [168, 172]. This later 
activity is likely coincident with the stepwise advance of the polymer through the 
membrane as HA was shown to be synthesised at the inner surface of plasma 
membrane [156]. All these activities are present in a relatively small protein ranging 
from 419 (Streptococcal pyogenes HAS) to 558 (Xenopus laevis HAS) amino acids. 
In addition, all the available evidence supports the suggestion that only Streptococcal 
pyogenes HAS protein is required for HA biosynthesis in bacteria or in vitro although 
reports indicate that the larger eukaryotic HAS family members are part of 
multicomponent complexes [173]. Since the eukaryotic HAS proteins are -40% larger 
than that of Streptococcal pyogenes, their additional protein domains could be 
involved in more elaborate functions such as intracellular trafficking and localization, 
regulation of enzyme activity and mediating interactions with other cellular 
components.
1.7.5 Enzymatic properties of the three human HAS isoforms
Although the 3 HAS isoforms are expressed in mammalian cells, all catalyse 
the same biosynthetic reaction. Each isoform when individually expressed in 
mammalian cells, with no intrinsic ability to synthesize HA, leads to de novo 
biosynthesis of HA [174], thus each HAS protein appears to be independently active. 
However, the respective HAS transfectants differ in their ability to form HA matrix 
when HAS isoforms are individually expressed at similar levels as HAS1- 
transfectants formed significantly smaller coats than HAS2- or HAS3 -transfectants 
[174].
Because the biological and physiological roles of HA are related to its size, it 
is important to determine the molecular sizes synthesised by different HAS isoforms. 
HAS1 and HAS3 transfectants secreted HA with an estimated molecular weight of 2 x 
105 to 2 x 106 Da while HAS2 secreted HA of more than 2 x 106 [174]. These findings 
suggest that the size distribution of the products may be partly determined by the 
intrinsic enzymatic properties of HAS proteins. In agreement with this theory, the 
recombinant protein of each HAS isoform synthesized HA of different size in vitro 
[174]. However, HA synthesized by recombinant HAS3 was significantly smaller in 
molecular weight than that secreted from the transfectants. It is therefore more likely
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that the intracellular environment and additional mechanisms involving accessory 
molecules affect the molecular size distribution of HA.
2.7.6 Transcriptional and post-transcriptional regulation o f HAS
The metabolism of HA is a dynamic process in vertebrates and the 
biosynthesis is both spatially and temporally controlled. The presence of three HAS 
isoforms with different enzymatic properties raises the question of whether or not the 
expression is also regulated in a different fashion. Several lines of evidence show that 
increased transcription of HAS, induced by different growth factors and cytokines, is 
responsible for the increase in HA production, and that transcriptional regulation is 
unique to each gene and is stimulus-specific [175-183]. For example, Kennedy et al 
have shown that while both IL-ip and TNF-a stimulated HA synthesis in adult 
fibroblasts, IL-lp stimulation led to an increase in HAS1 mRNA with no effect on 
either HAS2 or HAS3 while TNF-a increased HAS3 mRNA with slight effect on 
HAS1 and no effect on HAS2 [177].
A variety of potential binding sites for transcription factors have been found in 
the promoter region of the mouse HAS1 gene including: CCAAT box, AP-2, GATA 
and GAGA [184]. Recent work from our laboratory has shown the absence of the 
common TATA box, while CCAAT and Sp-1 binding sites were detected in the 
promoter region of human HAS2 gene (Monslow J et al. -  unpublished observation).
Physical stimuli also affect HA regulation, Yung et al. demonstrated that 
mechanical injury to a mesothelial monolayer induces HAS2 mRNA and suppresses 
HAS3 mRNA but with a net increase in total secreted HA [185]. Others have reported 
that HAS3 mRNA (but not HAS2) was up-regulated in chick chondrocytes after 
applying mechanical strain [186]. Recklies et a l [187] demonstrated that changes in 
the transcriptional level of HAS genes did not always correlate with changes in the 
secretion of HA after the exposure of synovial cells to growth factors and the response 
to these growth factors was cell-type specific. This suggests that the synthesis can also 
be regulated post-transcriptionally.
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Regarding HA regulation in PTCs, neither TGF-|51 nor PDGF had an effect on 
HA generation while IL-lp or high glucose stimulated HA synthesis via NK-kB 
activation [175]. Notably here, the increase in HA generation was concomitant with 
up-regulation of HAS2 mRNA with no effect on HAS 3 mRNA and inhibition of 
either gene transcription or protein synthesis abolished HA synthesis in response to 
IL-ipor high glucose. Increased HA generation was also noted in mechanically 
wounded PTC monolayers but the mechanism of this increment was not elucidated in 
that study [188]. Thus, the regulation of HA synthesis by HAS proteins appear to be a 
multifaceted process involving enzymatic properties and both transcriptional and 
post-transcriptional regulation.
2.7.7 Manipulation o f the HAS genes: lessons from  knockouts and over- 
expressions
The presence of multiple HAS proteins implies that each isoform has a 
different biological significance. Genetic manipulation of HAS may provide clues as 
to the respective roles of the isoforms in the broad range of physiological functions 
performed by HA. The study by Camenisch et a l [189] demonstrated that HA was 
virtually absent in HAS2T E9.5 mouse embryos. Lack of HA (in these mice) led to 
defective HA-mediated epithelial-to-mesenchymal transformation (EMT) and finally 
to severe cardiac malformations and embryonic fatality. Interestingly, the HAS2 
knockout embryos closely resembled that of heart defect Qidf) mice lacking the HA- 
binding protein versican (discussed below), showing that a composite matrix 
requiring HA and versican is essential for forming cardiac jelly to support cushion 
morphogenesis and subsequent cardiac development. However, heterozygous mice for 
HAS2 were fertile and exhibited no obvious abnormalities. Moreover, HAS1 or 
HAS3 knockout mice were viable and fertile (Itano, Kimata, Spicer and McDonald, 
unpublished data).
Increased synthesis of HA is often related to tumour malignancy. Genetic 
manipulation of HAS genes in cancer cells allows one to investigate the role of HA in 
tumour formation and progression. Over-expression of HAS2 enhanced anchorage- 
independent growth and tumourigenicity of human fibrosarcoma [190]. Similarly, 
over-expression of HAS3 promoted the growth of a prostate cancer cell line along
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with increased angiogenesis [191]. While HAS1 over-expression restored the 
metastatic ability of mouse mammary carcinoma cells that were defective in HA 
synthesis [192]. Taken together, these findings suggest that HAS isoforms differ in 
their involvement in tumour progression. While the HA synthesized by HAS2 or 
HAS3 may play roles in cancer growth, HAS 1-derived HA may participate in 
conferring tumour metastasis. However, some reports conflict with the above. For 
example, HAS2 transfection of glioma cells caused a reduction in tumour growth rate 
[193] and anti-sense inhibition of HAS2 or HAS3 significantly diminished adhesion 
of prostate cancer cells to bone marrow endothelial cells [194] suggesting that HAS2 
and HAS3 are also involved in cancer metastasis. These conflicting results could be 
attributable to the characteristics and expression levels of HAS isoforms and the 
differences in cell types used for transfection.
L  7.8 HA turnover and degradation
Before discovering that lymphatic vessels carry a considerable amount of HA 
from the tissues to the blood [195], it was thought that all HA turnover occurred 
within the tissue. However, in densely structured tissues such as bone and cartilage, it 
is probable that HA turnover occurs by metabolic degradation in situ concurrently 
with that of collagen and other proteoglycans since there is no lymphatic drainage. In 
skin and joints, about 20-30% of HA turnover occurs by local metabolism and the rest 
is removed by the lymphatic pathways. Metabolic studies have shown that the half- 
life of a HA molecule in different tissue varies greatly [196-198]. The half-life of the 
polymer in skin and joints is about 12 h; in the anterior chamber of the eye it is 1-1.5 
h although in the vitreous body it is about 70 days. On reaching the blood stream, 
about 85-90% is eliminated in the liver by receptor-facilitated uptake and catabolism 
in the hepatic sinusoidal endothelial cells. The kidneys extract about 10% but excrete 
only 1-2% in urine. The normal fractional turnover of plasma HA in humans is about 
15-35% per minute, which explains the low plasma levels in the face of high 
lymphatic input (reviewed in [199]). This means that approximately one-third (~5 g) 
of total HA in the human body is metabolically removed and replaced during an 
average day. This rapid turnover was unexpected as HA has been regarded as a 
structural component in connective tissue and structural components are usually quite
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stable. However, the rapid turnover facilitates the use of HA in physiological 
regulatory mechanisms.
HA can be degraded via the action of oxygen free radicals, peroxynitrites and 
ultraviolet (UV) irradiation or by the hyaluronidase (HYAL) family of enzymes [200, 
201]. Hyaluronidase activity was first identified as a "spreading factor" in extracts 
from mammalian testes. The term "hyaluronidase" was introduced by Karl Meyer in 
1940 to denote the enzymes that degrade hyaluronan. In humans, six HYAL genes 
have been identified. They occur in clusters of three at two chromosomal locations. 
HYAL1, HYAL2 and HYAL3 make up the cluster on chromosome 3p21.3 and share 
about 40% similarity. HYAL4, HYALP1 and SPAM1 (Sperm adhesion molecule 1) 
make up the second cluster on chromosome 7q31.3. These genes code respectively for 
HYAL1-4 and PH-20. With the possible exception of HYAL4 and PHYAL1 (a 
pseudogene), all the HYALs degrade HA [202,203].
The degradation of HA occurs in a stepwise fashion with quantum decreases 
in polymer size. From the cluster on chromosome 3, HYAL1 and HYAL2 constitute 
the major hyaluronidases of somatic tissues. HYAL2 cleaves high molecular weight 
HA to a limited product of approximately 20 kDa (about 50 disaccharide units) and is 
bound to the plasma membrane by a glycophosphatidylinositol (GPI)-anchor [204] 
(although a portion of HYAL2 also occurs in a soluble form). Beside its function in 
HA digestion, HYAL2 has been reported to have a role in oncogenesis by acting as a 
cell surface receptor for some retroviruses [204]. On the other hand, evidence of 
tumour suppressor function of HYAL2 is also available as HYAL2 can accelerate 
apoptosis [205] and suppress tumour growth in mice [206].
HYAL1 appears to be lysosomal, cleaving the 20 kDa chains (produced by 
HYAL2 action) into small HA disaccharides (reviewed in [207] & [208]) which are 
further degraded by the action of 2 enzymes on the non-reducing end: a beta- 
glucuronidase and a beta-N-acetyl glucosaminidase to yield glucuronic acid and N- 
acetylglucosamine [209]. HYAL1 is also the only plasma hyaluronidase [210] with no 
known tissue origin and the only urine hyaluronidase [211]. Although it is considered 
as a lysosomal enzyme, it has a pH optimum of 3.8, well below the pH 4.5 inside the 
lysosomes.
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Very little is known about HYAL3. Transcripts have been found in the brain 
and liver, but the protein product remains uncharacterised [212]. Expression occurs in 
chondrocytes [213], and increases when fibroblasts undergo chondrocyte 
differentiation [214]. There may be coordinate expression of HYAL2 and 3 as they 
are both up-regulated by inflammatory cytokines such as TNFa, whereas HYAL1 is 
not [213].
PH-20 is expressed in testes. It facilitates the penetration of sperm through the 
cumulus mass that surrounds the ovum and has a role in fertilisation [215]. At first 
thought to be sperm-specific, it is now known to be expressed in the epididymis [216], 
female genital tract [217], breast [218] and foetal tissues [202].
/. 7.9 HA signalling pathway
HA signalling can be mediated via several HA receptors. Generally, epithelial 
cells express mainly CD44 [219], although RHAMM is also reported to be expressed 
in epithelial cell such as bronchial epithelial cells [220]. The biochemical mechanisms 
by which HA-CD44 interactions are transduced into intracellular signals that bring 
about cellular effects are the subject of many investigations. The binding of CD44 
isoforms to HA affects cell adhesion to ECM components and is implicated in the 
processes of aggregation, proliferation, migration and angiogenesis [221-224]. It is 
clear, that in some cell types, the multivalent interaction of polymeric HA with CD44 
causes clustering of CD44 in the plasma membrane and that this event is associated 
with phosphorylation of CD44, interactions with the cytoskeleton and changes in cell 
behaviour [225, 226]. It has been shown that activation of various components of 
intracellular signalling pathways including Racl [222, 227], phosphoinositide 3’- 
kinase [228], erbB-2 [229], c-Src kinase [230] and NF-kB [231, 232] and that 
rearrangement of cytoskeletal elements, e.g. ankyrin [233] and ezrin [234] result from 
interaction of HA with CD44 in different cell types.
Hyaluronan is also involved in the regulation of MMP expression although its 
effect is variable. HA-CD44 interaction down-regulated MMP-9 mRNA expression in 
osteoclast-like cells [235] and reduced cell migration. On the other hand, increased 
MMP-9 expression in chondrocytes was shown upon degrading HA [236], an effect
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that was suppressed by anti-CD44 Ab and unseen upon adding high molecular weight 
HA to these cells. More recently, HA-oligosaccharides have been reported to induce 
MMP-9 and MMP-13 but this induction is neither CD44- nor RHAMM-dependent
[237].
The binding of exogenous HA to cell surface RHAMM plays a key role in 
activating signal cascades, probably as a co-receptor for integral membrane proteins. 
Although the role(s) of intracellular RHAMM protein forms are not yet known, their 
ability to associate with kinases [238, 239], calmodulin [240, 241] and the 
cytoskeleton [240, 242] predicts that they play key roles in cytoskeletal assembly. 
Cell surface RHAMM has been shown to activate signalling pathways including Src
[238], extracellular signal-regulated kinase (Erk) [243], and Ras [244, 245]. This is 
reviewed in greater detail in [246].
CD44 and RHAMM can perform separate functions in regulating cell 
signalling. For instance, CD44, but not cell surface RHAMM, can mediate adhesion 
of endothelial cells to HA and regulate proliferation [247]. In contrast, cell surface 
RHAMM, but not CD44, is required for migration of B lymphocytes and endothelial 
cells [247, 248]. In addition, cell surface RHAMM but not CD44 appears to be 
essential for activation of protein tyrosine kinase cascades by endothelial cells in 
response to HA [243]. On the other hand, HA-CD44 but not RHAMM interactions 
have been implicated in the cellular uptake of HA, which in turn affects growth 
regulation and tissue integrity [249, 250]. Deletion of either CD44 or RHAMM does 
not result in embryonic lethality and, therefore, either these two proteins share some 
functions and/or other cellular hyaladherins are able to compensate for the loss of 
CD44 or RHAMM [246].
There is growing evidence for the presence of intracellular HA. It was first 
found to be intracellular when it was isolated from rat brain nuclei in 1976 [251] but 
this report did not receive widespread attention. More recently, intracellular HA has 
been detected in the cytoplasm of vascular smooth muscle cells during late 
prophase/early prometaphase of mitosis and in key subcellular compartments such as 
the nucleus and lamellae during cell locomotion and following serum stimulation 
[252, 253]. In addition, the identification of intracellular HA binding proteins
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(IHABPs), including RHAMM, P32, CDC37 and IHABP4 lends further support to 
the intracellular presence of HA [254-256].
Intracellular HA can be derived from either the extracellular environment by 
internalisation [252] or synthesised from an as yet unidentified intracellular source 
[257]. There is evidence that intracellular HA is seen during mitotic events after viral 
infection [258] and following the onset of ER stress [170].
/ .  7.10 Hyaluronan in the kidney
In the normal kidney, HA is expressed mainly in the interstitium of the renal 
papilla (figure 1.6) and alteration in papillary interstitial HA has been implicated in 
regulating renal water handling by affecting physicochemical characteristics of the 
papillary interstitial matrix and influencing the interstitial hydrostatic pressure [154]. 
The lipid-laden interstitial cells are thought to be the major source of hyaluronan 
synthesis in the inner medulla and therefore they function to regulate hydration as the 
amount of medullary hyaluronan correlates with the hydration state [259].
More recently, alterations in HA synthesis within the glomerulus of the kidney 
have been implicated in the pathogenesis of renal diseases such as diabetic 
nephropathy [260, 261]. In animal experiments, Mahadevan et a l demonstrated 
increased HA production in the glomeruli of diabetic rats [260]. In vitro studies from 
this group also demonstrated that HA production in response to a raised glucose 
environment can contribute to mesangial hypercellularity [261].
Although HA is not a major constituent of the normal renal corticointerstitium, 
it is known to be expressed around proximal tubular cells after renal injury caused by 
diverse diseases [262-265]. Interaction of CD44 with HA participates in the 
tubulointerstitial inflammatory response in the murine model of tubulointerstitial 
nephritis [262]. The function of CD44-HA interactions has been implied in the 
regenerating proximal tubule, participating in the process of recovery after ischaemic 
injury [263]. Increased HA in acutely rejected human kidney grafts was also 
identified [266]. Furthermore, the previous study has demonstrated the correlation of 
CD44 and HA expression in the glomeruli and interstitium with proteinuria.
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Clinically, interstitial CD44 and HA expression have also been found to be correlated 
with changes in creatinine clearance rate. Increased deposition of interstitial HA has 
been shown to correlate with both proteinuria and renal function in progressive renal 
disease [267].
Previous work from our laboratory has examined the regulation of HA 
synthesis by renal PTC in vitro under conditions that mimic the diabetic state or 
inflammatory conditions [175]. These studies have demonstrated that exposure of 
PTC to elevated D-glucose concentrations or IL-lp leads to NF-KB-dependent 
transcriptional activation of the HA synthase HAS2 and stimulation of HA synthesis. 
Previous work has also characterized PTC expression of the HA-receptor CD44 and 
demonstrated that stimuli inducing HA synthesis by PTC also regulate PTC-HA 
interactions, with increased binding and internalization resulting from post- 
translational modification of CD44 by O-glycosylation [219]. In vitro, HA 
oligosaccharides induce PTC chemokines and leukocyte adhesion molecule 
expression [268, 269]. These findings suggest a role for HA in the pathogenesis of 
renal interstitial inflammation.
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Figure 1.6: HA in the kidney: Alcian blue staining of normal rat kidney revealing 
distribution of hyaluronan in inner medulla. Bar = 2 mm (taken from Knepper et al. 
[270]).
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L 7.11 Extracellular HA structures: coats and cables
Several cell types exhibit highly hydrated, HA-dependent pericellular matrices 
or ‘coats’. They are usually 5-10 pm in thickness and can be destroyed by 
hyaluronidase treatment [271-273]. These pericellular matrices provide the essential 
environment for certain biological processes like proliferation and migration [253]. 
During tissue formation or remodelling, such matrices provide a hydrated, fluid 
environment in which assembly of other matrix components and presentation of 
growth and differentiation factors can readily occur without interference from the 
highly structured fibrous matrix usually found in fully differentiated tissues. 
Embryonic mesenchymal cells, including the precursors of muscle and cartilage, 
embryonic glial cells, neural crest cells and even some embryonic epithelial cells 
exhibit prominent pericellular matrices. In some cases, such as cartilage, the 
pericellular coat is a unique structural component that protects cells and contributes to 
the characteristic properties of the differentiated tissue (reviewed in [274]). The HA 
pericellular structures are also reported to have some hyaladherins in them: aggrecan
[275], versican [276], PTX3 [277], TSG-6 [278] and Ial [279], and are thought to be 
anchored directly to the cell via the CD44 receptor [280].
Much less work has been done regarding HA cable-like structures because of 
their novelty. In 1999, De La Motte et al. reported, while investigating the 
mechanisms of increased leukocyte adhesion in inflammatory bowel disease, that 
monocytes bound preferentially via their CD44 receptor and not via their p2-integrins 
[281] to virally-infected smooth muscle cells that express high levels of VCAM-1. 
Further work by the same group showed that the increase of leukocyte binding was 
due to their interaction with HA cable-like structures [258], and that Ial has a crucial 
role in the formation of these structures. These HA cables also stain positive for other 
hyaladherins like versican although this is not thought to be crucial in cable formation 
(De La Motte, CA -  personal communication). Majors et a l have shown that the 
formation of HA cables is linked to the induction of ER stress in colonic and aortic 
smooth muscle cells [170], while Wang et al. have linked the cable formation in 
mesangial cells to high glucose exposure [282]. All the reports above have shown 
leukocytes binding to HA cables and speculated that these cable structures are 
involved in certain pathological conditions, namely inflammatory bowel disease and
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diabetes mellitus. The cellular origin(s) of these cables remains elusive. Theories 
include a dormant HAS isoform that is present on the ER and is activated once the 
cell is stressed to produce these unique structures [170]. Also, it is thought that HA 
cables, unlike HA coats, are attached to their cells of origin via their synthesising 
enzymes i.e. HAS and are not attached to CD44 receptors.
1.8 Hyaluronan-binding proteins: The Hyaladherins
The many and differing biological roles of HA are thought to be due not only 
to its intrinsic properties but to the proteins bound to it. These are called the 
hyaladherins [283]. The figure from Day and Prestwich [283] gives a schematic 
representation of the structure of the currently known hyaladherins (figure 1.7). The 
link module superfamily includes proteins that bind HA through one or more common 
consensus binding sites known as the link module (thus named after it was first 
described in a link protein). Of direct relevance to this work are: CD44, TSG-6 and 
versican (of the link module superfamily) and Ial which does not contain the link 
module.
Also shown in figure 1.7, are other proteins that bind HA via alternative 
mechanisms. Of note is RHAMM, the second major cell surface receptor for HA 
which also does not contain the link module.
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Figure 1.7: The modular organisation of the hyaladherins.
Taken from Day and Prestwich [283].
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1.8.1 CD44
Cluster of differentiation-44 (CD44), a glycoprotein termed also H-CAM, is 
the major cell surface HA receptor. It is widely distributed. In haematopoietic tissue, 
CD44 is expressed on B and T lymphocytes, monocytes and neutrophils. Other CD44- 
positive cells include epithelial cells, glial cells, fibroblasts and myocytes (reviewed 
in [284]). The broad distribution of CD44 suggests a general role in cell-cell and cell- 
matrix adhesion. CD44 has been shown to be important in retention of pericellular 
matrix by chondrocytes [280] and in catabolism of HA by many cell types including 
chondrocytes, epidermal keratinocytes [285] and PTCs [219]. Although HA is the 
main ligand for CD44 [286, 287], CD44 variants with attached chondroitin sulphate 
are able to bind fibronectin, laminin and collagen [288]. CD44 may also bind 
homotypically [289] and to osteopontin [290-292], a secreted phosphoprotein 
expressed on many epithelial cell surfaces in communication with the outside 
environment including the nephron [293,294].
CD44, unlike other HA receptors, requires multiple interactions to hold its 
substrate [295]. The data show that CD44 binding to HA is regulated by receptor 
clustering [295], degree of sulphate moiety addition to the extracellular domain [296] 
and glycosylation [297], as well as by alternative splicing of the molecule [298].
The structure of CD44 glycoprotein consists of four functional domains 
(figure 1.8). The distal extracellular domain is the region primarily responsible for the 
binding of HA. The membrane-proximal extracellular domain is the primary site of 
alternative splicing of CD44 mRNA that produces the many isoforms of CD44. The 
CD44 transmembrane domain is fairly typical of most single-pass membrane 
glycoproteins. In most isoforms of CD44, a 70-amino-acid cytoplasmic domain or 
“tail” is also expressed. This cytoplasmic domain exhibits protein motifs that indicate 
a capacity for interaction with cytoskeleton proteins as well as the potential for 
intracellular signalling [298].
In addition to its major function as an anchoring protein for HA-rich 
pericellular matrices, CD44 contributes to HA internalization (leading to HA 
degradation) [298] and is also linked to inflammation, cancer metastasis and invasion
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(reviewed in [299]). For example, CD44/HA interactions have been reported to be 
important in the pathology of arthritis [300], atherosclerosis [301], lung [250] and 
skin inflammation [302]. While in the haematopoietic cells, ligation of CD44 with 
cross-linking antibodies activates peripheral blood T cells, causing increased IL-2 
levels [303, 304]. Likewise, monocytes treated similarly release higher levels of the 
pro-inflammatory cytokines IL-1 and TNF-a [304, 305]. Macrophage CD44/HA 
interaction has been shown to up-regulate IL-12 as well as the chemokines RANTES, 
macrophage inflammatory protein-la (MIP-la) and MIP-lp [306]. In addition to 
signalling the production of soluble mediators, DeGrendele et a l have shown that 
activation of T cell-associated CD44 is required for leukocyte extravasation into 
inflammatory sites [307], and Brooke et a l have shown that CD44 is critical to the 
secondary leukocyte recruitment observed during inflammation of the central nervous 
system and in experimental encephalomyelitis [308]. CD44 is reported to mediate 
leukocyte motility on HA-coated plates [309], although other HA receptors (like 
RHAMM) are present on PMN leukocytes. Also, CD44 on the surface of leukocytes 
has been shown to enhance their functions including cell killing and phagocytosis 
[310,311].
In the normal kidney, CD44 expression is weak with few CD44-positive 
interstitial and urothelial cells [312]. However, CD44 expression is reported to be 
increased in several pathological conditions like lupus nephritis [312] and acute 
ischaemic injury [263]. It is thought that de novo CD44expression after renal injury is 
vital in the process of re-epithelialization which is mediated via cellular proliferation 
and migration across portions of denuded proximal tubule basement membrane [263]. 
Primary PTCs express at least 5 CD44 variants [219], with the most prominent variant 
expressed being CD44s (s for standard; also called CD44H since it is the most 
predominant variant in haematopoietic cells). CD44 expressed by the PTCs binds and 
internalizes HA although its mRNA expression is not altered by stimuli that increases 
HA generation in these cells [219].
42
r
Distal
Proximal < Variant
Exons
► ProximalV ariant exon alternative 
Splice S i t e ---------------- *
T ransmentbrane 
Domain
Cytoplasmic
Domain
Actin
Cytoskeleton
Figure 1.8: Protein Domains of CD44.
The four principal protein domains of CD44 are diagrammed including (1) the distal 
extracellular domain (link protein-homologous domain), (2) the membrane proximal 
extracellular domain, (3) the transmembrane domain, and (4) the intracellular 
cytoplasmic domain. Also shown is an isoform of CD44 containing protein extensions 
within the membrane proximal extracellular domain (3 exons shown in yellow). These 
protein extensions are absent in CD44s, the most common isoform of CD44. Adapted 
from [298].
1.8.2 TSG-6
Originally, TSG-6, (also called TNF-induced protein-6; Tnfip-6) was reported 
as a gene of unknown function, which was regulated in mesenchymal cells by TNF-a 
[313]. The secreted protein product of this gene (-35 kDa) is now known to contain a 
consensus binding site for HA, known as the link module as shown in figure 1.7. The 
tertiary structure of its binding site has been elucidated [314]. TSG-6 is known to 
form a stable, covalent complex with the HC of Ial [315], and several cooperative 
functions have been ascribed to the complex as mentioned earlier [315].
Under normal conditions, TSG-6 serves a role in reproductive physiology in 
the process of ovulation [315], and cervical ripening [316]. Under pathological 
conditions, TSG-6, probably through a mechanism involving its link module, is a 
potent inhibitor of PMN migration [317], which is an important inflammatory event. 
Up-regulated TSG-6 is also associated with the inflammatory process of rheumatoid
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arthritis and osteoarthritis in humans and in animal models [318-321]. TSG-6 is 
secreted by chondrocytes [322, 323] and synoviocytes [324] where it plays a part in 
down-regulating inflammation.
1.8.3 Versican
Versican is a member of the family of large aggregating proteoglycans, or 
hyalectins [325]. The term “versican” was proposed by Zimmerman et al. from its 
potential “versatile” reactivity and from its “proteoglycan” structure [326]. The 
macromolecule was first reported in 1983 [327] and was recently reviewed by Wight 
[325]. As shown in figure 1.7, versican core protein contains two globular domains at 
the amino (Gl) and carboxyl termini (G3) and a mid region to which chondroitin 
sulphate side chains attach. The protein is a single gene product of one of four 
alternately spliced variants of the versican or CSPG2 gene. Expressed by 
mesenchymal cells, it can be present at molecular weights greater than 106 Da [325, 
327] depending on the number and size of the chondroitin sulphate side chains. The 
Gl domain contains two copies of the specialized HA-binding link protein molecule. 
The carboxy terminus G3 domain contains two EGF-like repeats, and a lectin-like 
domain that can bind to other matrix proteins such as fibulin 1 [328]. Due to the 
molecule’s complexity, this protein is capable of binding many ligands 
simultaneously, a feature that makes it important to matrix organisation.
Reports have shown the versican can be an important component of matrix 
during the normal processes of proliferation and cell migration [276]. Mitogens that 
induce smooth muscle cell proliferation, such as PDGF and TGF-p, induce versican
[276]. Certain cancers are also associated with increased levels of versican [329]. 
Versican can play a role in embryonic development, where site-specific expression of 
this proteoglycan seems to direct cell migration in the development of the neural crest 
and heart [325].
Versican, through its multiple binding moieties, may be important in cross- 
linking HA to other matrix structures, and may participate in leukocyte adhesion. 
Recently, L-selectin, a leukocyte receptor important to inflammatory extravasation 
[132](discussed later), has been shown to be a counter-ligand for versican [139, 330,
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331]. Association of versican, mostly in conjunction with HA, is observed in 
pathological conditions as atherosclerosis [332], lung oedema [333], asthma [334], 
lipid-induced renal damage [335], and skin aging [336]. Based on the known 
properties of versican and its involvement with other inflammatory conditions, 
exploring the function of versican may provide insights into changes in renal disease.
1.8.4 Inter alpha trypsin inhibitor
The Ial family is a group of serum protease inhibitors that binds to proteases 
with a weaker affinity than other, more abundant serum inhibitors. This family 
includes four plasma proteins, designated according to their behaviour in non­
denaturing electrophoresis at pH values greater than 8 (figure 1.9): free bikunin, pre- 
a-inhibitor (Pal), inter-a-like inhibitor (IaLI) and Ial. Each of the last three proteins 
exists as distinct assembly of one bikunin chain covalently linked with one or more 
unique HCs designated HC1, HC2 and HC3. The covalent inter-chain link in the 
molecules is quite unusual as it is made up of a chondroitin 4-sulphate glycan bond 
that has been termed a protein-glycosaminoglycan-protein (PGP) cross-link [337].
The three chains and the bikunin chain are encoded by four genes on three 
different chromosomes [338]. The bikunin component, which carries a 7 kDa 
chondroitin sulphate chain, is responsible for the protease activity of these family 
members (reviewed in [339]). A unique feature of these protease inhibitors is their 
ability to inhibit both soluble and cell-receptor bound plasmin activity [340]. Despite 
low intrinsic plasmin inhibitory activity, the interaction of bikunin with TSG-6 
potentiates the plasmin inhibitory activity [324].
Ial-family proteins are synthesised mainly in hepatocytes. The HCs, but not 
bikunin, are also synthesised in the brain [341]. Iida et al. have demonstrated 
increased expression of bikunin mRNA transcripts in whole kidney tissue in response 
to ethylene glycol-induced hyperoxaluria [342] and previous work in the Institute has 
demonstrated that PTCs produce Pal (1 bikunin chain + 1 HC3) [343].
Ial-related proteins are important in the formation of HA-based matrices of 
certain cells, including those of fibroblasts and mesothelial cells [344,345], and of the
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cumulus cells during expansion of the cumulus oophorus in the pre-ovulatory follicle 
[346-348]. Ial is so crucial to the reproductive process that bikunin-null mice are 
infertile [279] because of failure of the cumulus oophorus to expand.
When Ial in serum encounters HA within extravascular tissue, as may also 
occur with vascular leakage during an inflammatory response, HCs can be covalently 
transferred from chondroitin sulphate chains to HA by transesterification and 
therefore may contribute to the structure of the resulting matrix. Ial HCs proteins, 
also termed SHAP (serum-derived HA-associated proteins), have been identified in 
rheumatoid arthritis in humans [349]. In addition, changes in Ial-component tissue 
distribution have been linked to pathological conditions as diverse such as kidney 
stones [350], malignancies [351,352], and inflammation [353].
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Figure 1.9: Current view of the structure of the Ial family proteins (taken from 
[343]).
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1.9 Project aims
This thesis examines the regulation and function of HA in PTC. The specific 
aims were:
1. To assess the capability of PTCs to produce HA cables, and to assess the 
functionality of such structures if they are produced by these cells.
2. To examine the effect of BMP-7 on HA regulation and whether it influences 
HA cable formation and, to contrast the effect of BMP-7 of HA regulation 
with a known HA synthesis stimulant (IL-1 (3).
3. To examine the role of different hyaladherins in the formation of HA 
cables.
4. To examine the structural and functional consequences of HAS2- and 
HAS3-driven HA synthesis by using an over-expression system. This was 
done by: (/) Analysing the alterations in HA synthesis and extracellular 
structures (HA quality and quantity), and by (w) Investigating the changes in 
two specific functions in the transfected cells, namely monocytes binding and 
cell migration.
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Chapter II 
Methods
2.1 Tissue culture
2.1.1 Selection o f a proximal tubule cell line
In addition to the lack of human PTCs source and their relatively short in vitro 
life span, the need of repeated isolation and confirmation of preparation uniformity 
are major limiting factors for not using primary cells in experiments.
The HK-2 cell line was selected because it is been shown to retain the 
functional characteristics of fully differentiated proximal tubule cells. The HK-2 cell 
line has been derived by transduction of human proximal tubule cells with Human 
Papilloma Virus 16 E6/E7 genes. Features of the HK-2 cells identical to human 
proximal tubular cells include: a. Sodium-dependent and phlorizin-sensitive sugar 
transport, b. Adenylate cyclase responsiveness to parathyroid hormone, c. positive for: 
alkaline phosphatase, gamma glutamyltranspeptidase, leucine aminopeptidase, acid 
phosphatase, cytokeratin, oc3pl integrin and fibronectin. d. negative for: Factor VIII- 
related antigen, 6.19 antigen and CALLA endopeptidase which are markers of distal 
tubular cells.
To date, extensive comparison of HK-2 cells with primary proximal tubule 
cells has not yielded any differences in innate behaviour (like migration and 
proliferation) nor in response to certain cytokines (as IL-ip and TGF-pl) [175, 188, 
354, 355].
2.1.2 HK-2 cell culture conditions
HK-2 cells (American Type Culture Collection, Manassas, VA, USA) were 
cultured in a 1:1 mixture of Dublecco’s modified Eagle’s medium (D-MEM) and 
Ham’s F12 medium (Invitrogen, Paisley, UK) supplemented with 10% bovine calf 
serum (Biological Industries Ltd, Cumbernauld, UK), 20mM Hepes buffer 
(Invitrogen), 2mM L-glutamine (Invitrogen), 5pg/ml bovine Insulin (Sigma-Aldrich, 
Poole, UK), 5pg/ml human Apo-transferrin (Sigma-Aldrich), 5ng/ml Sodium Selenite 
(Sigma-Aldrich) and 0.4pg/ml Hydrocortisone (Sigma-Aldrich). Cells were kept in a 
humidified incubator (Cell House 170, Heto Holten, Derby, UK) at 37° C in an 
atmosphere of 5% CO2. Fresh growth medium was added to the cells every 3-4 days
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until confluence. Confluent cells were either used in experiments, or passaged at a 
ratio of 1:3 to 1:5. Cells were made quiescent by removing serum 48 h prior to the 
start of the experiment. All experiments (except where indicated) were done in serum- 
free conditions.
2.1.3 Sub-culturing HK-2 cells
Confluent cells were subcultured by treatment with Trypsin/EDTA 
(GIBCO/BRL Life Technologies) diluted 1:1 with PBS (GIBCO/BRL Life 
Technologies). After 5-10 minutes, and with gentle agitation, cells were detached 
from the flask. The resulting cell suspension was treated with an equal volume of FCS 
to neutralize the protease activity. The cells were collected by centrifugation at 1500 
rpm for 7 min. Cells were re-suspended in fully supplemented medium and seeded 
into fresh tissue culture flasks (Falcon, Becton Dickinson, Oxford, UK).
2.1.4 Selection o f a monocytic cell line
Difficulties in achieving similar monocyte conditions, in addition to the 
relatively low yield of monocytic cells after isolation from peripheral blood samples 
necessitated the usage of an immortalised monocytic cell line. U937 monocytic cells 
were originally derived from the pleural fluid of a patient with diffuse histiocytic 
lymphoma [356].
Morphologically the cells are monoblastic and the histochemical profile, non­
specific esterases (like ANAE, NASDAE) and P-glucuronidase reveal a monocytic 
lineage [356, 357]. Acid and alkaline phosphatases, which are markers of PBMN, are 
weakly detected in U937 cells. U937 cells release lysozyme into the culture medium, 
a monocyte-specific characteristic [358]. The surface of these cells bears few Fc, C3 
and chemotactic peptide receptors when compared to normal monocytes [356]. U937 
cells express receptors for both insulin and histamine [359]. Only small numbers of 
U937 are phagocytic and they do not have the capacity for micro-organism and 
tumour cell killing. [360, 361].
Advantages of using U937 monocytes include: a. Rapid growth with 
population doubling time between 20-48 h (allowing the production of large number
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of cells quickly), b. Easily labelled with 51Cr (helps for quantification procedure), c. 
No tendency to attach to tissue culture plastic (important for adhesion studies), d. As 
peripheral blood monocytes, U937 cells express both CD44 and CDlla/CD18 
integrin by which U937 can interact with HA or ICAM-1 respectively [362].
2.1.5 U937 cell culture conditions
U937 cells were purchased from American Type Culture Collection. The cells 
were grown in suspension culture in RPMI-1640 medium (Invitrogen) containing 2 
mM glutamine, 10% FCS and 100 U/ml penicillin (Invitrogen). The cells were 
subcultured 3 times/week and 24 h before doing experiments. Cells were subcultured 
at a ratio of 1:5 -  1:7 with fresh supplemented medium.
2.1.6 Separation o f human monocytes
Few experiments with human peripheral blood monocytes were done to 
confirm the observations obtained from experiments done with the U937 cells. More 
comparative experiments were done in the department and have shown similar results 
between freshly-separated monocytes and U937 cells [135,363].
Total mononuclear cells were separated from heparinized peripheral blood 
(100 units/ml, taken from healthy donors) by centrifugation on Ficoll-Hypaque 
density gradients (Amersham Biosciences)[364]. The isolated peripheral blood 
mononuclear leukocytes (PBML) were resuspended in RPMI-1640 medium 
supplemented with 5% FCS in a Teflon beaker to prevent attachment during labelling. 
Isolated cells were used on the same day and viability was always more than 90% as 
assessed by trypan dye exclusion.
2.2 Assessment of cell count and viability
2.2.1 Cell counting using a haemocytometer
Cells (HK-2 or monocytes) for counting were well re-suspended in culture 
medium. Trypan blue dye was added to a sample of the cell suspension (final 
concentration=0.2% w/v) incubated for 5 min at room temperature before pipetting a
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small volume into both chambers of a haemocytometer (Weber Scientific Ltd, 
Teddington, UK). The chambers were left to be filled by capillary action. Trypan blue 
dye is a vital stain recommended for use in estimating the proportion of viable cells in 
a population [365]. Chemically, trypan blue is an acid that contains 2 chromophores. 
The reactivity of this dye is based on the fact that chromophore is negatively charged 
and does not react with the cell unless the membrane is damaged thus viable cells do 
not take up the dye while non-viable cells do.
Cells were counted in 10 big squares (5 from each chamber of the 
haemocytometer) and if the cell numbers were not between 50-200/square then a re­
count with a different dilution was made. For accurate counting, cells touching square 
borders (top or right borders) were counted while cells in touch with bottom or left 
borders were not counted. A separate count was done for viable and non-viable cells.
The formula used to calculate cell number is:
Cells/ml = (Mean cell count/square) x (dilution factor) x 104
The formula used to calculate cell viability is:
Cell viability (%) = (total viable / total viable and non-viable) x 100
2.2.2 Alamar blue assay
Alamar blue assay is designed to measure quantitatively the proliferation of 
human cells [366]. The assay incorporates an oxidation-reduction indicator (REDOX) 
that both fluoresces and changes colour in response to chemical reduction of the 
growth medium resulting from cell growth. The REDOX indicator is demonstrated to 
be minimally toxic to living cells thus it is suitable for repeated use to establish a 
growth curve and to assess the cytotoxic effect of some compounds and cytokines. 
Data may be collected using either fluorescence-based or absorbance-based 
instrumentation. In all experiments, fluorescence was monitored at 544nm excitation 
wavelength and 590nm emission wavelength using a Fluostar Optima Meter (BMG 
Labtechnologies Ltd, Aylesbury, UK).
A linear relationship between cell number and alamar blue fluorescence was 
established in HK-2 cells (figure 2.1). HK-2 cells were harvested by trypsinization (as
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described in HK-2 subculture) and resuspended in serum-free medium. Cells were 
counted using a haemocytometer and a range of different cell numbers were plated 
into a 24-well plate (Falcon). The culture medium volume was standardized in all 
wells and alamar blue reagent was added to make up 10% of the final volume. The 
plate was incubated for 60 min at 37°C. 100 pi aliquots of medium were transferred 
into a black 96-well plate (Thermo Labsystems, MA, USA) and fluorescence was 
measured.
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Figure 2.1: Linear relationship between HK-2 cell number and alamar blue 
fluorescence: Values represent averages of 3 wells (± SD), regression line calculated 
using Microsoft Excel (R2=0.998).
2.3 Leukocytes adhesion assay
This assay was done as described by DiCorleto et el [362]. HK-2 cells were 
plated into a 24-well plate (Falcon) and grown until confluence before removing 
serum for 48 h after which HK-2 cells were either stimulated with either IL-1 p (R&D 
Systems, MN, USA), BMP7 (Creative BioMolecules Inc., MA, USA) or medium only 
for further 24 h (before addition of labelled monocytes) or, in the case of transfected 
cells, allowed to interact with monocytes. U937 cells (up to 70 x 106 cells/ml) were 
collected by centrifugation and then labelled for 90 min at 37°C with 100 pCi 5lCr as 
sodium chromate (Amersham Biosciences) in 1 ml culture medium. Monocytes were 
then washed with culture medium (x3) and collected by centrifugation. An aliquot of 
monocytes were incubated with trypan blue dye before counting in a haemocytometer 
and accordingly U937 monocytes were resuspended at 106 viable cells/0.5ml in 
RPMI-1640 culture medium.
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Just before the binding phase, HK-2 cells’ media were removed and cells were 
washed with serum-free medium (xl). 106 monocytes were added to each well of HK- 
2 cells. This number of monocytes represents a ratio of about 10:1 between U937 
cells and HK-2 cells and was selected to ensure complete coverage of the HK-2 
monolayer by the monocytes. The binding phase of the assay was done at 37°C for 1 
h. The wells were then washed with cold RPMI-1640 medium (x3) before lysing with 
1% triton X-100 (for 10 min at room temperature). The cells lysates were then 
transferred into tubes for radiolabel quantification. A standard curve of monocyte 
number against radioactivity was done for each experiment and was used to calculate 
the number of bound monocytes (figure 2.2). Spontaneous release of chromium from 
monocytes in control incubations (without HK-2 cells) was also measured in each 
experiment and was always less than 10%.
In case anti-CD44 Ab (5 pg/ml; mouse monoclonal; The Binding Site Ltd, 
Birmingham, UK) or soluble ICAM-1 (200 ng/ml; recombinant human; R&D 
Systems) were added to the monocytes, and incubated at 37°C for 60 min before the 
binding phase.
U937 Cell number (x 105)
Figure 2.2: Linear relationship between U937 cell number and incorporated 
radioactivity: Values represent averages of 3 wells (± SD).
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2.4 Fluorescence Activated Cell Sorter (FACS) Analysis
2.4.1 Preparation and staining for cells
HK-2 cells were grown in 6-well plate (Falcon) and growth arrested for 48 h 
before FACS analysis. HK-2 cells were trypsinized as done for routine HK-2 
subculturing and resuspended in PBS, spun again and resuspended in 0.5 ml FACS 
buffer (PBS containing: 10 mM EDTA pH 7.35, 15 mM Sodium Azide and 1% w/v 
Bovine Serum Albumin). 100 pi aliquots of the cell suspension were transferred into a 
round-bottom 96-well plate (Falcon). Anti-CD44 Ab (Rat monoclonal; Calbiochem 
Corporation, Nottingham, UK) was added to the wells so that the final concentration 
of the Ab would be 1/500 of the stock concentration. The cells were incubated with 
the Ab for 30 min at 4°C before spinning the plate at 3000 x g for 4 min at 4°C, cells 
were resuspended in FACS buffer. Two more washes were done using FACS buffer. 
FITC-conjugated rabbit anti-rat Ab (1/50 final concentration; DakoCytomation, 
Denmark) was added to the cells and left at 4°C for 30 min in the dark. Further three 
washes with FACS buffer were done before resuspending the cells in 250 pi FACS 
buffer and transferring into 6ml tubes (Falcon) for analysis. Each FACS analysis was 
done with 2 controls: First control was HK-2 cells processed with no antibodies (to 
detect autofluorescence) while the second control was HK-2 cells incubated with 
FITC-conjugate anti-rat Ab only (to detect fluorescence due to non-specific binding).
2.4.2 Acquisition and analysis o f cells
The cells were analysed in a Becton Dickinson FACScaiiber (Becton 
Dickinson, San Jose, CA, USA) using previously defined settings for forward scatter 
(FCS), side scatter (SSC) and channel fluorescence (FL1). The FL1 detector measures 
fluorescence readings optimally in the green region of the spectrum. 10,000 cells were 
acquired for each sample. HK-2 cells analysed were from a well-defined group of 
cells in the mid-range of FCS and SSC values that included more than 50% of the 
cells counted.
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2.5 RNA extraction and analysis
2.5.1 Cell lysis and RNA extraction
Total RNA was extracted from HK-2 cells with 0.5 ml of Trireagent (Sigma- 
Aldrich) per well of a 6-well plate. The lysate was incubated for 10 min at room 
temperature to allow RNA-protein dissociation. Chloroform (0.2 ml; Sigma-Aldrich) 
was added (to induce phase separation of RNA, DNA and proteins) and incubated on 
ice for 5 min before spinning at 16000 x g for 20 min at 4°C. The top aqueous layer 
(containing the RNA) was collected and 0.5 ml of Isopropanol (Sigma-Aldrich) was 
added and incubated overnight at -70°C to induce RNA precipitation. Next day, the 
sample was spun for 20 min at 16000 x g at 4°C to pellet the RNA, the supernatant 
was removed and discarded. Two washes were performed with 1 ml 70% ethanol and 
repeat spinning at 16000 x g 4°C for 20 min. After the final wash, the supernatant was 
removed and the pellet was air-dried for 0.5-1 hour in a fume hood before being 
dissolved in 20 pi sterile water.
2.5.2 Measurement o f RNA quality and quantity
RNA was routinely quantified by measuring the absorbance at 260 nm (A260) 
in Beckman DU64 single beam spectrophotometer (Beckman Instruments, High 
Wycombe, UK) using RNase-free quartz cuvettes. To ensure significance, only 
samples with readings between 0.15 and 1.0 were further processed. To achieve 
absorbance readings at this range, 2pi of samples were diluted into 100 pi sterile 
water and transferred into the cuvette for absorbance measurement. 1 unit of 
absorbance at 260nm corresponds to 40pg of RNA per ml {A.26(T 1 —» 40pg/ml). The 
ratio of the readings at 260nm and 280nm (^260/^280) was used as an index of RNA 
purity with respect to other contaminants that absorb UV such as protein. Only 
samples with ratios of 1.5-2.1 were further processed.
In parallel, RNA integrity was confirmed by electrophoresis of 2 pi of samples 
in a 1% agarose gel containing ethidium bromide (0.2 pg/ml). Typically, the 28S 
ribosomal RNA (5.0 Kb) bands would be present with intensity approximately twice 
that of the 18S rRNA (1.9kb) band (figure 2.3). Equal intensities of the two bands
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generally indicate that some degradation has occurred since the 28S rRNA is more 
labile than the 18S rRNA.
28S rRNA 
18S rRNA
28S rRNA 
18S rRNA
Figure 2.3: Intact RNA on 1% 
Agarose gel: Extracted from HK-2 
cells in 6-well plate.
2.5.3 Reverse Transcription-Polymerase Chain Reaction
Random hexameric (hexadeoxyribonucleotides) primers were used to initiate 
cDNA synthesis from internal sites within the mRNA molecule. This method can be 
used to prime cDNA synthesis from mRNA molecules which do not possess a 
poly(A)+ tail. The reaction mixture contained:
1 pi purified RNA (1 pg/pl) + 2 pi random hexamers (100 pM; Pharmacia 
Biosystems, Milton Keynes, UK) + 5 pi dNTPs (2.5 mM; Invitrogen) + 2 pi lOx PCR 
buffer (Applied Biosystems, Beaconsfield, UK) + 10 pi Dithiothreitol (100 mM, 
Invitrogen).
The 1st phase of the transcription reaction was done using a Gene Amp PCR 
system 9700 Thermocycler (Applied Biosystems). The reaction was incubated for 4 
min at 95°C followed by cooling to 4°C for 5 min, then 1 pi Superscript Reverse 
Transcriptase (200 U/pl; Invitrogen) and 1 pi RNAsin (40 U/pl; Promega) was added 
for each reaction. For the second phase of the transcription reaction (using the same 
Thermocycler), the samples were annealed at 62°C for 10 min followed by cDNA 
synthesis at 42°C for 60 min, and finally denaturation at 95°C for 5 min. The single 
stranded complementary DNA (cDNA) was stored at 20°C until PCR was done.
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PCR was done in a total volume of 50 pl/reaction. The primers used were all 
18-30 nucleotides in length and their GC content were between 40-60% (table 2.1). 
The reaction mixture contained:
2 pi cDNA + 1.25 pi Forward Primer (20 mM) + 1.25 pi Reverse Primer (20 mM) + 
4 pi dNTPs (2.5 mM; Invitrogen) + 5 pi PCR lOx buffer + 0.25 pi Taq Polymerase 
(10 U/ml; Amplitaq Gold, Applied Biosystems) + 36.25 pi H2O
PCR amplification was done using a GeneAmp PCR system 9700 
Thermocycler. PCR was done over a range of cycle numbers (28-40) to ensure that 
the amplification was in the linear range of the curve and to obtain the best 
discrimination of alterations in gene expression. Test reactions for all the genes 
investigated were determined previously in our department (except for ICAM-1, for 
which a series of test PCRs were done before establishing the best cycle number; 
figure 2.4). The PCR protocol was as follows: 1st cycle: 72°C for 10 min, 94°C for 3 
min, 55°C for 1 min, 72°C for 1 min. 2nd -  cycle before last: 94°C for 40 seconds, 
55°C for 1 min, 72°C for 1 min. The final cycle was 94°C for 1 min and 60°C for 10 
min. Negative controls were included in all PCR experiments. A negative PCR (- 
PCR) control consisted of a PCR reaction containing water instead of cDNA while a 
negative RT (-RT) control contained water instead of RNA.
2.5.4 Detection of PCR products
One tenth of the amplified cDNA (5 pi) was mixed with 5 pi loading buffer 
(H2O containing 15% Ficoll Type 400 (Sigma), 0.25% Orange G (Sigma)) and 
separated by electrophoresis using a 3% agarose gel (Invitrogen) made up in TEA 
buffer (40 mM Tris, 40 mM Acetic Acid, 10 mM EDTA) with Ethidium bromide (0.2 
pg/ml). 123 base pair ladder (Invitrogen) was used to confirm that the PCR products 
were of the expected size. The gel was run at 90V until the loading buffer reached the 
edge of the gel. PCR products were visualised under ultraviolet light, digital images 
were captured and analysed using Chemidoc System (BioRad, Hemel Hempstead, 
UK). In all the experiments included in this work, none of the negative controls 
showed any detectable bands.
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Primer Sequence Product
Size
Cycle
Number
p-Actin
F=5'-CCTTCCTGGGCATGGAGTCCT-3,
R=5,-GGAGCAATGATCTTGATCTT-3' 204 bp 28
HAS2
F=5'-GC AGGCGGAAGAAGGGAC AAC-3' 
R=5'-TC AGGCGGAT GC AC AGTAAGGA-3' 313 bp 36
HAS3
vl
F=5,-AGTGCAGCTTCGGGGATGA-3'
R=5,-TGATGGTAGCAATGGCAAAGAT-3, 453 bp 36
HYAL1
F=5'-CAGGCGTGAGCTGGATGGAGA-3'
R=5,-GTATGTGCAACACCGTGTGGC-3’ 400 bp 36
HYAL2
F=5'-GAGTTCGCAGCACAGCAGTTC-3'
R=5’-CACCCCAGAGGATGACACCAG-3’ 446 bp 32
HYAL3
F=5'-GATCTGGGAGGTTCCTGTCC-3' 
R=5’-TGTCC ACC AGGTCGTC ATGG-3' 150 bp 36
TSG-6
F=5,-GGTGTGTACCACAGAGAAGCA-3’
R=5'-GGGTTGTAGCAATAGGCATCC-3' 284 bp 40
HC3
F=5,-AGTACCCCGAGAACGCTATCCTG-3,
R=5,-TGGCCCTCTCATCCTCGTTGTCC-3' 411 bp 36
Bikunin
F=5,CGTTGGCGGAAAGGTGTCTGTG-3'
R=5,-ACCCCCTGATCCTTCCTCTTCT-3' 399 bp 36
ICAM-1
F=5,AAAGTCATCCTGCCCCGGGG-3'
R=5'-AGGGCAGTTTGAATAGCA-3, 189 bp 32
Table 2.1: PCR Primers (Invitrogen): F: Forward primer; R: Reverse primer.
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Figure 2.4: 3% Agarose gel electrophoresis showing ICAM-1 PCR products:
HK-2 cells were serum-starved for 48 h then stimulated with serum-free medium as
control (lane 1), 1 ng/ml IL-1 p (lane 2) or 400 ng/ml BMP-7 (lane 3) for 6 h. RNA
was extracted followed by RT PCR as described above. Products from 32 cycles PCR 
show the most discriminating differences.
2.6 DNA cloning and transfection of HK-2 cells
2.6.1 History and mechanism o f transfection
“Transfection” is defined as the process of introducing nucleic acid into cells 
by non-viral methods. The process is distinct from “infection” which is a viral method 
of nucleic acid introduction into cells. Transfection is generally used to study gene 
function or; less commonly; it can be used for therapeutic purposes. Transfection is 
achieved using either chemical reagents (DEAE-dextran or calcium phosphate co­
precipitation or Lipofection using artificial liposomes) or physical methods (as direct 
microinjection, electroporation or biolistic particle delivery).
Vaheri and Pagano [367] were the first to use DEAE-dextran for transfer of 
nucleic acids into cultured mammalian cells in 1965. In 1972, Graham and van der Eb 
[368] published their systematic examination of calcium phosphate co-precipitation. 
Both studies paved the way for future experiments necessitating DNA transfer into 
eukaryotic cells. By 1980, artificial liposomes were being used to deliver DNA into 
cells [369]. The next advancement in liposomal vehicles was the development of 
synthetic cationic lipids by Feigner and colleagues [370]. Liposome-mediated 
delivery offers advantages such as relatively high efficiency of gene transfer, ability 
to transfect certain cell types that are intransigent to calcium phosphate or DEAE- 
dextran, successful delivery of DNA of all sizes from oligonucleotides to yeast
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artificial chromosomes [370-374], delivery of RNA [375] and delivery of protein 
[376]. Cells transfected by liposome techniques can be used for transient and for 
longer term experiments that rely upon integration of the DNA into the chromosome 
or episomal maintenance. Unlike the DEAE-dextran or calcium phosphat, liposome- 
mediated nucleic acid delivery can be used for in vivo transfer of DNA and RNA to 
animals and humans [377].
A lipid with overall net positive charge at physiological pH is the most 
common synthetic lipid component of liposomes developed for gene delivery. 
FuGENE 6  Transfection Reagent (Roche Diagnostics Ltd, Lewes, UK) is an advanced 
non-liposomal lipid formulation that transfects a wide variety of eukaryotic cells with 
high efficiency and minimal cytotoxicity. It is effective for the transfection of DNA 
(very large plasmids [1 0  kb], oligonucleotides, or nucleotides) into eukaryotic cell 
types, including primary cultures and “hard-to-transfect” cell lines. It has been in use 
in our department and proved to be efficient in transfecting epithelial cells [355]. The 
amount of positive charge contributed by the cationic lipid component of the 
transfection reagent exceed the amount of negative charge contributed by the 
phosphate in the DNA backbone, resulting in tliposomes containing plasmid cDNA 
with a net neutral or positive charge on the vesicles. By the process of endocytosis or 
fusion with the plasma membrane via the lipid moieties of the liposome, these 
liposome complexes enter into the cells. Following endocytosis, the complexes appear 
in the endosomes, and later in the nucleus. It is still unclear how the nucleic acids are 
released from the endosomes and traverse the nuclear membrane before integration 
with the genomic DNA. The neutral lipid L-dioleoyl phosphatidyl ethanolamine 
(DOPE), often mixed with the cationic transfection lipid, is considered a “Fusogenic” 
lipid [378] and it is thought that its role may be to release these complexes from the 
endosomes, as well as to facilitate fusion of the outer cell membrane with the 
liposome/nucleic acid complexes.
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2.6.2 Plasmid preparation
2.6.2.1 pcDNA4/TO expression vector
pcDNA4/T0 is a 5.1 kb expression vector (Invitrogen; figure 2.5). The vector 
contains 2 important elements:
A. Hybrid promoter: consisting of the human cytomegalovirus immediate-early 
(CMV) promoter and tetracycline operator 2 (Tet02) sites for high-level tetracycline- 
regulated expression in a wide range of mammalian cells.
B. Zeocin resistance gene: for the selection of stable cell lines [379].
Although the presence of TetC>2 sites within the CMV promoter allow 
tetracycline-regulated expression of the gene of interest [380], cells that are 
transfected only with pcDNA4/TO (and not co-transfected with pcDNA6/TR vector 
that expresses the Tet repressor) will show a constitutive over-expression of the gene 
of interest.
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Figure 2.5: Diagrammatic representation of pcDNA/TO vector: Showing key 
components of the vector, including the multiple cloning site (bases 967-1077).
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2.6,2.2 HAS2-pcDNA4/TO preparation
HAS2 ORF (sequence can be retrieved from the National Centre for 
Biotechnology Information (NCBI) database at http://www.ncbi.nlm.nih.gov: 
accession number NM_005328 [166]) was provided kindly by Dr Bowen (Institute of 
Nephrology, Cardiff University College of Medicine). A modified PCR was used to 
reproduce the original HAS2 ORF using a combination of polymerases to increase the 
fidelity of the PCR product [381]. The combination included Taq polymerase 
(Promega) and Pfu polymerase (Promega) in a 9:1 ratio. The highest cloning 
efficiency is generally achieved with DNA cleaved by 2 different restriction enzymes 
that produce non-complementary overhangs. Ligating templates prepared in this 
manner is referred to as “directional cloning” because the insert DNA can be ligated 
into the vector in only one orientation. This will reduce the background level of non­
recombinants because re-ligation of the vector to itself would be greatly hindered. The 
primers designed to reproduce the HAS2 ORF included sites for 2 different restriction 
enzymes (Pst I  & Not I; table 2.2) to ensure cloning in the sense orientation of HAS2 
ORF into the pcDNA4/T0 vector.
Pst I  Forward Primer 5 ’ -CCCTGCA GACCATGGATTGTGAGAGGTTTCTATGTATC-3 ’
Not I  Reverse Primer y-C C G C  GGCCGCTCATACATCAAGCACCATGTCATATTG-3 ’
Table 2.2: Sequences of the primers used to reproduce the HAS2 ORF: RE
recognition sites are in bold italics and space in between indicate the site of action.
PCR was done for 20-30 cycles (figure 2.6), the reaction mixture contained: 
0.45 pi Taq polymerase + 0.05 pi Pfu polymerase (Invitrogen) + 5 pi Pfu buffer 
(10X) + 1 pi Forward primer (10 pmol/pl) + 1 pi Reverse primer (10 pmol/pl) + 1 pi 
HAS2 ORF + 4 pi dNTPs + 37.5 pi H20
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Figure 2.6: 1% Agarose gel electrophoresis showing HAS2 ORF: DNA was
amplified using the polymerase combination, numbers indicate number of PCR 
cycles. Samples from 20 cycles reaction were used for subsequent cloning reactions.
After the amplification reaction, HAS2 ORF (using sample from 20 cycles 
PCR) was subjected to RE digestion using Pst I  and Not I  to cleave any over-hanged 
bases. The sample was then run on a 1.5% agarose gel (to prevent gel damage during 
extraction) followed by extraction (using 1 ml pipette tip with filter) and purification 
of the HAS2 ORF using the Qiaquick PCR purification kit (Qiagen) following the 
manufacturer’s protocol.
HAS2 ORF was inserted into the vector using a standard ligation reaction 
(using Promega Ligase enzyme). Experiments showed that the best ligation resulted 
when the vector/insert molar ratio was 1:3. The ligation reaction was done at 16°C 
overnight and contained:
12 pi HAS2 ORF + 4 pi pcDNA4/TO + 2 pi ligase buffer (Promega) + 1 pi ligase 
(Promega) + 1 pi H2O
2.6.2.3 Bacterial transformation, plasmid isolation and purification
Following the ligation reaction, reproduction of the cloned vector was done by 
bacterial transformation (JM109 competent E. coli\ Promega). 10 pi of the ligation 
reaction was incubated with 40 pi of freshly thawed E. coli for 15 min on ice. To 
facilitate cDNA entry into the bacteria, a heat shock (42°C for 45 seconds) was 
applied followed by 5 min incubation on ice before incubation with 150 pi of SOC 
medium (Invitrogen) for 90 min at 37°C in an orbital shaker; 200 rpm (to allow 
recovery from heat shock and to express the newly introduced DNA). Afterwards,
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bacteria were streaked onto LB medium plates (containing 100 pg/ml Carbenicillin; 
Sigma) and left to grow at 37°C overnight. Several colonies were picked for 
screening, grown in 5 ml LB medium with Carbenicillin (100 pg/ml) for 8 h at 37°C.
1.5 ml of the bacterial culture was used for plasmid extraction and purification using 
MiniPrep kit (QIAGEN) following the manufacturer’s instructions. Purified DNA was 
subjected to RE double-digestion. A sample of the RE digest was then resolved by 1% 
agarose gel electrophoresis to check for HAS2 ORF (figure 2.7). 1 ml of each positive 
sample (with HAS2 ORF inserted into pcDNA4/TO) was re-cultured in 100 ml LB 
medium (with 100 pg/ml Carbenicillin) at 37°C overnight (to increase the yield of 
transformed bacteria). Plasmid extraction and purification was done using MaxiPrep 
kit (Qiagen). Plasmid DNA concentration was measured using a Beckman DU 64 
single beam spectrophotometer using the following formula: 
cDNA concentration (pg/ml) = Absorbance at 260 nm (A260) x 50
The A26(/A28o ratio is used as an indicator of DNA purity. Purified plasmid 
DNA ratio values were always higher than 1.8 and considered suitable for mammalian 
cell transfection.
5TS
2000 bp 
1650 bD
Figure 2.7: 1% Agarose gel electrophoresis of RE digests: Transformed E.coli 
were picked from LB plates, plasmid DNA wan then extracted and subjected to Pst I 
and Not I  digestion. Clones 2, 4 and 7 had empty vector (re-circularised pcDNA4/TO) 
while clones 3, 5, 6 and 8 had an insert of approximately 1700 bp (arrow).
2.6.2.4 HAS3-pcDNA4/TO preparation
HAS3 ORF (sequence can be retrieved from the National Centre for 
Biotechnology Information (NCBI) database at http://www.ncbi.nlm.nih.gov: 
accession number NM 005329 [167]) was provided kindly by Dr Bowen (Institute of 
Nephrology, Cardiff University College of Medicine). The HAS3 ORF was already
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cloned into pCI-neo mammalian expression vector (Promega). The pCI-neo vector is 
ideal for transient expression or stable expression by selecting transfected cells with 
the antibiotic G418 (an aminoglycoside). However, repeated experiments showed that 
HK-2 cells are resistant to the G418 antibiotic at doses even higher than that 
recommended by the vector manufacturer. Hence, all attempts to establish HAS3/pcI- 
neo stable-transfected cell lines have failed. Because of this, the decision was made to 
cut the HAS3 ORF from the pCI-neo vector and clone it into the pcDNA4/TO 
expression vector.
HAS3 ORF was excised using 2 different RE enzymes (Xho I  and Xba /; at 
37°C overnight). pcDNA4/TO was digested by Xho I and Xba I  (at 37°C overnight). 
Those RE were selected because they cut once only through pcDNA4/TO and so 
HAS3 ORF obtained by Xho I  and Xba I  digestion can be cloned directly into 
pcDNA4/TO that was also digested by these enzymes. The digestion reactions were 
resolved by agarose gel electrophoresis (figure 2.8). The HAS3 ORF was extracted 
(using 1 ml pipette tip with filter) from the gel and purified using the Qiaquick PCR 
purification kit (Qiagen).
Figure 2.8: 1.5% Agarose gel electrophoresis showing products of RE digestions:
In (A), samples were digested with Xho I  and Xba I  while (B) shows undigested 
vectors (used to confirm the action of RE). Arrows indicate the samples that were 
extracted and ligated.
Before the ligation, both HAS3 ORF and pcDNA4/TO were treated with 
shrimp alkaline phosphatase (SAP; Promega) at 37°C for 30 min (to remove the 
phosphate groups from 5’- termini to prevent re-circularisation of vector). SAP was 
then deactivated by heating to 65°C for 30 min before proceeding to cloning. HAS3 
ORF was cloned into pcDNA4/TO using a standard ligation reaction (using Promega
2000 bp 
1650 bp
m
A B A B
pCI-neo/HAS3 pcDNA4/TO
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Ligase enzyme) as described above. Following the ligation, reproduction of the 
cloned vector was done by bacterial transformation as described above. RE digestion 
to check for the presence of HAS3 ORF in the pcDNA4/TO vector was done using 
Xho I  and Xba I  enzymes (figure 2.9).
Figure 2.9: 1% Agarose gel
electrophoresis showing products of RE 
digestion: all samples were digested with 
Xho I  and Xba /. (1 and 2) represent 
product of HAS3-pcDNA4/TO ligation 
while (3) represents the original HAS3- 
pCI-neo. The inserts match in size as 
predicted while the vectors differ.
The identity of the cloned PCR products in the positive samples and the 
fidelity of the amplification were confirmed by sequencing. Samples were submitted 
to the Sequencing Service (University of Dundee, Dundee, UK). 2 standard primers 
were used for sequencing: CMV (forward primer; Invitrogen) and BGH (reverse 
primer; Invitrogen).
2.6.3 Transient transfection o f HK-2 cells
The rationale behind doing transient transfection was to confirm the activity of 
our HAS2 and HAS3 expression vectors before creating a stable cell line. The activity 
would be positive if there is: a. An increment in specific HAS isoform mRNA 
transcription (to be detected by RT PCR). b. An increment in HA synthesis (to be 
detected by HA ELISA and gel chromatography) and c. bigger exclusion zones when 
particle exclusion assay is utilised.
All experiments were done using 50-80% confluent HK-2 cells (as 
recommended by the manufacturer), seeded into 6-well plates and serum starved for 
48 h (because serum is a known HA-producing stimulus). Transfection mixtures were 
prepared in advance to reduce any bias in transfection conditions. The transfection
3000 bp
2000 bp 
1500 bp
2.6.2.5 cDNA sequencing reaction
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mixtures were made by incubating the plasmid cDNA with FuGENE 6 in a ratio of 
1:3 in serum-free medium (final volume =100 pi) at room temperature for 15 min. 
HK-2 cell medium was replaced with fresh serum-free medium prior to the addition 
of the transfection mixture (for each well: 1 pg cDNA + 3 pi FuGENE6). The plates 
were then incubated at 37°C until the end of the experiment.
2.6.4 Stable transfection o f HK-2 cells
2.6.4.1 Determining Zeocin sensitivity
Zeocin (MW=1535Da; Invitrogen) is a formulation of phleomycin Dl, a basic 
water-soluble, copper-chelated glycopeptide isolated from stertomyces vertivillus. 
This copper-chelated form is inactive. When the antibiotic enters the cell, the copper 
cation is reduced from Cu+2 to Cu+1 and removed by sulfhydryl compounds in the cell. 
Upon removal of the copper, Zeocin is activated and will bind DNA and cleave it, 
causing cell death. The Zeocin resistance protein binds stoichiometrically to Zeocin 
and inhibits its DNA strand cleavage activity. Expression of this protein in cells 
confers Zeocin resistance. Mammalian cells exhibit a wide range of susceptibility to 
Zeocin with effective concentrations ranging from 50 pg/ml to 1000 pg/ml.
To determine Zeocin sensitivity in HK-2 cells, a “kill-curve” was done. HK-2 
cells were seeded in a 24-well plate to achieve 25-50% confluence. 24 h later, alamar 
blue measurement was done followed by addition of supplemented medium with 
varying concentrations of Zeocin (0, 50,100,200,400,600, 800,1000 pg/ml) to each 
well. The medium was replenished every 4 days after alamar blue measurement. The 
Zeocin concentration selected (400 pg/ml) killed more than 99% of the cells after 8 
days (figure 2.10).
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Figure 2.10:
wells ± SD.
Cells dying due to zeocin toxicity exhibited the following morphological 
features (figure 2.11): a. Vast increase in size. b. Abnormal cell shape with the 
appearance of long appendages, c. Presence of large empty vesicles in the cytoplasm 
(breakdown of the endoplasmic reticulum and Golgi apparatus or scaffolding 
proteins), d. Breakdown of plasma and nuclear membrane (appearance of many holes 
in these membranes).
Figure 2.11: Effect of Zeocin on untransfected HK-2 cells: Zeocin (400pg/ml) was 
added to HK-2 cells 24 h after transfection. Medium (with Zeocin) was replaced every 
3 days. Pictures were taken at day 5 post-transfection using light microscopy 
(magnification x 100). Cells display typical Zeocin toxicity features.
Control (no Zeocin) 
Zeocin 1000 microg/ml 
Zeocin 800 microg/ml 
Zeocin 600 microg/ml 
Zeocin 400 microg/ml 
Zeocin 200 microg/ml 
Zeocin 100 microg'ml 
Zeocin 50 microg/ml
pre-Zeocin 4 days post-Zeocin 8 days post-Zeocin
Zeocin “kill-curve” in HK-2 cells: Data represents the average of 3
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2.6.4.2 Stable transfection
To establish stable transfected cell lines, sub-confluent HK-2 cells in 35 mm 
Petri dishes were transfected with either HAS2-pcDNA4/TO, HAS3-pcDNA4/TO or 
empty pcDNA4/TO (as mock transfection) using FuGENE 6 Transfection Reagent 
under serum-free conditions (3 pi FuGENE 6, 1 pg plasmid DNA). Zeocin (400 
pg/ml) was added to the culture medium (with 10% serum) 24 h after transfection. 
Medium was changed afterwards with (200 pg/ml Zeocin) every 72 h until distinct 
cell colonies were macroscopically visible (usually within 21 days after transfection; 
figure 2.12). Selection of colonies was done by using special cloning discs 
(Scienceware, Bel-Art products, NJ, USA) impregnated with trypsin/EDTA. Discs 
were left on HK-2 colonies for no longer than 5 min and then transferred into new 35 
mm dishes (containing 200 pg/ml Zeocin). Cells were left to grow until cells were 
more than 50% confluent. Cells were then subcultured into 75cm culture flasks from 
which cells were either frozen or processed for further experimentation. Transfected 
cell lines were maintained in 200 pg/ml Zeocin (to prevent growth of cells that have 
lost their plasmids) except during experimental time.
Figure 2.12: Transfected HK-2 clones: Light microscopy photographs of growing 
clones; cells shown in the pictures are HAS2-transfected HK-2 cells (A and B 
magnification x 250; C magnification x 100).
2.7 Hyaluronan measurement and molecular weight 
analysis
2.7.1 Determination o f HA concentration
Hyaluronan concentration in conditioned medium was measured by enzyme- 
linked binding protein assay (HA quantitative test kit from Coregenix Inc., Colorado,
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USA). The assay uses a naturally occurring Hyaluronan binding protein (HABP) to 
specifically capture HA and an enzyme-conjugated (Horseradish Peroxidase, HRP) 
version of the HABP to detect and measure the HA captured from the sample. The 
intensity of the colour after the final step is measured in a spectrophotometer at 450 
nm. HA levels in experimental and control samples are determined against a reference 
curve prepared from the reagent blank (0 ng/ml) and the HA reference solutions 
provided with the kit (50,100,200, 500, 800 ng/ml). The assay has no cross-reactivity 
to other glycosaminoglycans. To ensure that equal cell numbers were studied in these 
experiments, alamar blue readings were taken for all the samples and there was no 
significant difference between them. All the measurements were done using the same 
amount of medium; therefore, the HA results are expressed as an absolute 
concentration of HA.
All the HA ELISA experiments were corrected for cell number estimated by 
the alamar blue assay. Culture media were removed and stored at -70°C and replaced 
with fresh medium containing 10% alamar blue reagent. After 60 min incubation at 
37°C, 100 pi of culture medium was transferred into a 96-well plate and fluorescence 
was measured. There were no significant differences in cell number between 
experimental groups in any of the HA ELISA data presented.
2.7.2 Analysis o fsH-radiolabelled Hyaluronan
In vitro 3H-labelling of HA was performed as previously described [185]. 
Growth-arrested confluent HK-2 cells were stimulated with fresh medium with or 
without specific cytokines in the presence of 20 pCi/ml 3H-glucosamine (Amersham 
Biosciences) for a specific time (indicated for each experiment).
Supernatant samples were collected and treated with an equal volume of 200 
pg/ml pronase (Sigma-Aldrich) in 2X pronase buffer (100 mM Tris-HCL pH 8.0, 
0.1% Na Azide) for 24 h at 37°C to analyse HA released into the culture medium 
(Conditioned Medium fraction; CM). The remaining cell monolayer was incubated 
with 10 pg/ml trypsin (Sigma-Aldrich) in PBS for 10 min at room temperature to 
remove pericellular, protein-bound 3H-hyaluronan (Trypsin extract fraction; TE) prior 
to the addition of an equal volume of 200 pg/ml pronase in 2X pronase buffer for 24 h
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at 37°C. Following trypsinisation, 100 pg/ml pronase in IX pronase buffer was 
added to the cell pellet for 24 h at 37°C to solubilise the remaining cells-associated 
3H-hyaluroanan (Cell associated fraction; CA).
Each of the fractions was subsequently gravitationally passed over DEAE ion- 
exchange columns (Amersham Biosciences) equilibrated with 8 M urea buffer (8 M 
urea in 20 mM Bis Tris buffer, pH 6 containing 0.2% Triton-XlOO). The columns 
were washed using 8 M urea buffer until the radioactivity returned to background 
level (to remove low molecular weight peptides and unincorporated radiolabel). HA 
was then eluted with 0.3 M NaCl urea buffer until the radioactivity returned to 
background. The remaining Glycosaminoglycans were eluted with 8 ml of 4 M 
Guanidine HC1 buffer (containing 50 mM Sodium Acetate, 0.5% Triton X-100, 
0.05% (w/v) Sodium Azide; pH 6).
Equal volumes (2 for each sample) of eluted HA were incubated with 3 
volumes of 1.3% wt/vol potassium acetate in 95% ethanol in the presence of 50 pg/ml 
of each of HA, heparin (Sigma-Aldrich) and chondroitin sulphate (Sigma-Aldrich) as 
co-precipitants at 4°C overnight. The precipitated HA was collected by spinning at 
1500 rpm for 10 min and washed twice with 95% ethanol before leaving the 
precipitate to dry at room temperature for 30 min.
For each sample, two HA precipitates were prepared with one directly re­
suspended with 500 pi 4M Guanidine HC1 buffer and the other incubated with 1 IU 
Streptococcal hyaluronidase (ICN Biomedicals, Basingstoke, UK) in 200 pi 
Hyaluronidase buffer (20 mM Sodium Acetate containing 0.05% Sodium Azide, 0.15 
M NaCl) at 37°C for 24 h prior to addition of 300 pi 4 M Guanidine HC1 buffer.
Each sample was run through a dissociating Sephacryl S-500 (Amersham 
Biosciences) column (1.5m x 0.6cm) and collected using a fraction collector 
(Pharmacia Biotech, NJ, USA; pump speed=2.4 ml/hour, 0.6 ml/fraction) prior to 
quantification of radioactivity using a p counter. For p counting, an equal volume of 
70% ethanol was added to each tube in addition to 4ml of scintillation liquid (InstaGel 
Plus; PerkinElmer Life and Analytical Science, MA, USA). The column was
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calibrated with: (a) 3H-glucosamine hydrochloride, Mr 215 Da; (b) 35S-chondroitin 
sulphate GAG, Mr 25 x 103 Da; (c) 35S-decorin, Mr 10 x 104 Da; (d) 35S-versican, Mr
1.3 x 106 Da [382].
Since Streptococcal hyaluronidase will not degrade other GAG, the value of 
the hyaluronidase-treated portion subtracted from the non-hyaluronidase-treated 
portion was taken as hyaluronan-associated radioactivity (multiplied by -1 for 
correction).
2.8 Western blotting
2,8.1 Gel preparation
Gradient gels (5-20%) were used for Ial western blotting. The gels 
components were shown in the below table:
Stacking 5% 10% 20%
h 2o 6.1 ml 5.68 ml 4 ml
1.5 M Tris(pH 8) - 2.5 ml 2.5 ml 2.5 ml
0.5 M Tris(pH 6.8) 2.5 ml - - -
10% SDS 100 pi 100 pi 100 pi 100 pi
30% Bis-acrylamide 1.3 ml 1.67 ml 3.34 ml 5.01 ml
10% APS 50 pi 50 pi 50 pi 50 pi
Temed 10 pi 5 pi 5 pi 5 Ml ,
2.8.2 Sample preparation and electrophoresis
Confluent HK-2 cells were growth arrested for 48 h after which cells were 
washed once with PBS and lysed by the addition of SDS sample buffer (2% SDS, 
10% v/v glycerol, 60 mM Tris and 5% v/v mercaptoethanol) [383]. This was 
designated as “total” extract. For the Ial WB, a duplicate monolayer of HK-2 cells 
was digested with Streptococcal hyaluronidase (2 IU for 1 h at 37°C) to release matrix 
molecules bound to HA. Following the enzymatic digestion, the hyaluronidase digest 
and the remaining cells were collected and incubated with SDS sample buffer and 
referred to as “matrix” and “cell” extracts respectively. Samples were stored at -20°C 
until analysis. When the gels were ready, samples were thawed on ice and then heated 
to 100°C for 5-10 min before cooling on ice. Equal volumes were loaded into the gels. 
10 pi of dye-conjugated protein standards (See Blue Plus Two; Invitrogen) were
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loaded in an adjacent well. Gels were electrophoresed in a discontinuous vertical 
minigel apparatus (Beckton Dickinson) using IX “running” buffer (10X buffer: Tris 
HC1 30 g (pH 8.3), Glycine 144 g, SDS 10 g, made up with water to 1 litre) at 150V 
for 60 min.
2.8.3 Transblotting
After finishing electrophoresis, the gel was removed from the casting 
membrane and placed on a nitrocellulose membrane (Amersham Pharmacia) 
immersed in “transfer” buffer (1.44% w/v Glycine, 0.3% w/v Tris, 20% v/v 
methanol). Both membrane and gel were sandwiched in an inner layer of filter paper 
and an outer layer plastic wool before electroblotting at 100 V for 90 min in chilled 
transfer buffer. The appearance of protein standard bands indicated successful 
transfer.
2.8.4 Blocking, primary and secondary antibodies
Membrane blocking was done using 5% w/v non-fat milk in PBS-Tween for 
60 min at 37°C, followed by three washes lasting 5 min each on a shaker. Primary 
antibodies used were: a. anti-Ial Ab (Rabbit polyclonal, dilution 1:1000; 
DakoCytomation). b. anti-active ERK Ab (Rabbit polyclonal, dilution 1:1000; 
Promega) which recognises the dually phosphorylated active form of MAPK 
(p44/ERKl and p42/ERK2). c. anti-total ERK Ab (Rabbit polyclonal, dilution 1:5000; 
Promega). All the primary antibodies were diluted in 5% w/v non-fat milk in PBS- 
Tween (10 ml/membrane) and the membranes were incubated at 4°C overnight. 
Incubation was followed by three washes, 5 min each on a shaker. Appropriate HRP- 
conjugated secondary antibodies (Sigma) were diluted in 5% w/v non-fat milk in 
PBS-Tween and the membranes were incubated for 1 h at room temperature.
2.8.5 Detection
The membrane was developed using the ECL enhanced chemiluminescence 
system (Amersham Biosciences). The membrane was dabbed dry on filter paper, 1 ml 
of each of reagents A and B were mixed, applied to the membrane and incubated for 2 
min. Excess reagents were removed afterwards with filter paper, the membrane was
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wrapped in cling film and exposed immediately to chemiluminescence photographic 
film (Amersham Biosciences). Exposure times varied between 1-10 min.
2.8.6 Membrane stripping and reprobing
After detecting active MAPK as described above, the membrane was stripped 
of antibodies by incubating in “stripping” buffer (100 mM 2-mercaptoethanol, 2% 
w/v SDS, 62.5 mM Tris-HCl (pH 6.7)) for 30 min at 50°C followed by two washes, 
10 min each in PBS-Tween. The membrane was then blocked and probed (for total 
MAPK) as described above.
2.9 Immimocytochemistry
All immunocytochemistry experiments were done using 8-well multi-chamber 
slides (Invitrogen) and analysed by confocal laser scanning microscopy (TCS-40; 
Leica Microsystems, Cambridge, UK). HK-2 cells were seeded and grown to different 
degrees of confluency (indicated for each experiment) with supplemented medium 
containing 10% FCS. Afterwards, cells were either fixed or stimulated with different 
stimuli under serum-free conditions and then fixed. One PBS wash was routinely 
done prior to fixation.
Two fixation methods were used depending on antibodies’ manual 
instructions: a. Paraformaldehyde (3%) was used as a cross-linking fixative; the 
mechanism of fixation involves formation of covalent bonds between adjacent amine- 
containing groups through a Schiff acid-base reaction. These bonds form both inter- 
and intra-molecularly. Paraformaldehyde was added to the cells and incubated for 15 
min at room temperature. Cells were subsequently permeabilised using 0.2% Triton in 
PBS for 5 min at room temperature after which cells were washed once with PBS. 
b. Methanol (100% ice-cold) was used to simultaneously denaturate and precipitate 
samples. Although quantitative comparisons of different fixation protocols have 
shown that cultured cells fixed with cold methanol shrink by as much as 50% [384], 
methanol-fixed samples preserve their antibody binding sites as epitopes are not 
covalently modified as they might be with paraformaldehyde fixation. Also, using 
methanol fixation circumvented the necessity for detergent treatment as methanol 
permeabilises cell membranes.
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After fixation, cells were incubated with 10% FCS in PBS (30-60 min at RT) 
to block non-specific binding. This step was followed by primary antibody incubation 
diluted according to the manufacturer’s instruction (table 2.3) at 4°C overnight. Cells 
were then washed with PBS (x3) and incubated with appropriate secondary antibody 
(Table 2.3) for 60 min at room temperature. Cells were then subjected to another PBS 
wash (x3). Slides were finally mounted with Vectashield mounting medium (Vector 
Laboratories, Burlingame, CA, USA) with or without DAPI.
Primary Antibody
Concentra­
tion or 
dilution
Source/Type Company
b-HABP 5 pg/ml Bovine Seikagaku
anti-CD68 5 pg/ml Mouse monoclonal PharMingen
anti-CD44 10 pg/ml Rat monoclonal Calbiochem
anti-Versican 1 in 500 Mouse monoclonal 
(clone 2B1)
Seikagaku
anti-Ial 1 in 200 Rabbit polyclonal DakoCytomation
anti-TSG6 5 pg/ml Rat monoclonal 
(clone Q75)
Kind gift from Prof, 
AJ Day 
[385]
anti-KDEL 5 pg/ml Mouse monoclonal Stressgen
anti-E-cadherin 5 pg/ml Rabbit polyclonal Santa Cruz 
Biotechnology
anti-cytokeratin 1 in 50 Mouse monoclonal DakoCytomation
anti-ZOl 1 in 100 Rabbit polyclonal Zymed Labs.
Secondary
Antibody
Fluorescein
Avidin-D 20 pg/ml . Vector Labs.
anti-rabbit Alexa 
Fluor 568
10 pg/ml Goat Molecular Probes
anti-rabbit FITC 1 in 40 Swine polyclonal DakoCytomation
anti-mouse Alexa 
Fluor 568
10 pg/ml Rabbit Molecular Probes
anti-mouse FITC 1 in 40 Rabbit DakoCytomation
anti-rat H-L 1 in 40 Rabbit BioMeda corp.
Table 2.3: Primary and secondary antibodies used in immunocytochemistry.
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2.10 Cell migration studies
2.10.1 Scratch wound experiments
Cell migration was examined as previously described [354, 386]. Confluent 
HK-2 cells were grown to confluence in a 24-well plate (Falcon) and then serum 
starved for 48 h. Two intersecting, perpendicular wounds were generated using a 
sterile 1 ml pipette tip. The cells were then washed with PBS once before incubation 
with serum-free medium with or with out cytokines. Migration of HK-2 cells into the 
denuded area was monitored using Axiovert 100M inverted microscope fitted with a 
digital camera (ORCA-1394; Hamamatsu Photonics K.K. Hamamatsu, Japan) and 
images of the denuded area were captured as a digitalised sequence (figure 2.13). The 
rate of motility of cells was calculated as the number of cells entering the central 
denuded area during standard periods of time. Cell number was expressed as cells per 
mm2 of original denuded area per time point. A positive control was included in all 
experiments and it was composed of standard culture medium with 0.1% FCS.
2.10.2 5-BrdU immunostaining
HK-2 cell proliferation in the wounding experiments was studied by 5-bromo- 
2’-deoxyuridine (5-BrdU; Sigma-Aldrich) labelling before proceeding to 
immunocytochemistry as described previously [188, 386]. 5-BrdU is incorporated 
into the DNA of cells entering the S-phase of the cell cycle, thus it can be used as an 
indicator of cellular proliferation. HK-2 cells were wounded as described above and 
incubated with medium containing 5-BrdU (0.01 mM). At certain time points, cells 
were fixed in ice-cold acetone/methanol (1:1) for 90 sec. Cells were washed with 
Tris-buffered saline (TBS; pH 7.6) once and then incubated with 95% (v/v) 
formaldehyde in Trisodium citrate (0.15 M) for 45 min at 70°C to denature double­
stranded DNA. Cells were incubated in 50% FCS for 30-60 min at room temperature 
to block non-specific binding. Monoclonal anti-BrdU antibody (mouse; Sigma- 
Aldrich, 1:1000) was added and incubated for 30 min at room temperature followed 
by washing with TBS (x3) before addition of anti-mouse alkaline phosphatase- 
conjugated antibody (DakoCytomation) for 30 min at room temperature. Finally, 
BrdU was detected by staining with FAST RED (Sigma-Aldrich). Digital pictures 
were taken using Kodak DC290 digital camera and Leitz DIAVERT microscope.
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Figure 2.13: Wound closure in unstimulated HK-2 cells: Sequential phase-contrast 
photos of the wounded area were taken at the 0 h and every 24 h thereafter. The black 
square in 0 h represents the denuded area in which migrating cells were counted 
(highlighted areas in the other time points).
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2.11 Particle exclusion assay
HA dependent pericellular matrices were visualised by the particle exclusion 
assay in which formalised horse erythrocytes (TCS Biosciences Ltd, Claydon, UK) 
were excluded from the cell membrane due to the size of the coat and the negative 
charge of HA.
Sub-confluent of cells cultured in 35 mm dishes were washed with PBS (x2). 
Formalised horse erythrocytes were washed in PBS and centrifuged at 1000 x g for 7 
min at 4°C. This was repeated twice to remove any traces of sodium azide. The pellet 
was resuspended in serum-free medium at about 108 cells per ml. 500 pi of the 
erythrocytes suspension was added to each 35 mm dish and swirled gently to 
distribute the suspension evenly. The dished were incubated at 37°C for 15 min to 
allow the erythrocytes to settle around the cell layer. Photographs were taken using 
Axiovert 100M inverted microscope fitted with a digital camera (ORCA-1394; 
Hamamatsu Photonics).
2.12 Statistical analysis
Comparison of groups of data was done by student’s t-test, using the “two 
sample assuming unequal variances” within Microsoft excel (2003 edition). Two- 
sided tests with a hypothesised mean difference of zero and alpha level of 0.05 were 
performed. Implicit in this analysis is the assumption that the data populations were 
normally distributed, although this was not formally tested.
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Chapter III 
Extracellular HA structures: 
HA cables and the role of BMP-7 
and IL-ip in its regulation
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3.1 Introduction
To date, most work investigating the functional consequences of HA has been 
done by either adding exogenous HA or by defining stimuli that increase HA 
generation. Much less has been done to define the way in which cells (and PTCs in 
particular) package HA and what this means in terms of cell function and HA 
regulation. The work in this chapter aims to shed light on this, less understood, side of 
HA.
As mentioned in chapter one, extracellular HA is present in 2 main forms: 
soluble and pericellular (structural). The pericellular form is further subdivided into 
coats and cable-like structures. De La Motte et el. have clearly demonstrated that HA 
in a novel cable-like form mediated the adhesion of resting monocytes to colonic 
smooth muscle cells and that the expression of these cable-like structures was 
influenced by viral infection [258]. As predicted from their large size, these HA 
cables needed more time to form (17 h post-viral infection) compared to the HA coats 
(4 hours-post viral infection). Inflammatory cell infiltrates, and particularly 
monocyte/macrophage infiltrates, have been implicated in the pathogenesis of a wide 
diversity of renal diseases [387-389]. Understanding the mechanism by which HA 
mediates inflammatory cell recruitment and its regulation, therefore, has important 
relevance to kidney disease. The adhesion assay used here was originally developed 
by DiCorleto and De La Motte for investigating endothelial cell expression of 
adhesion molecules [362]. The assay exploits the fact that U937 monocytic cells carry 
the ligands for most of the recognized leukocyte adhesion molecules [64].
BMP-7 is an important potential therapeutic agent for renal diseases. Its 
relationship with HA regulation is shown in other systems but not in the kidney. For 
example, in normal human articular chondrocytes, BMP-7 promoted the assembly of 
ECM through the up-regulation of HAS2 and CD44 mRNA [179]. How BMP-7 
achieves its anti-fibrotic effect is still elusive in spite of the extensive research in this 
area. Further, influence of BMP-7 on HA regulation by PTCs is not known yet.
The role of endoplasmic reticulum (ER) stress in the formation of HA cables 
was recently reported [170] in colonic smooth muscle cells [170]. The ER is a 
dynamic membranous organelle with diverse functions including: 1. Protein synthesis,
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modification, folding and subunit assembly. 2. Steroid synthesis. 3. Lipid synthesis. 4. 
Glycogen production. 5. Sequestration of Calcium. 6. Maintenance of Calcium 
homeostasis. Many infectious agents, environmental toxins and adverse metabolic 
conditions interfere with ER function and homeostasis and induce ER stress [390- 
393]. Cells elicit an ER stress response/unfolded protein response in an attempt to 
restore homeostasis by eliminating the discrepancy between ER capacity and demand 
[390-393]. How the ECM is affected by ER stress is not known yet. Majors et el. have 
reported that induction of ER stress was associated with increased monocytes binding 
that was mediated via HA cables [170]. Further, the increase in HA cables was not 
associated with de novo protein synthesis but rather with more HAS activity. Finally, 
IL-ip has been linked with ER stress as it causes excessive nitric oxide (NO) 
production via NF-kB activation [394-396]. Since IL-lp stimulate HA production in 
HK-2 cells [175], the association of ER stress and HA cables was examined in this 
chapter.
Specifically, the aims in this chapter were to:
1. Establish the capability of HK-2 cells to produce HA cable-like structures.
2. Assess the potential of these cables in mediating monocyte binding and 
elucidate the mechanism of such interactions.
3. Determine whether the anti-fibrotic factor BMP-7 affect the formation of 
HA cables.
4. Determine whether a known HAS-inducer (IL-lp) can induce cable 
formation.
5. Investigate whether IL-1 p/BMP-7 influence ER stress and its relation with 
HA cables.
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3.2 Results
3.2.1 Visualisation o f Hyaluronan: extracellular cable-like structures are 
produced by HK-2 cells
Confocal imaging of HK-2 cells was used to examine the organisation of HA 
on the cell surface. HA was identified with a biotinylated preparation of the 
Hyaluronan-binding protein and detected with fluorescent Avidin-D. 
Photomicrographs of fixed growth-arrested HK-2 cells demonstrated a thin, diffusely- 
arranged layer of HA over the cell surface (HA coats). In addition, HA was identified 
in cable-like structures that spanned several cell lengths (figure 3.1). These cables 
appear to be composed of coalescing bundles of thinner HA strands originating from 
neighbouring cells. HK-2 expression of HA cables was variable, although they were 
present in both sub-confluent and confluent cells (figure 3.1 A and D). The number 
and the size of these cables appear to relate directly to cell number as more and bigger 
cables were noted in confluent monolayers compared to sub-confluent cultures.
Confirmation of the nature of the HA content of the cable structures was 
sought by treatment of confluent monolayers of HK-2 cells with bovine testicular 
hyaluronidase prior to addition of b-HABP. Following limited hyaluronidase 
digestion, we were unable to identify any of the cable-like structures in either 
confluent or sub-confluent cells (figure 3.IB and E). Specificity of testicular 
hyaluronidase in removing HA based structures was confirmed in parallel 
experiments in which confluent monolayers of unstimulated cells were treated with 
1U Streptomyces hyaluronidase (ICN Biochemicals, Ohio USA) prior to visualisation 
of HA (figure 3.1C) as Streptomyces hyaluronidase is considered more specific than 
bovine testicular.
High power confocal images also suggested an association between HA cables 
and the cell nuclei (figure 3.2). Using fluorescent microscopy, HA cables appear to 
traverse cells (figure 3.2B), and by visualisation of cell nuclei by staining with DAPI, 
HA cables could be seen in intimate contact with the nuclear area (figure 2C).
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Figure 3.1: Expression of HA on HK-2 cells.
Confluent (A, B and C) and sub-confluent (D and E) monolayers of HK-2 cells were 
serum deprived for 48 h prior to fixation with methanol and detection of HA by 
addition of biotinylated HABP. HA cables (arrows) were present in both confluent 
and sub-confluent HK-2 cultures.
To confirm the nature of HA staining, in parallel experiments, cells were treated with 
bovine testicular hyaluronidase (200 pg/ml) at 37°C for 5 min, prior to fixation and 
addition of biotinylated HABP (B and E).
Specificity of testicular hyaluronidase was confirmed by removal of cell surface HA 
using 1U of Streptomyces hyaluronidase (at 37°C for 60 min) prior to visualisation of 
HA (C).
In (F), only FITC-labelled streptavidin was added and it shows minimal non-specific 
binding to confluent monolayers of HK-2 cells. Sections were imaged by confocal 
microscopy.
A-F magnification x 100.
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Figure 3.2: HA cables are closely associated with HK-2 cells nuclei.
HK-2 cells were fixed and stained for HA as described in chapter two. Pictures were 
taken using confocal microscopy in A (magnification x 100) and B (magnification x 
400), and fluorescence microscopy in C (magnification x 400) where cell nuclei were 
visualised with DAPI staining.
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3.2.2 Monocytes bind to extracellular HA cables
To study the functionality of HA cables, monocytes binding was assessed in 
order to know whether these extracellular HA structures provide a site of attachment 
or not. Observations made by light microscopy revealed that unstimulated HK-2 cells 
bind U937 cells abundantly. Cell localisation was determined by DAPI staining of 
nuclei. Adherent U937 cells appeared as either cells bound individually, or cells 
bound in chains (figure 3.3A). These observations, however, can’t confirm whether 
HA is involved in the adhesion process or not.
The relationship between bound U937 cells and HA cable structures was 
examined by confocal microscopy. U937 cells added to monolayers of unstimulated 
HK-2 cells were detected with anti-CD68 monoclonal antibody. The confocal images 
showed co-localisation of the HA cables and the chains of U937 cells (figure 3.3C). 
Monocytes were also present in areas devoid of HA cables and no association was 
seen between pericellular HA coats and individually bound monocytes. These 
findings suggested the involvement of a different receptor. A similar interaction 
between monocytes and HA cables was seen with human mononuclear cells isolated 
from peripheral blood and HA cables (figure 3.3F).
Treatment of HK-2 monolayers with bovine testicular hyaluronidase prior to 
addition of U937 cells prevented U937 binding in chain-like configurations, although 
binding of scattered individual cells persisted after hyaluronidase treatment. This was 
demonstrated after DAPI staining (figure 3.3B), and also following HA and U937 
staining (figure 3.3G). Similarly, when cell monolayers were treated with testicular 
hyaluronidase after the addition of the monocytes, no binding of monocytes in chain­
like configurations, and no HA cables were seen (data not shown).
It has been previously suggested that monocytes may interact with HA via 
monocyte cell surface CD44 [397]. Pre-incubation of U937 cells with anti-CD44 Ab, 
before adding them to an unstimulated HK-2 monolayer, markedly decreased binding 
of monocytes to HA cables (figure 3.3F). Addition of the CD44 antibody did not 
affect monocytes binding in the scattered pattern.
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The nature of monocyte-PTC interaction was further examined by addition of 
radiolabelled monocytes to unstimulated confluent monolayers of HK-2 cells (figure 
3.4). Bound radioactivity was reduced by either addition of soluble ICAM (200 
ng/ml; R&D Systems) or addition of CD44 antibody (5 pg/ml; The Binding Site, UK) 
to the monocytes (prior to the binding phase of the experiment), although this was 
more prominent following CD44 blockade (about 20% reduction). Combined 
blockade of both ICAM ligands and CD44 receptors further reduced monocyte 
binding (about 40% reduction; p<0.005), thus suggesting that both HA-based 
interactions and ICAM-dependent interactions contribute to monocyte binding to 
unstimulated HK-2 cells.
The nature of monocyte-PTC interaction was studied in parallel by using 
hyaluronidase treatment. Removal of the HA cables by incubation with bovine 
testicular hyaluronidase prior to the addition of radiolabelled monocytes led to an 
increase in bound radioactivity, thus suggesting that HA cable-dependent monocyte 
binding may limit or block monocyte binding to cell surface ICAM by physically 
preventing the monocytes from reaching HK-2 cell ICAM receptors (figure 3.4).
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Figure 3.3: HA cables on confluent monolayers of HK-2 cells bind unstimulated 
monocytes.
Confluent monolayers of HK-2 cells were serum deprived for 48 h prior to the 
addition of unstimulated U937 cells at 37°C for 1 h prior to fixation. Localisation of 
monocytes was visualised by staining of cell nuclei with DAPI (A and B; 
magnification x 100). Binding of monocytes in chain like configurations can be seen
(A). This was abrogated when cells were treated with bovine testicular hyaluronidase 
at 37°C for 5 min prior to addition of monocytes (B).
In parallel experiments (C-G), HA (green) and monocytes (red) were visualised by 
addition of bioinylated HABP and anti-CD68 antibody respectively. U937 cells 
binding to HA cables on unstimulated HK-2 cells is shown in (C; magnification x 
100) and (D; magnification x 300) while PBMC binding is shown in (E; 
magnification x 300).
The role of CD44 in monocyte binding was assessed by addition of anti-CD44 
antibody (5 pg/ml) to monocytes for 1 h at 4°C prior to their addition to confluent un­
stimulated HK-2 cells (F; magnification x 200). Monocyte binding was also assessed 
following treatment of HK-2 monolayers with bovine testicular hyaluronidase at 37°C 
for 5 min (G; magnification x 200).
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Figure 3.4: Quantification of monocyte binding to unstimulated HK-2 cells.
In control experiments, confluent monolayers of serum-deprived HK-2 cells were 
washed with PBS prior to addition of 1 x 106 51Cr-labelled U937 cells under serum- 
free conditions for 1 h at 37°C. Quantification of bound radioactivity was carried out 
as described in chapter two. Soluble ICAM (sICAM; 200 ng/ml) or anti-CD44 
antibody (CD44; 5 pg/ml), were added to 51Cr-labelledU937 cells for 1 h at 4°C prior 
to their addition to confluent monolayer of unstimulated HK-2 cells, or the monolayer 
was treated with bovine testicular hyaluronidase (200 pg/ml) at 37°C for 5 min prior 
to addition of monocytes. Bound radioactivity was subsequently quantified. Data 
represent mean ± SD of four individual experiments (* p<0.005).
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3,2,3 BMP-7 stimulates HA cable formation and increases HA-dependent 
monocyte binding
As mentioned earlier, BMP-7 induced HA production in other systems. 
However, no data are available regarding the effect of BMP-7 on HA regulation in 
renal epithelial cells. Addition of BMP-7 to confluent monolayers of HK-2 cells led to 
a marked increase in cell surface HA-based cable structures as assessed by confocal 
imaging of HA (figure 3.5B and C). The functional significance of the increase in HA 
cables was assessed by addition of U937 cells to BMP-7 stimulated HK-2 cells. U937 
cell binding was examined by fluorescence microscopy and quantified by 
determination of bound radioactivity following addition of 5ICr-labelled U937 cells.
Examination by fluorescence microscopy demonstrated increased numbers of 
monocytes bound in chain-like configurations (figure 3.5H), and also showed thicker 
aggregations of monocytes in these cables (figure 3.5G). Double 
immunocytochemistry confirmed co-localisation of HA cables and U937 cell chains 
(figure 3.5F). As with the unstimulated cells, treatment of BMP-7-stimulated 
monolayers of cells with bovine testicular hyaluronidase prior to the addition of U937 
cells removed the HA cables and also abrogated binding of U937 cells in chain-like 
configurations, although binding of individual cells was still seen.
Quantification of monocyte binding, following stimulation with BMP-7 for 24 
h, confirmed that there was a significant increase in bound U937 cells at all doses of 
BMP-7 added (figure 3.6A). Following stimulation with BMP-7 (200 ng/ml) this 
represented a 118% increase of bound U937 cells over control, and for BMP-7 (800 
ng/ml) a 160% increase (p=0.0001 for both). The increase in monocyte binding 
following stimulation with BMP-7 was attenuated (about 25% reduction; p=0.0005) 
when the monocytes were pre-incubated with anti-CD44 blocking antibody prior to 
the binding phase (figure 3.6B) suggesting that this increment in monocyte binding 
was mediated by interaction with HA.
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Figure 3.5: Induction of HA cables and monocyte binding by BMP-7.
Following 48 h of serum deprivation, BMP-7 (400 ng/ml) was added to confluent 
monolayers of HK-2 cells for 24 h under serum free conditions (B and C). In control 
cultures cells were exposed to serum-free medium alone (A). Following fixation HA 
was visualised by addition of biotinylated HABP and confocal imaging 
(magnification x 100).
In parallel experiments following BMP-7 stimulation (400 ng/ml), the monolayers 
were washed prior to addition of unstimulated U937 cells. Monocytes were visualised 
both by staining of cell nuclei with DAPI (G; magnification x 200 and H; 
magnification x 100), and double immunocytochemistry using biotinylated HABP and 
anti-CD68 antibody (D; magnification x 100, E and F; magnification x 200).
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Figure 3.6: Quantification of monocyte binding following BMP-7 stimulation.
Confluent monolayers of HK-2 cells were stimulated with increasing doses of BMP-7 
(0-800 ng/ml) under serum-free conditions for 24 h (A). At the end of the stimulation 
period, the monolayer was washed with PBS prior to addition of 1 x 106 51Cr-labelled 
U937 cells again under serum-free conditions for 1 h at 37°C. Quantification of 
bound radioactivity was carried out as described in chapter two (* p<0.05).
Parallel experiments were performed to determine the role of CD44 in BMP-7- 
mediated monocyte binding (B). Cells were stimulated with 400 ng/ml BMP-7 for 24 
h. Anti-CD44 antibody (5 pg/ml) was added to 51Cr-labelledU937 cells for 1 h at 4°C 
prior to their addition to confluent monolayers of stimulated HK-2 cells. Bound 
radioactivity was subsequently quantified. Data represent the mean ± SD of four 
individual experiments.
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3.4 IL -lfi increases HA synthesis but does not increase HA cable formation
Jones et el. have previously demonstrated that IL-ip is a potent stimulus for 
HA synthesis as it increases HAS2 mRNA and also increases HA levels in the cell 
culture supernatant [175]. However the effect of IL-ip on the quality of the HA 
produced remained unknown, and therefore I investigated the effect of IL-lp on HA 
cable formation and monocyte binding in HK-2 cells.
Comparison of extracellular HA structures between IL-lp-treated and 
untreated control cultures, by confocal microscopy, showed a slight reduction or no 
change in cable formation compared to control (figure 3.7A and B). Fluorescence 
microscopic examination of IL-lp stimulated monolayers demonstrated binding of 
individual U937 cells, but minimal binding in chain-like configurations (figure 3.7D).
To confirm microscopic observations, monocyte adhesion experiments were 
done. Stimulation of monolayers of HK-2 cells with IL-ip led to a dose-dependent 
increase in binding of 51Cr-labelled U937 cells. IL-ip stimulated adhesion was 
significantly greater than binding of 51Cr-labelled U937 cells to control monolayers of 
HK-2 cells at all doses. IL-ip at a dose of 1 ng/ml induced a 45% increase in bound 
U937 cells over control (p=0.0012), whilst at the highest dose of IL-lp used (100 
ng/ml) a 76% increase in bound U937 cells was seen (p=0.0001) (figure 3.8A). In 
contrast to BMP-7-induced adhesion, IL-lp-induced monocyte binding was not 
affected by the addition of a blocking antibody to CD44 (figure 3.8B).
Since the increment in monocyte binding was not HA/CD44-dependent, I 
investigated the role of other monocyte adhesion molecules. ICAM-1 was the best 
candidate in here as ICAM-1 is expressed by PTCs [121] and can also be induced by 
various inflammatory cytokines including IL-ip [398, 399].
Addition of monocytes pre-treated with soluble ICAM-1 receptor to IL-pl- 
stimulated monolayers of HK-2 cells resulted in marked inhibition of the IL-ip- 
induced increase in monocyte binding (about 55%; p=0.0001, figure 3.8B). Similar
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results were obtained when the monocytes were incubated with an anti-LFA-1 Ab 
(ICAM-1 counter-ligand; data not shown).
The state of ICAM-1 RNA expression was also investigated to see whether it 
had a role in the increased monocyte binding seen following IL-lp stimulation. IL-ip 
, as reported by others [400, 401], increased the expression of ICAM-1 mRNA and 
this effect was most evident at 6 h (80% increase) but it is still noted after 24 and 48 
h. BMP-7, as reported by Gould et el. [106], reduced ICAM-1 mRNA. This reduction 
was seen from 6 h (60% reduction) and it was most evident 24 h after stimulation 
(80% reduction). By 48 h, ICAM-1 mRNA levels were similar to that of control 
(figure 3.9).
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Figure 3.7: IL-lp did not induce HA cable formation.
Visualisation of HA and monocytes in control cells (A and C) and following IL-lp 
stimulation (B and D). Following 48 h of serum deprivation, IL-ip (1 ng/ml) was 
added to confluent monolayers of HK-2 cells for 24 h under serum-free conditions. In 
control experiments cells were exposed to serum-free medium alone. Following 
fixation HA was visualised after the addition of biotinylated HABP by confocal 
imaging (A and B; magnification x 100).
In parallel experiments following IL-ip stimulation, the monolayers were washed 
prior to addition of unstimulated U937 cell. In both IL-lp stimulated (D) and control 
(C) monolayers, monocytes were visualised by staining of cell nuclei with DAPI 
(magnification x 100).
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Figure 3.8: Quantification of monocyte binding following IL-ip stimulation.
Confluent monolayers of HK-2 cells were stimulated with increasing doses of IL-lp 
(0-100 ng/ml) under serum-free conditions for 24 h (A). At the end of the stimulation 
period, the monolayer was washed with PBS prior to addition of 5,Cr-labelled U937 
cells again under serum free conditions for 1 h at 37°C. Quantification of bound 
radioactivity was carried out as described in chapter two.
Parallel experiments were done to determine the role of CD44 and ICAM in IL-ip- 
mediated monocyte binding (B). Cells were stimulated with 1 ng/ml IL-lp for 24 h. 
Anti-CD44 antibody (5 pg/ml), or soluble ICAM (200 ng/ml) was added to 51Cr- 
labelled U937 cells for 1 h at 4°C prior to their addition to confluent monolayers of 
stimulated HK-2 cells. Bound radioactivity was subsequently quantified. Data 
represent mean ± SD of four individual experiments (* p<0.05).
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Figure 3.9: ICAM-1 mRNA expression in HK-2 cells.
Confluent monolayers of HK-2 cells were stimulated with either IL-lp (1 ng/ml) or 
BMP-7 (400 ng/ml) for 6, 24 or 48 h. In control (C) experiments, cells were exposed 
to serum-free medium only. At the end of the experimental period total cellular RNA 
was extracted and RT-PCR done as described in chapter two. Ethidium bromide- 
stained PCR products were separated on a 3% agarose gel. Densitometric ratios, 
normalised to the control value, of each of the genes of interest compared to the 
house-keeping gene, p-actin, of 4 individual experiments are shown in the graph. 
Data represents mean ± SD. *p<0.05, **p=0.0001 compared to the mean control ratio 
for each experiment.
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3.2.5 Hyaluronan analysis following IL -lp  or BMP-7 stimulation via gel 
chromatography
To further understand how BMP-7 influences HA regulation in PTC, HA 
analysis was done by gel chromatography and the results were compared to those 
obtained using unstimulated cells and after IL-ip stimulation. Characterisation of HA 
synthesis following either BMP-7, or IL-lp stimulation was performed by addition of 
3H-glucosamine to cells at the time of stimulation to generate 3H-labelled HA. 
Analysis on Sephacryl S-500 of the samples from control HK-2 cells demonstrated 
that the majority of the labelled HA in all three extracts (conditioned medium [CM], 
trypsin extract [TE], cell-associated [CA] fractions) appeared near the void volume 
and therefore was considered to be of high molecular mass (figure 3.10). The cell- 
associated fraction did contain a smaller peak of lower molecular weight HA 
consistent with a pool of intracellular, partially degraded HA as previously reported 
[402].
Following addition of BMP-7, an increase in the amount of radiolabelled HA 
was seen in the supernatant (CM) fraction, the TE fraction, and the CA fractions. The 
increase in HA was, however, most apparent in the pericellular and cell associated 
fractions. Furthermore in the cell-associated fraction, there was an apparent increase 
in the molecular weight distribution of the second, lower molecular weight peak 
(figure 3.10). When the data were plotted in percentage graphs, low molecular weight 
HA constituted about 45% of total CA (figure 3.11 CA fraction) while BMP-7 
reduced that percentage to about 22% in spite of increased total HA in the CA 
fraction. This suggested an altered HA catabolism in the BMP-7-treated sample.
Following IL-ip stimulation, there was also an increase in the amount of HA 
in all three cellular pools. However, in contrast to BMP-7-associated changes, IL-lp 
induced the largest change in the high molecular weight HA secreted into the cell 
culture supernatant (figure 3.10 and 3.11). Consistent with previous reports that 
showed increased intracellular and pericellular HA after IL-ip stimulation [219], IL- 
lp stimulation produced an increment of HA in both CA and TE fractions (figure 3.10 
and 3.11).
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Figure 3.10: Analysis of 3H-radiolabelled HA.
Confluent serum deprived monolayers of HK-2 cells were stimulated with BMP-7 
(400 ng/ml) or IL-lp (1 ng/ml), or exposed to serum free medium (for Control) for 24 
h in the presence of 20 pCi/ml 3H-glucosamine. Subsequently conditioned medium 
(CM), protein bound (TE) and cell-associated (CA) Hyaluronan fractions were 
prepared as described in chapter two. Radiolabelled HA was subsequently analysed 
by Sephacryl S-500 chromatography, followed by measurement of the radiolabel.
The bars labelled as high, medium and low represent molecular weight ranges (high 
molecular weight > 106 Da, medium molecular weight between 105-106 Da, low 
molecular weight < 10^  Da).
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Figure 3.11: Analysis of 3H-radiolabelled HA.
Confluent serum-deprived monolayers of HK-2 cells were stimulated with BMP-7 
(400 ng/ml) or IL-1 p (1 ng/ml), or exposed to serum free medium (as control) for 24 h 
in the presence of 20 pCi/ml 3H-glucosamine. Subsequently conditioned medium 
(CM), protein bound (TE) and cell associated (CA) Hyaluronan fractions were 
prepared and analysed as described in chapter two. The graphs on the left represent 
the absolute counts while the graphs on the right represent the percentage of different 
molecular weight HA in each fraction (High molecular weight > 106 Da, Low 
molecular weight < 105 Da). The lower left graph represent the total data from all 3 
fractions plotted together and the percentage of each fraction.
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3.2.6 The influence o f IL -lp  or BMP-7 on HA synthases (HAS2 and 3) and on 
hyaluronidases (HYAL1,2 and 3)
RT-PCR was done to investigate the mechanism(s) by which BMP-7 and IL- 
lp altered HA profile. The candidate genes were HAS2 and HAS3 and also HYAL1, 
2 and 3 because they represent the main regulators of HA in HK-2 cells.
BMP-7 stimulation led to induction of HAS2 mRNA above that seen in the 
control cells (figure 3.12). HAS3 mRNA is constitutively expressed by HK-2 cells as 
previously demonstrated [175], and was not influenced by the addition of BMP-7 
(figure 3.12). Examination of hyaluronidase expression following addition of BMP-7 
showed a significant decrease in the expression of both HYAL1 and HYAL2 mRNA 
(figure 3.12) with a no change in HYAL3 expression (figure 3.13).
On the other hand, stimulation with IL-ip increased the expression of HAS2 
mRNA, without affecting expression of HAS 3 mRNA (figure 3.12). However, IL-lp 
did not alter the expression of any of the 3 HYALs.
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Figure 3.12: Expression of HA synthases (HAS2 and HAS3) mRNA and 
hyaluronidase (HYAL1 and HYAL2) mRNA.
(A) Confluent monolayers of HK-2 cells were stimulated with either IL-lp (1 ng/ml) 
or increasing doses of BMP-7 (0-800 ng/ml) for 24 h. In control (C) experiments, 
cells were exposed to serum-free medium only. At the end of the experimental period 
total cellular RNA was extracted and RT-PCR done as described in the chapter two. 
Ethidium bromide-stained PCR products were separated on a 3% agarose gel. Upper 
bands represent genes indicated in the picture; lower bands represent corresponding 
P-actin.
(B) Densitometric ratios, normalised to the control value, of each of the genes of 
interest compared to the house-keeping gene, P-actin, of 4 individual experiments are 
shown in the graph. Data represents mean ± SD. *p<0.05 compared to the mean 
control ratio for each experiment.
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Figure 3.13: HYAL3 mRNA expression in HK-2 cells.
Confluent monolayers of HK-2 cells were stimulated with either IL-ip (1 ng/ml) or 
BMP-7 (400 ng/ml) for 24 h. In control (C) experiments, cells were exposed to 
serum-free medium only. At the end of the experimental period total cellular RNA 
was extracted and RT-PCR done as described in chapter two. Ethidium bromide- 
stained PCR products were separated on a 3% agarose gel. Densitometric ratios, 
normalised to the control value, of each of the genes of interest compared to the 
house-keeping gene, p-actin, of 4 individual experiments are shown in the graph. 
Data represents mean ± SD.
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3.2.7 The role o f ER stress in HA cable formation
As mentioned earlier, the association of ER stress and HA cables was reported 
recently by Majors et al. [170]. Using confocal imaging, visualisation of ER and HA 
was done using anti-KDEL antibody and b-HABP respectively. KDEL is a carboxyl- 
terminal tetrapeptide Lys-Asp-Glu-Leu that is found at the carboxyl terminus of a set 
of soluble ER proteins and is essential for their retention [403,404].
Unstimulated growth-arrested HK-2 cells showed little KDEL staining and it 
was not associated with HA cables (figure 3.14). The faint KDEL staining is a 
possible effect of serum-starvation as it might induce ER stress. IL-lp-stimulated HK- 
2 cells showed strong KDEL staining but, as described earlier, HA cables were scarce. 
Although there were prominent HA coats in IL-lp-stimulated HK-2 cells, there was 
no consistent relation with ER stress (i.e. cells exhibiting big HA coats varied in their 
ER stress status). Finally, BMP-7-stimulated HK-2 cells stained faintly for KDEL 
although they produced more HA cables.
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Figure 3.14: Visualisation of ER stress and HA.
Confluent growth-arrested HK-2 cells were stimulated with either serum-free medium 
as control (A), 400 ng/ml of BMP-7 (B) or 1 ng/ml IL-lp (C) for 24 h before fixation 
with 100% ice-cold methanol and staining with anti-KDEL Ab (Red) & b-HABP 
(Green) as described in chapter two (magnification x 300).
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Discussion
Although numerous studies have demonstrated that increased HA within the 
kidney cortex is associated with different renal pathologies, the functional 
significance of these changes is not clear. What is clear is that the traditional view of 
HA being a structural scaffold is now being revised as it becomes apparent that it may 
function as a cellular signalling molecule, following either binding to its cell surface 
receptors (CD44 and RHAMM) or internalisation via CD44-mediated endocytosis 
[405].
In this chapter, it is been demonstrated that HA can mediate binding of 
monocytes to proximal tubular cells when HA coalesces into cable-like structures. 
These structures seem to originate from numerous different cells and form cables 
spanning several cell lengths (figure 1 and 2). HA cables present on unstimulated 
cells bind unstimulated monocytes, and their formation is up-regulated by BMP-7. As 
a consequence of increased HA cable formation, BMP-7 also increased HA- 
dependent monocyte binding. Increased HA cable formation following addition of 
BMP-7 was associated with induction of HAS2 mRNA, and an increase in newly 
synthesised cell associated HA was also observed. This would suggest a specific 
effect of BMP-7 on the assembly of pericellular HA structures in renal epithelial cells 
similar to the effect of BMP-7 on bovine articular cartilage chondrocytes [406].
Previous studies utilising colonic mucosal smooth muscle cells have 
suggested that the HCs of Ial are critical to the formation HA-based cables [258]. In 
my work, it was noted that there was a marked attenuation of HA cable formation in 
the absence of serum. All experiments described in this chapter were performed in 
the absence of serum. However, we have previously demonstrated that proximal 
tubular cells express bikunin and HC3 components of the Ial family constitutively 
[343]. This may, therefore, explain the ability of proximal tubular cells to generate 
stable HA-based cable structures in the absence of serum components. The role of 
Ial/preal in the formation of HA cables will be discussed later in more detail (chapter 
five).
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The specificity of the effect of BMP-7 was confirmed by data demonstrating 
that IL-lp, despite being a potent stimulus of HA synthesis, was unable to alter HA 
cable formation. IL-ip did however increase monocyte binding. This increase 
appeared to be unrelated to any alteration in formation of HA cables, but rather 
monocyte binding to HK-2 cells was mediated by other leukocyte adhesion 
molecules, in particular ICAM-1. Importantly, this data provides evidence that not 
only the quantity, but also the structure of HA is crucial for leukocyte binding.
In vitro studies shed some further light on the mechanistic basis of the mode of 
action of BMP-7. In mesangial cells, BMP-7 reduces TGF-pi-induced ECM effects 
[111] and in vitro, in proximal tubular cells, BMP-7 antagonises TNF-a-stimulated 
increases in expression of pro-inflammatory cytokines and chemokines [106]. There 
are no reports to date, apart from the work presented here, that relate the anti­
inflammatory and anti-fibrotic effects of BMP-7 to increased HA production and the 
subsequent HA-mediated monocyte binding.
An important difference between BMP-7 and IL-ip in terms of their impact on 
HA turnover is their effects on hyaluronidase expression. Data in this chapter 
demonstrate down-regulation of hyaluronidase (HYAL1 and HYAL2) at the level of 
transcription by BMP-7 while IL-ip did not alter expression of either enzyme. The 
change in the molecular weight of the cell-associated HA following stimulation with 
BMP-7 is consistent with decreased intracellular degradation of HA due to reduced 
hyaluronidase activity. As yet there are no antibodies available to confirm that this 
was also paralleled by a decrease in protein expression and enzyme activity, but it is 
interesting to speculate that this difference between BMP-7- and IL-ip—mediated 
regulation of hyaluronidase may be key to understanding their differential effects on 
HA cable formation. HA synthesis occurs at or close to the cell membrane, and the 
growing HA chain is extruded through the membrane into the extracellular space 
[407], At this stage, it is plausible to postulate that down-regulation of hyaluronidase 
activity by BMP-7 allows HA to remain associated with HAS, and that HA extruded 
through the cell membrane is anchored to HAS isoforms and associates with similarly 
anchored HA from neighbouring cell thus forming cables. In contrast, when 
hyaluronidase activity is unaffected, as seen following addition of IL-lp, extruded
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HA is cleaved at the cell surface and secreted into the surrounding environment. In 
this study, this is reflected by the increased concentration of HA in the culture 
supernatant following addition of IL-ip, whilst BMP-7 led to a much smaller increase 
of HA in the culture supernatant, presumably due to less HA cleavage and release.
Binding interactions between leukocytes and other cells are best characterised 
in endothelial cells in which leukocyte integrins on their surface bind to their ligands 
such as ICAM-1 and VCAM-1 [408]. Similar mechanisms of binding have been 
demonstrated in resident renal cells such as PTCs [409] and fibroblasts [410]. 
Unstimulated PTCs express low levels of ICAM-1 with no VCAM-1 expression 
[121], and up-regulation of the adhesion molecules predict outcome in inflammatory 
renal disease [409]. Interaction of infiltrating inflammatory cells with PTCs through 
these adhesion molecules, stimulate the generation of several cytokine cascades [411]. 
It is likely that such as inflammatory loops, if not controlled appropriately, will turn 
into a chronic phase which leads to the development of progressive fibrosis 
characteristic of chronic renal disease. Data in this chapter show that BMP-7-induced 
monocyte binding is distinct from IL-ip-induced monocyte binding. We postulate 
that the HA cables keep the monocytes away from the pro-inflammatory receptors. 
This hypothesis is supported by the demonstration of increased monocyte binding to 
unstimulated cells when HA cables were removed by hyaluronidase treatment prior to 
the addition of the U937 cells. Our work also confirmed what previous studies have 
suggested [106], that BMP-7 may also influence ICAM/leukocyte interaction by 
down-regulation of ICAM expression in proximal tubular cells. In an in vivo setting, 
therefore, this would reduce the impact of any infiltrating monocytes, and prevent the 
development of a pro-inflammatory amplification loop, which may lead to 
progressive interstitial fibrosis.
This effect of cell-associated HA cables, in which HA is predominantly of 
high Mw, is in marked contrast to the reported effects of soluble low MW HA. 
Addition of HA of low MW is a potent stimulus for increased expression of ICAM-1 
and VCAM-1 in tubular epithelial cells [412]. This together with increased expression 
of chemokines following addition of fragmented HA to PTCs [413], suggest that 
secreted HA, particularly when partially degraded, enhances leukocyte adhesion and
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subsequent cell activation, providing an amplification loop for pro-inflammatory 
effects of cytokines such as IL-ip. This reinforces the principle that, in general high 
MW HA represents the normal homeostatic state whereas the generation of low MW 
HA fragments signals a disruption of the normal homeostatic environment. More 
recently, high MW has been shown to inhibit monocytes population growth by the 
dual actions of impeding cell proliferation and inducing apoptosis [414]. This 
inhibition was mediated by interaction of HA with either CD44 or RHAMM 
expressed by U937 monocytes.
Although induction of ER stress in colonic fibroblasts is reported to induce 
HA deposition and subsequent HA-mediated leukocyte adhesion [170], confocal 
microscopy imaging did not reveal this relationship between an ER marker (KDEL) 
and HA cables in HK-2 cells and although IL-ip stimulated HA synthesis and 
induced ER stress, it failed to induce HA cable assembly. It is worth noting; however, 
that induction of ER stress in vivo is associated with increased HA deposition in mice 
colonic tissue and this association in also present in inflamed colonic tissue of human 
or mouse origin [170]. Moreover, HA-mediated monocyte binding is also increased 
after inducing ER stress in other cells such as lung mesenchymal cells and dermal 
fibroblasts (Majors A, unpublished observation). The differences in the cell types 
(epithelial cells versus fibroblasts) and in the stimulus used for ER induction (IL-lp 
versus tunicamycin) could be the reason behind the difference in the results.
The data presented in this chapter provide insight into how alterations in HA 
synthesis in the renal cortex may be involved in modulation of the interaction between 
infiltrating inflammatory cells and resident cells, and furthermore suggests a 
mechanism by which the known anti-inflammatory and anti-fibrotic effects of BMP-7 
in renal disease may be mediated. We speculate that the presence of BMP-7 is an 
important determinant of the function of HA. Chronic renal impairment is associated 
with a relative deficiency of BMP-7 but increased HA in the kidney. Under these 
conditions, increased HA generation is unlikely to form HA-based cables and 
therefore may be contribute to the damaging fibrotic response. In the presence of 
BMP-7, however, the formation of HA cables would be beneficial with decreased 
interaction of infiltrating cells with resident cells surface adhesion molecules.
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Chapter IV 
The functional consequences of 
HAS2 over-expression and its 
effect on HA structures
110
4.1 Introduction
As outlined in chapter one, renal PTCs are important in the initiation of 
fibrosis. There is evidence that HA of low MW may have pro-inflammatory effects on 
PTCs [412, 413, 415, 416]. In contrast to these potential disease-promoting effects of 
HA, Ito et al. have demonstrated that binding of MW weight HA to its principle 
receptor, CD44 activates the MAP-kinase pathway and enhances PTC migration, 
suggesting that CD44 may be involved in the repair and restoration of PTC integrity 
following injury [417]. There is overwhelming evidence implicating TGF-p 1 in 
progressive renal fibrosis. In PTCs, the interaction of HA with CD44 and crosstalk 
between the CD44 and TGF-p receptor leads to attenuation of TGF-p 1 signalling
[418], and increased trafficking of TGF-P receptors to lipid rafi-associated pools
[419], which facilitates increased receptor turnover [420]. These data therefore 
suggest that HA may also limit the pro-fibrotic response associated with progressive 
renal dysfunction.
Data presented in chapter three and data from previous work done in the 
department [175] have shown that HAS2 is the inducible isoform out of the two HAS 
isoforms expressed by the PTC. As mentioned in chapter one, three separate genes for 
human HA synthase (HAS) have been cloned and characterised, HAS1, HAS2 and 
HAS3 [421]. Previous work at the Institute of Nephrology examined the regulation of 
HA synthesis by renal PTCs in vitro [175] and demonstrated that stimulation of HA 
synthesis, by either IL-lp or high glucose, was associated with transcriptional 
activation of HAS2. HAS3 mRNA was constitutively expressed by PTCs but was not 
altered by stimuli increasing HA synthesis. HAS1 mRNA expression, on the other 
hand, was not detected in PTCs although on going work at the Institute suggests that 
induction of HAS1 may be a marker of terminal differentiation of myofibroblasts. 
Also, data from chapter three have demonstrated an association between stimulation 
of HA cables and induction of HAS2 mRNA in PTCs.
Several cell types surround themselves in vitro with HA in an organised 
pericellular matrix or “coat” [253, 422] in which, HA may be anchored to the surface 
of cells via an interaction with CD44 [423]. In chapter three, it is been shown that 
PTCs produce HA cable-like structures that bind mononuclear leukocytes via their
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cell surface CD44 receptors. Further to this, Zhang et al. have shown that binding of 
monocytes to these structures attenuates monocyte-dependent PTC generation of 
TGF-pl [135]. Regulation of HA synthesis and assembly of extracellular HA-based 
structures, therefore, represents an important mechanism that regulates PTC function.
The aim of this chapter was to examine the functional consequences of HAS2- 
driven HA synthesis. For this, HAS2 ORF was cloned into an expression vector 
(pcDNA4/TO) which was used to generate a stable-transfected HK-2 cell line that 
would constitutively over-express HAS2 (detailed in chapter two). The HAS2-over- 
expressing cell line was then used, in comparison with mock-transfected cell line, to 
(0 study the alterations in HA synthesis and extracellular structures (HA quality and 
quantity), and to (//) investigate the changes in two specific functions in the 
transfected cells, namely monocyte binding and cell migration.
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4.2 Results
4,2,1 Confirmation o f HAS2 over-expression in transfected HK-2 cells
After cloning of HAS2 ORF into pcDNA4/TO and generation of zeocin- 
resistant clones (detailed in chapter two). The next step was to confirm more HAS 
activity in these transfected cells. Several HK-2 clones were scanned for HA 
production in the supernatant by ELISA and one clone that showed a significant 
increase in HA production was picked for further analysis. All mock-transfected cells 
showed similar HA profiles and, therefore, one clone was selected as a control cell 
line.
Over-expression of HAS2 mRNA in the selected cell line was confirmed by 
RT-PCR (figure 4.1 A). The specificity of HAS2 mRNA expression was demonstrated 
by examining the expression of HAS3 mRNA in both the HAS2 over-expressing cell 
line and in a stable cell line transfected with the empty vector (Mock). By scanning 
densitometry there was a 35% increase in HAS2 mRNA expression in the stable 
HAS2 cell line, with no significant change in HAS3 mRNA compared to the mock- 
transfected cell line (figure 4.IB).
HA generation by the cell lines was examined both by ELISA of the cell 
culture supernatant and also following 3H-glucosamine labelling of HA and gel 
chromatography. Confluent monolayers of HAS2 over-expressing cells or mock- 
transfected cells were serum deprived for 48 h. Fresh serum-free medium was 
subsequently added for a further 24 h prior to collection and quantification of HA by 
ELISA (figure 4.1C). HA concentration in the culture supernatant was significantly 
greater in the HAS 2 over-expressing cell line. This represented a 70% increase in the 
HA over the mock transfected cells.
Analysis on Sephacryl S-500 of the 3H-glucosamine-labelled HA samples 
from both the HAS2 over-expressing cell line and the mock transfected HK-2 cells 
demonstrated that the biggest difference in HA quantities was in the CM fraction 
(figure 4. ID). Also, the majority of the labelled HA in the conditioned medium and in 
the TE fraction appeared near the void volume and therefore was considered to be of
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high molecular mass (figure 4.2). In addition, in the HAS2 transfected cells, there was 
a marked increase in lower molecular weight HA in the CA fraction (representing 
more than 60% of this fraction) as compared to the mock-transfected cells (which had 
about 40% as low MW HA; figure 4.2).
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Figure 4.1: HAS2/HAS3 expression & HA production in HAS2-transfected HK-2 
ceils.
(A) Total mRNA was extracted from confluent, transfected monolayers after 48 h of 
serum deprivation. Ethidium bromide-stained PCR products were separated on a 3% 
agarose gel. Four representative PCR reactions are shown.
(B) densitometry data normalised to their respective actin bands.
In parallel experiments, supernatant samples were collected from confluent serum- 
deprived cells exposed to serum-free medium for 24 h after growth-arrest. HA was 
then quantified by ELISA (C). Data represent mean ± SD of four separate 
experiments.
In (D), the totals of the 3 fractions analysed by gel chromatography were plotted. The 
samples analysed were collected from either mock- or HAS2-transfected confluent 
serum-deprived monolayers that were exposed to serum-free medium for 24 h (CM; 
conditioned medium, TE; trypsin extract, CA; cell-associated. Detailed 
chromatography data are shown in figure 4.2.
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Figure 4.2: Analysis of HA in transfected HK-2 cells.
Confluent serum-deprived monolayers of HAS2 over-expressing cells or mock- 
transfected cells were exposed to serum-free conditions for 24 h in the presence of 20 
pCi/ml 3H-glucosamine. Subsequently, conditioned medium (CM), trypsin extract 
(TE) and cell-associated (CA) HA fractions were prepared and analysed as described 
in chapter two. The bars labelled as High, Medium and Low represent MW ranges 
(high MW > 106 Da, medium MW from 105 to 106, low MW < 105 Da). The graphs 
on the right represent the percentage of different MW HA in each fraction.
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4.2.2 Visualisation o f HA
Confocal imaging was used to examine the organisation of HA on the cell 
surface. HA was identified with b-HABP and detected with fluorescent Avidin-D. 
Photomicrographs of fixed, growth-arrested mock-transfected HK-2 cells 
demonstrated diffusely arranged pericellular HA over the cell surface (pericellular 
coats). In addition, HA was demonstrated in cable-like structures that spanned several 
cell lengths (figure 4.3A and 4.4A). These results are consistent with the previous 
characterisation of cell surface HA in un-manipulated HK-2 cells (data from chapter 
three). In contrast, in the HAS2 over-expressing cell line HA was seen predominantly 
in pericellular coats with relatively few HA-based cables identified (figure 4.3B and 
4.4B). Furthermore, the thickness of the pericellular HA coats in the HAS2 expressing 
cells was significantly greater than that seen in the mock-transfected cells. 
Confirmation of the nature of the HA content of the cable structures was shown by 
treatment of confluent monolayers of cells with bovine testicular hyaluronidase (200 
pg/ml at RT for 5 min) prior to addition of b-HABP. Limited hyaluronidase digestion 
removed both the cable structures in the mock transfected cells and the pericellular 
matrices in both the mock- and HAS2- transfected cells (figure 4.3C and E). High 
digital magnification after hyaluronidase treatment showed that HAS2 transfected 
cells, unlike the mock cells, have foci of HA around their nuclei (figure 4.3D and F).
The pericellular HA coat was also visualised by the particle exclusion assay in 
living cells. Following sub-culture, mock-transfected cells exhibit a “native” matrix as 
demonstrated by a thin halo of exclusion of formalin-fixed horse erythrocytes (figure 
4.4C). In contrast, HAS2-transfected cells assembled a much more prominent 
pericellular matrix (figure 4.4D).
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Figure 4.3: Visualisation of HA in transfected cells.
Confluent monolayers of mock-transfected (A) and HAS2 over-expressing (B) cells 
were serum deprived for 48 h prior to fixation with methanol and detection of HA by 
addition of biotinylated-HABP. Cells were imaged by confocal microscopy 
(magnification x 200). Pericellular coats are highlighted by red arrow heads and HA 
cables by yellow arrows.
To confirm the nature of HA staining, in parallel experiments, cells were treated with 
bovine testicular hyaluronidase (200 pg/ml) at 37°C for 5 min, prior to fixation and 
addition of b-HABP (Mock (C) and HAS2 (E); magnification x 200). Red squares 
indicate areas that were digitally magnified (Mock (D) and HAS2 (F)). Pink arrows 
indicate the sites of membrane-bound HA (?CD44-bound), mostly evident in mock 
transfected cells (D).
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Figure 4.4: Visualisation of HA in transfected cells.
Sub-confluent mock-transfected (A) and HAS2 over-expressing (B) HK-2 cells were 
serum deprived for 48 h prior to fixation with methanol and detection of HA by 
addition of b-HABP. Sections were imaged by fluorescent microscopy (magnification 
x 200). Pericellular coats are highlighted by red arrows and HA cables by yellow 
arrows. Cell nuclei are visualised by DAPI staining (blue).
Functional pericellular matrix in the mock (C) and HAS2 over-expressing (D) cells 
was visualised by the particle exclusion assay. The zones of exclusion of formalin- 
fixed red blood cells in both cell lines are indicated by red arrows and dotted lines 
(magnification x 200).
4.2.3 HA-dependent monocyte binding
U937 monocytic cells were used to examine the binding capacity of 
inflammatory cells by either HAS2 over-expressing or mock-transfected HK-2 cells. 
Quantification of monocyte binding was done by determination of bound radioactivity 
following addition of 51Cr-labelled U937 cells. In the mock-transfected cells, 
monocyte binding was significantly reduced by removal of cell surface HA by adding 
bovine testicular hyaluronidase (200 pg/ml) at 37°C for 5 min to the epithelial cell 
monolayers, prior to addition of monocytes. Despite increased HA generation in the 
HAS2 over-expressing cells, binding of labelled U937 cells was significantly greater 
in the mock-transfected cells (figure 4.5A). Addition of hyaluronidase to the HAS2 
cell line did not significantly reduce the binding of labelled U937 cells. These data are 
therefore consistent with the marked difference in the expression of HA cables 
between the two cell lines.
Data in chapter three suggested that the increase in HA cables is associated 
with a down-regulation of hyaluronidase, suggesting that alteration in HA turnover 
may be involved in their generation. To further explore this possibility, hyaluronidase 
expression (HYAL1 and HYAL2) was examined by RT-PCR in the HAS2- and 
mock-transfected cells. Confluent cell monolayers were serum-deprived for 48 h 
prior to extraction of total mRNA. The marked decrease in HA cables in the HAS2 
over-expressing cell line, and the increase in low molecular weight HA in the cell 
extract were associated with a significant increase in both HYAL1 and HYAL2 
mRNA expression compared to mock-transfected cells (figure 4.5B and C).
120
p=0.01
(A)
10
=  4
p=0.02
M o c k HAS2
+ HYAL digestion
(B)
—
H Y A Ll
HYAL2
p actin
— v— 
Mock
j --V---
HAS2
(C)
p=0.004 p=0.005
Mock
HAS
H Y A Ll/A ctin  HYAL2/Actin
Figure 4.5: Reduced HA cable generation is associated with reduced monocyte 
binding and increased expression of hyaluronidases in HAS2 over-expressing 
cells.
(A) Quantification of monocyte binding: Confluent monolayers of serum-deprived 
cells were washed with PBS prior to addition of 1 x 106 51Cr-labelledU937 cells under 
serum-free conditions for 1 h at 37°C. Quantification of bound radioactivity was 
carried out as described in chapter two. To quantify HA-dependent binding, the 
monolayer was treated with bovine testicular hyaluronidase (200 pg/ml) at 37°C for 5 
min prior to addition of monocytes. Data represent mean ± SD of four individual 
experiments.
(B) Expression of hyaluronidase (HYALl and HYAL2) mRNA. Total mRNA was 
extracted from confluent monolayers of mock-transfected and HAS2 over-expressing 
cells after 48 h of serum deprivation. Ethidium bromide-stained PCR products were 
separated on a 3% agarose gel. Three representative PCR reactions are shown.
(C) Densitometry data normalised to their respective actin bands.
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4.2.4 Cell migration
Cell migration was assessed in a previously characterised scratch wound 
system [188, 354] (detailed in chapter two). Confluent monolayers of cells were 
serum deprived for 48 h prior to wounding. Closure of the denuded area was then 
monitored at different times. Initially, the cells at the wound edge rounded up but 
quickly regained their epithelial-like appearance. Cells moved as a monolayer of flat 
polygonal cells with some cells at the leading edge detaching from the advancing 
monolayer. At 24 h post-scratch and at all time points thereafter, the number of 
migrating cells entering the “denuded area” was significantly greater in the HAS2 
over-expressing cells compared to the mock-transfected cells (figure 4.6).
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Figure 4.6: Quantification of cell migration.
Confluent serum-deprived monolayers of mock- or HAS2-transfected cells were 
scratched as described in chapter two to produce an intersecting area denuded of cells. 
Subsequently, following washing of the monolayer to remove detached cells, the rate 
of cell migration of each of the two cell lines was assessed by directly counting the 
number of cells migrating into the intersecting denuded area at the time points 
indicated. The data are expressed as the number of cells per denuded area. Data 
represent the mean ± SD of four individual experiments.
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4.2.5 Enhanced cell migration is not due to an increased cell proliferation at the 
wound edge
The contribution of cell proliferation to the process of wound healing 
following mechanical injury was examined by incubating cells with BrdU followed 
by staining for BrdU. Figure 4.8 shows that almost no BrdU was incorporated into 
cells at/close to the wound edge in either mock- or HAS2-transfected cells at 24 h 
post wounding. Contrary to the observations at the wound edge, positive BrdU 
staining was detected in areas away from the wound edge (figure 4.7). BrdU 
incorporation experiments were repeated at 72 h post-wounding and no difference 
was seen between mock- or HAS2-transfected cells near the wound edge unlike areas 
away from the wound edge where HAS2-transfected cells showed more BrdU 
staining than mock-transfected cells (figure 4.7). The latter observations were 
confirmed by doing alamar blue experiments to quantify the difference in the 
proliferation rate in the absence of serum. HAS2-transfected cells significantly 
outgrow their mock counterparts at day four post-seeding (figure 4.8).
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Figure 4.7: BrdU staining in transfected cells 24 and 72 h post-wounding.
Transfected HK-2 cells were wounded and incubated for 24 h (A, B, E and F) or 72 h 
(C, D, G and H) in serum-free medium. After that, medium was replaced with 
medium containing BrdU and incubated at 37°C for 5 h before fixing and staining as 
detailed in chapter two. (A and C/B and D) show mock-/HAS2-transfected cells at the 
wound edge. (E and G/F and H) show mock-/HAS2-transfected cells away from the 
wound edge (magnification x 100). Arrows indicate cells positively stained with 
BrdU.
124
250
200
1 5 0
p=0.01n
-2 100
50
Day 1 Day 4
□  Mock-transfection 
F I  HAS2-transfection
Figure 4.8: Growth profile in mock- and HAS2-transfected cells.
Transfected cells were seeded at low density with 10% FCS for 24 h. After 24 h, 
medium was replaced with serum-free medium containing 10% alamar blue and 
fluorescence measured after 1 h. After washing with PBS, cells were incubated with 
serum-free medium until the next alamar blue measurement (at day 4 post-seeding).
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4.2.6 Enhanced cell migration in HAS2-transfected cells is not CD44-dependant
Previous work in the department demonstrated that migration in a scratch 
wound system utilising non-transfected HK-2 cells is mediated by CD44-dependent 
activation of ERK and that this effect may be enhanced by the addition of exogenous 
HA [188]. However, addition of monoclonal blocking antibody to CD44 (5 pg/ml) to 
a monolayer of HAS2 transfected cells following wounding had no effect on the rate 
of cell migration as compared to migration of HAS2 over-expressing cells in the 
absence of antibody (figure 4.9A).
Furthermore, reduction in the ERK activation was observed by immunoblot 
analysis of phosphorylated MAPK in the HAS2 over-expressing cells compared to 
mock-transfected cells (figure 4.10A). Cell surface CD44 expression was examined 
by flow cytometry and immunocytochemistry using an antibody to the common 
region of CD44. There was a marked decrease in cell surface expression of CD44 in 
the HAS2 over-expressing cells compared to the mock-transfected cells (figure 4.1 OB 
andC).
To demonstrate that migration in HAS2-transfected cells was related to the 
generation of HA, exogenous HA (MW 2 x 106 Da, 25 pg/ml) was added to the 
monolayer following the generation of a wound. Despite reduction in the expression 
of CD44, HAS2 over-expressing cells responded positively to exogenous HA and this 
represented a significant increase in migration at all time points beyond 48 h (figure 
4.9B).
126
A B
4 0 0 □  HAS2□  HAS2
□  HAS2 + anti-CD44 HAS2 + HA
Time (h) Time (h)
Figure 4.9: Role of CD44 in HAS2 over-expression-mediated enhanced cell 
migration.
Confluent HAS2-transfected cells were serum-deprived for 48 h prior to wounding. 
Migration was then assessed in (A) with or without CD44 blocking Ab and in (B) 
with or without HA (25 pg/ml; 2 x 106 kDa). No significant difference was noted at 
any of the time points between the 2 samples in (A). Data represent the average of 4 
individual experiments ±SD.
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Figure 4.10: Reduced phosphor-ERK and CD44 expression in HAS2-transfected 
cells.
(A) Whole cell extracts from growth-arrested transfected cells were resolved by SDS- 
PAGE. The blots were probed with anti-phospho ERK (active ERK) before stripping 
and re-probing with anti-total ERK to ensure no change in the expression of whole 
cell ERK had occurred.
(B) CD44 expression assessed by FACS analysis in confluent growth-arrested cells. 
The graph shows a comparison between mock- and HAS2-transfected cells.
(C) CD44 expression shown by immunocytochemistry in growth-arrested mock- or 
HAS2-transfected HK-2 cells (magnification x 200).
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4.2.7 Role o f Ia l/P a l in the migration o f transfected HK-2 cells
Ial is known to be involved in the formation of extracellular HA structures 
(detailed in chapter one). Since HAS2-transfected cells showed an enhanced 
migratory rate, I wanted to investigate the importance of Ial in this regard. Following 
scratch wounding, incubation of either mock- or HAS2-transfected cells with 
antibody to Ial/Pal led to significant inhibition of cell migration (figure 4.11).
Previously, Janssen et al. [343] have demonstrated that HK-2 cells synthesise 
both HC3 and bikunin components of the Ial complex. Expression of HC3 was 
examined in the HAS2 over-expressing cells by RT-PCR and for protein expression 
by western analysis. In the HAS2 over-expressing cells there was a decrease in HC3 
mRNA expression compared to mock-transfected cells (figure 4.12A) while bikunin 
expression was unaffected.
In addition, Ial/Pal protein expression in total cell lysates was analysed by 
western blotting (figure 4.12C). Western blot analysis detected many bands in the 
total extract of both mock- and HAS2-transfected cells where the highest molecular 
mass species are likely to correspond to Ial/Pal covalently attached to HA as 
previously described [424]. Duplicate samples were treated with Streptomyces 
hyaluronidase and this showed two major Ial positive bands. The lower MW species 
(-75 kDa) most likely represents HCs that were covalently bound to HA. The 
appearance of the upper band (—125 kDa) on hyaluronidase digestion and its 
sensitivity to NaOH treatment is similar to that described for the TSG-6-HC 
complexes in the murine cumulus-oocyte complex [346]. Also worth noting is that 
although HC3 mRNA expression was decreased, Ial/Pal-HA complex (figure 4.12C; 
lanes 1 and 4) was more prominent in HAS2-transfected cells which could mean that 
larger extracellular HA pools could act as a reservoir for secreted hyaladherins.
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Figure 4.11: Ab to Ia l/P a l reduced transfected HK-2 cells migration.
Confluent growth-arrested transfected HK-2 cells were mechanically scratched before 
addition of serum-free medium with or without polyclonal Ab to Ial/Pal (dilution 
1/50). Wound closure was monitored as described in chapter two. Data represent the 
average of 4 individual experiments ± SD.
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Figure 4.12: Ia l/P a l mRNA and protein expression in transfected HK-2 cells.
Levels of mRNA expression of HC3 and bikunin in transfected HK-2 cells were 
assessed by RT-PCR after 48 h of serum-deprivation (A). Ratios of band densities of 
HC3 and bikunin/p-actin were measured and plotted in (B).
(C) Western blot analysis of Ial/Pal extracted from growth-arrested transfected HK-2 
cells. l=Total lysate (both cells and matrix), 2=HYAL-extracted matrix, and 
3=NaOH-treated matrix (HYAL-extracted). Protein amounts loaded in lanes (1) were 
normalised to viable cell number (by alamar blue). The Ab used recognises intact Ial 
family members including: Pal (120-130 kDa), individual HCs (75-80 kDa), bikunin 
(35 kDa) and Ial associated with TSG-6 (TSG-6 molecular weight is 42 kDa).
131
4.2.8 Role of TSG-6 in transfected HK-2 cells migration
The role of TSG-6 was investigated because of its reported importance in the 
stability of extracellular HA structures (detailed in chapter one). In the scratch wound 
system, incubation of HAS2-transfected cells, but not mock-transfected cells, with rat 
anti-human monoclonal antibody A3 8 (5 pg/ml), previously demonstrated to block 
the formation of TSG-6-HCs complexes in vitro [278], significantly attenuated cell 
migration (figure 4.13).
The role of TSG-6 in the two cell lines was further examined by assessing 
migration in the presence of a full-length recombinant TSG-6 (Q allotype; designated 
TSG-6Q); or a mutant of TSG-6Q, where Tyr-94 has been replaced by phenylalanine 
(designated TSG-6Q_Y94F). It has been shown previously that an equivalent 
mutation in the isolated Link module of TSG-6 (i.e. the Y59F mutant of Link_TSG6) 
caused a 25-fold reduction in HA-binding activity compared to wild type Link_TSG6 
[425], and that mutation of this residue in the context of the full-length TSG-6 protein 
impairs its HA-binding function to a similar degree (Rugg et al., manuscript in 
preparation). In addition, we have also assessed the effect of this mutation on TSG-6- 
mediated HC transfer onto HA (i.e. to form HC-HA). From figure 4.14A it can be 
seen that TSG-6Q and TSG-6Q_Y94F can both support HC transfer from Ial and Pal 
onto HA, albeit with a slightly reduced activity of the mutant compared to wild type 
protein. Thus, it is possible to use a comparison of TSG-6Q and TSG-6Q_Y94F to 
differentiate between HA- and HC-HA-mediated effects. In this regard, both the TSG- 
6Q and TSG-6Q_Y94F significantly increased the migration of cells over-expressing 
HAS-2 (figure 4.14B). In contrast, addition of Link_TSG-6, which can bind to HA 
[426-428] but is unable to form stable complexes with HCs [317], had no effect of 
migration. From these experiments it is clear that TSG-6-mediated HC transfer is 
critical for the enhancement of migration of cells in which HA production is increased 
through over-expression of HAS2 mRNA. Furthermore, by using a monoclonal Ab 
that recognises TSG-6 link module epitopes [385], the presence of endogenous TSG-6 
in the pericellular matrix was confirmed by immunocytochemistry revealing that 
TSG-6 co-localised with HA around the HAS2-transfected cells (figure 4.15).
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Figure 4.13: Effect of TSG-6 Ab on cell migration is exclusive to HAS2- 
transfected HK-2 cells.
Confluent growth-arrested transfected HK-2 cells were mechanically scratched before 
addition of serum-free medium with or without TSG-6 monoclonal Ab (clone A3 8; 
5 pg/ml). Wound closure was monitored as described in chapter two. Data represent 
the average of 4 individual experiments ± SD.
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Figure 4.14A: Mechanism of TSG-6 effect on cell migration in HAS2-transfected 
cells.
Effect of mutation on TSG-6-mediated transfer of HCs onto HA. Mouse serum (as a 
source of Ial and Pal), high molecular mass HA and human recombinant TSG-6Q 
(wild type (wt) or TSG-6QJY94F mutant (‘Y94F’)) were incubated at 37°C in the 
absence or presence of EDTA. Samples were run on SDS-polyacrylamide gels and 
analysed by western blotting using a polyclonal antibody against Ial that also 
recognises Pal. The presence of EDTA (+) inhibits HC transfer and intense bands are 
seen for Ial and Pal, as described previously [429]. The absence of a band or a 
significant reduction in its intensity indicates that TSG-6-mediated HC transfer has 
taken place. TSG-6Q and ‘Y94F’ in the absence of EDTA (-) both give rise to a high 
level of HC transfer, however, if TSG-6 is not added then transfer does not occur. 
Whilst the ‘Y94F’ mutant leads to a significant amount of HC transfer it is somewhat 
less active than the wild type protein for the transfer of Ial and Pal HCs onto HA.
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Figure 4.14B: Mechanism of TSG-6 effect on cell migration in HAS2-transfected 
cells.
Enhanced migration of HAS2 over-expressing cells is dependent on Ial/Pal transfer 
activity of TSG-6. Confluent growth-arrested HAS2-transfected HK-2 cells were 
mechanically scratched before addition of serum-free medium with or without TSG- 
6Q or TSG-6Q Y94F or Link_TSG-6 (all at a final concentration of 5 pg/ml). 
Wound closure was monitored as described in chapter two. The data are expressed as 
the number of cells per mm2 of denuded area. Data represent the mean ± SD of four 
individual experiments.
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Figure 4.15: Co-localization of TSG-6 and extracellular HA.
Confluent monolayers of transfected HK-2 cells were serum deprived for 48 h prior 
to fixation with methanol and detection of either HA by addition of b-HABP (5 
pg/ml) or TSG-6 using rat anti-human monoclonal antibody Q75 (5.3 pg/ml). 
Following overnight incubation, the slides were washed with PBS prior to incubation 
with either fluorescent Avidin-D (20 pg/ml) or anti-rat Texas red-conjugated 
antibody. Co-localisation of HA and TSG-6 was examined by merging of the two 
images.
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4.3 Discussion
Previous studies in the department have demonstrated that in PTCs, 
stimulation of HA production is associated with induction of the HAS2 gene [175]. 
Data from chapter three have shown that induction of HAS2 is stimulus specific. 
Induction with BMP-7 led to an increase in the formation of HA cable-like structures 
whilst increased HA in response to IL-1(3 was most apparent in the culture medium. 
Furthermore, phenotypic alteration in renal epithelial cells may be driven by 
adenoviral expression of HAS2 [430]. In order to further examine the potential role of 
HAS2-driven HA synthesis in the alteration of epithelial cell function, the aim of the 
work presented in this chapter was to characterise alterations in HA and its 
consequences on cell functions following HAS2-driven HA synthesis in PTCs.
The data presented demonstrate a marked increase in pericellular HA 
following over-expression of HAS2 in human proximal tubular epithelial cells. In 
marked contrast, there was a striking absence of HA cables when compared to the 
mock-transfected cells. Data from chapter three have demonstrated that HA cables are 
associated with monocyte adhesion, which is consistent with the data presented in this 
chapter that the HAS2 over-expressing cells exhibit a reduction in HA-dependent 
monocyte binding. The big pericellular coats can also have a role in preventing 
monocyte adhesion via masking other receptors (like ICAM-1) and being unreceptive 
themselves to monocytes. This relative “un-reactivity” of the pericellular HA is also 
seen in other systems like colonic smooth muscle cells (De La Motte, CA -  personal 
communication.). In chapter three, stimulation of cable formation following addition 
of BMP-7 was associated with decreased expression of both HYAL1 and HYAL2. In 
contrast to BMP-7, IL-lp did not influence HYAL expression and did not stimulate 
cable formation although it is a potent stimulus of HA synthesis. This led us to 
postulate that down-regulation of hyaluronidase activity by BMP-7 allowed HA to 
remain associated with HAS, and that HA extruded through the cell membrane is 
anchored to HAS isoforms and associates with similarly anchored HA from 
neighbouring cell thus forming cables. Data in this chapter are consistent with this 
hypothesis; a consequence of the up-regulation of hyaluronidase in the HAS2- 
transfected cells is that extruded HA is cleaved at the cell surface. Although we have
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only demonstrated alteration of HYAL1 and HYAL2 at the level of their mRNA, the 
increase in low molecular weight HA in the HAS2 cells suggest that this is also 
associated with increased HYAL enzyme activities.
The increase in the pericellular HA in the HAS2-transfected cells is consistent 
with the observation that inhibition of HAS2 activity has been demonstrated to inhibit 
pericellular matrix assembly in human articular chondrocytes [273]. The generation of 
such a pericellular matrix has been previously associated with the migratory capacity 
of cells [253] as was seen in the HAS2 over-expressing cells. Ito et al. have 
demonstrated that exogenous HA increased epithelial cell migration through CD44- 
dependent activation of the ERK MAPK pathway [188]. However, the enhanced 
migration seen in the HAS2-transfected cells is clearly not dependent on CD44 
activation. Furthermore, a reduction of CD44 expression was seen in the HAS2 over­
expressing cells. This would suggest that, in contrast to previous reports utilising 
articular chondrocytes [280], the pericellular HA matrix is not anchored by CD44 in 
this case. In certain cell types, HA is internalized for degradation by an endocytic 
pathway that requires CD44 function [431, 432]. A reduced endocytic capacity for 
HA as a consequence of reduced CD44 expression may therefore contribute to the 
accumulation of HA into the pericellular coats in our experimental system. Enhanced 
migration of the HAS2 over-expressing cells following addition of exogenous HA, 
however, demonstrates that they are still able to respond to alterations in HA. Other 
reports indicate that HA-dependent cell migration may be CD44 independent, but 
associated with another distinct HA cell surface receptor (like RHAMM) [247, 252]. 
More recent studies suggest that RHAMM compensates for CD44 in inflamed CD44- 
knockout mice [433]. It is interesting to speculate therefore that in the face of reduced 
CD44 expression in the HAS2 over-expressing epithelial cells, enhanced migration is 
related to preferential RHAMM activation. It is of note, however, that HA-induced 
transcription of metalloproteases has been demonstrated to be mediated via a cell 
surface receptor which is neither CD44 nor RHAMM [237], suggesting that further, 
as yet unidentified, cell surface receptors may mediate HA-dependent events.
In contrast to the lack of effect of the blocking antibody to CD44, antibodies 
to either Ial-related proteins or TSG-6 clearly attenuated migration of HAS2 over­
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expressing cells. Much of the work on the associations of Ial-related proteins with 
ECM has been done in the setting of the cumulus cell-oocyte complex (COC) [434]. 
In this system, it is clear that HA is the major structural component that determines 
the viscoelastic properties of the expanding matrix of the cumulus-oophorus. It is also 
well established that members of the Ia l family are pivotal for the formation of the 
COC matrix, where covalent linkage of HCs of Ial (HC1 and HC2) and Pal (HC3) to 
HA has been demonstrated [279, 315], an interaction postulated to contribute to the 
stabilisation of the ECM [347, 435]. The localisation of HCs within the pericellular 
HA coat and the inhibition of migration of both mock- and HAS2-transfected cells by 
inclusion of an antibody to Ial/Pal therefore support the notion that addition of HCs 
to HA is an important mechanism by which the pericellular HA coat is stabilised in 
renal epithelial cells.
The data in this chapter also point to a critical role for TSG-6 in cell migration 
because inhibition of TSG-6 abrogated the migration of the HAS2 over-expressing 
cells, while addition of the full-length recombinant protein enhanced their migration. 
TSG-6, and its Link module domain, has been found to enhance the adhesion of 
leukocytes by increasing the affinity of HA binding to CD44 on the surface of 
lymphocyte cell lines [428]; this may occur by the TSG-6-mediated formation of 
cross-linked HA fibres that can lead to the clustering of multiple CD44 molecules. 
The lack of effect after the addition of Link_TSG6 would suggest that its action is 
independent of its HA-binding capacity, and again this is consistent with the 
decreased expression of CD44 in the HAS2-transfected cells. TSG-6 also forms 
covalent complexes with HCs from either Ial (HC1 or HC2) or Pal (HC3) that act as 
intermediates in their covalent transfer onto HA [429] thus stabilising extracellular 
matrices rich in HA [315]. In this regard, there are no HCs of either Ial or Pal 
incorporated into the cumulus matrix in the TSG-6"7" mouse and these animals are 
infertile due to an inability to expand their COCs [315]. There would, however, 
appear to be differences in the mechanism of transfer of HC1/HC2 and HC3, because 
TSG-6 HC complexes derived through HC transfer from Ial can be generated in vitro 
in the absence of serum [429], whilst TSG-6HC3 complexes are only formed in vitro 
in the presence of serum [315, 429]. It has been proposed that the Link module of 
TSG-6 is directly involved in the formation of TSG-6 HC complexes since the A38
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antibody, which has its epitope in the Link module [436], can inhibit this process and 
consequently block HC transfer onto HA [278,429]. However, the Link module alone 
is unable to form covalent complexes with HCs [317]. In contrast to Link_TSG6, a 
mutated variant of the full-length protein, which has impaired HA binding but its 
ability to mediate the transfer of HCs from Ial and Pal is largely unaffected (figure 
4.15), was able to augment cell migration in our system. These data therefore support 
the hypothesis that TSG-6-mediated transfer of HCs into the HA rich pericellular 
matrix is a critical regulator of cell migration.
Although the components of the Ial family are synthesised predominantly in 
hepatocytes, PTCs are known to express Pal, a member of the Ial family [343]. In the 
HK-2 cell culture model, cells were grown to confluence in the presence of serum. 
During this period of growth HCs may therefore be incorporated into the matrix from 
serum-derived Ial or Pal, or alternatively from endogenous Pal. However, the HCs 
incorporated during the period of migration following scratch wounding are mostly 
derived from endogenous Pal as all the experimental manipulations were performed 
under serum-free conditions. Interestingly, the anti-migratory effect of blocking TSG- 
6 was only apparent in the HAS2 over-expressing cells. This could be related to the 
decreased expression of HC3 chains in the HAS2 over-expressing cells. In these 
cells, given the relative deficiency of HCs, the presence of TSG-6, which co-localises 
to the HA in the pericellular coat, may be more critical for the formation of a 
stabilised pericellular matrix.
The data in this chapter demonstrate that the functional consequences of 
increased HA synthesis may not be directly related to the HA synthase isoform that 
drives its synthesis, and from it we postulate that the process of extracellular HA 
structure formation and assembly is determined by a complex series of mechanisms, 
which seem to affect the expression patterns of HA degrading enzymes as well as 
some hyaladherins.
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Chapter V 
Further characterisation of HA 
cables: the role of hyaladherins 
and HAS3-overexpression
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5.1 Introduction
The aim of this chapter is to examine two aspects of HA structures produced 
by PTCs: the first is the structural components of HA cables, and the second is the 
role of the constitutive HAS isoform expressed by PTCs -  namely HAS3.
To date, few studies have been done to analyse the components of HA cables 
[170, 258]. All these studies have examined the composition of HA cables produced 
by colonic smooth muscle cells. There are no studies about the structural components 
of HA cables in the kidney.
Work in chapter four focused on the role of inducible HAS isoform in PTCs 
(i.e. HAS2), work in this chapter focused on the role of the constitutive HAS isoform 
(HAS3) and its role in regulating extracellular HA structures produced by PTCs. The 
study of HAS3 functionality became more important after HAS2-overexpression did 
not enhance cable synthesis which was shown to be part of the anti-inflammatory 
response of PTCs.
The specific aims in this chapter were to:
1. Further analyse the structural components of HA cables.
2. Clone HAS3 ORF into the expression vector (pcDNA4/TO) that was tested 
in chapter four.
3. Study the alterations in HA synthesis and extracellular structures (HA 
quantity and quality) following HAS3-overexpression.
4. Investigate the changes in two specific functions in the HAS3-transfected 
cells, namely monocyte binding and cell migration.
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5.2 Results
5.2.1 Characterisation o f HA cables in HK-2 cells: the role o f serum, led\ TSG-6, 
verslcan.
5.2.1.1 The role o f serum: Work done by the Cleveland group demonstrated 
that in colonic smooth muscle cells, HA cables are only formed in the presence of 
serum [258], therefore, the role of FCS in HA cable formation by PTC was 
investigated. For this, HK-2 cells were grown to confluence before growth-arresting 
for 48 h which was followed by replacement of culture medium with either serum- 
free medium or medium containing 2% FCS for 24 h. Confocal microscopy was used 
to examine the organisation of hyaluronan on the cell surface. As with previous 
experiments, HA was identified with b-HABP and detected with fluorescent Avidin- 
D. Photomicrographs of fixed, growth-arrested HK-2 cells demonstrated diffusely 
arranged pericellular HA over the cell surface in addition to cable-like structures that 
spanned several cell lengths (figure 5.1 A), as previously described in chapter three. 
Culture of HK-2 cells in the presence of FCS (2%) showed a markedly increased 
number of HA cables on their surface (figure 5.IB). The HA content of these 
structures was confirmed by 5 min treatment of bovine testicular hyaluronidase which 
removed all the cables (figure 5.1C).
Monocyte binding was also altered following incubation with FCS. Confluent, 
growth-arrested HK-2 cells were incubated with either serum-free medium or medium 
containing 2% FCS for 24 h before addition of radiolabelled monocytes. FCS-treated 
HK-2 cells bound more monocytes than unstimulated HK-2 cells (120% increase; 
p=0.0046; figure 5.3).
5.2.1.2 The role o f led: previous studies have shown that the HCs from the 
Ial family are important in the formation of pericellular HA coats [344]. Studies in 
smooth muscle cells have also demonstrated that HCs are an important structural 
component of HA cables in this cell type [258]. The Ial antibody used recognises all 
components of Ial (HC1, HC2 and bikunin) as well as intact Pal, but not HC3 [437]. 
Using this antibody, confocal microscopy of HK-2 cells grown in the absence of 
serum revealed co-localisation of Ial staining with the HA cables and coats (figure
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5.2). This suggests that components of the Ial family are incorporated into the 
extracellular HA structures, although it was not possible to distinguish between Ial 
HC1/HC2 and Pal.
Incubation of cells under serum-free conditions in the presence of the Ial/Pal 
antibody resulted in severe truncation of the HA cables, and at higher antibody 
concentration complete absence of HA cable formation (figure 5.ID and E). The 
effect of the antibody was not apparent when the antibody was added in the presence 
of 2% FCS (figure 5.IF). Under these conditions it is likely that serum-derived HCs 
are in excess and thus overcome the inhibitory action of the antibody.
Data from chapter three have demonstrated that monocyte binding is 
dependent on cell surface HA cables. Having demonstrated reduced cable formation 
in the presence of antibody to Ial/Pal, I subsequently examined the effect of the 
antibody on monocyte adhesion to HK-2 cells. Reduction of HA cable formation by 
antibody to Ial was accompanied by significant attenuation of monocyte binding 
(figure 5.3). This represented about 25% reduction in bound monocytes compared to 
control (p=0.01).
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Figure 5.1: Effect of FCS and Ia l  blockade on HA cable formation.
Confluent monolayers HK-2 cells were serum-deprived for 48 h prior to addition of 
serum-free medium only (A and C), or medium containing FCS (2%) (B), or serum- 
free medium with Ial Ab (1/200) (D), or serum-free medium with Ial Ab (1/50) (E), 
or medium with Ial Ab (1/50) containing FCS (2%) in (F). 24 h later, fixation done 
with methanol and detection of HA by addition of b-HABP (magnification x 100).
In (C), HK-2 cells were treated with bovine testicular hyaluronidase (200 pg/ml) at 
37°C for 5 min prior to labelling with b-HABP, to confirm the specificity of HA 
staining.
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Figure 5.2: Localisation of Ia l/P a l.
Confluent monolayers of HK-2 cells were growth-arrested for 48 h prior to fixation 
with methanol. HA was detected by addition of b-HABP and fluorescent Avidin-D 
(A), and Ial/Pal detected by addition of polyclonal antibody to Ial/Pal and anti-rat 
Texas red conjugated antibody (B). Co-localisation of HA and Ial/Pal was examined 
by merging individual images (C) (magnification x 100). The red square area in C 
was enlarged to show intracellular Ial/Pal staining (D).
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Figure 5.3: Monocyte binding is decreased after I a l  blockade and increased after 
FCS supplementation.
Confluent monolayers of HK-2 cells were serum-deprived for 48 h before incubation 
with either polyclonal antibody to Ial/Pal (1:200 or 1:50) or with medium containing 
2% FCS or with serum-free medium for further 24 h (as control). Subsequently, the 
monolayer was washed with PBS prior to addition of 1 x 106 51Cr-labelledU937 cells 
under serum-free conditions for 1 h at 37°C. Quantification of bound radioactivity 
was carried out as described in chapter two. Data represent mean ± SD (n=3).
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5.2.1.3 The role o f TSG-6: Studies utilizing the TSG-6^ mouse have 
demonstrated that TSG-6 is critical in formation of stable HA matrices. Furthermore, 
in a cell-free system TSG-6 is a key catalyst for the covalent transfer of HCs from 
both Ial and Pal to HA [438]. In chapter four, this catalytic activity of TSG-6 was 
shown to be involved in a pro-migratory function of cells associated with pericellular 
HA coat formation. Also in chapter four, confocal microscopy showed that TSG-6 co­
localised with pericellular HA coats (figure 4.15). However, incubation of HK-2 cells 
with anti TSG-6 monoclonal antibody A3 8 (previously demonstrated to block HA 
binding to TSG-6 [385] and prevent the formation of TSG-6-HCs complexes in vitro 
[278]) did not influence cable formation and, consistent with these observations, the 
antibody had no effect on HA-dependent monocyte binding to monolayers of HK-2 
cells (figure 5.4).
These results therefore suggest that TSG-6 is not involved in the stabilisation 
of HA cables by transfer of Ia l family components or that transfer of HCs to HA 
cables is not solely dependent on the effect of TSG-6.
5.2.1.4 The role o f versican: Versican is also reported to be important in the 
formation of extracellular HA structures [253]. Results from other laboratories have 
shown its localisation with both HA coats and cables (De La Motte, CA -  personal 
communication). Using confocal imaging, versican showed positive co-localisation 
with HA in the matrix with little or no positive staining intracellularly (figure 5.5).
The effect of blocking versican on extracellular HA structures was examined 
by incubating HK-2 cells with anti-versican antibody for 24 h before staining for HA. 
Confocal imaging showed no difference between control cultures and antibody- 
treated cultures (figure 5.6A and B). In addition, HK-2 cells incubated with versican 
Ab for 24 h did not differ significantly from untreated HK-2 cells in terms of 
monocyte binding capacity (figure 5.6C).
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Figure 5.4: Effect of TSG-6 blockade on HA cable formation and monocyte 
binding.
HK-2 cells were grown in the presence of 10% FCS and then serum-deprived for 48 h 
prior to the addition serum-free medium as control (A) or serum-free medium 
containing anti-TSG-6 antibody (clone A38; 5 qg/ml) for 24 h (B) . Cells were then 
fixed with 100% ice-cold methanol and labelled with HABP for HA detection 
(magnification x 200).
In (C), confluent HK-2 cells were serum-deprived for 48 h prior to the addition of 
serum-free medium as control, or serum-free medium containing anti-TSG-6 antibody 
(clone A38; 5 pg/ml) for 24 h. Subsequently, the monolayer was washed with PBS 
prior to addition of 1 x 106 51Cr-labelledU937 cells again under serum-free conditions 
for 1 h at 37°C. Quantification of bound radioactivity was carried out as described in 
chapter two. Data represent mean ± SD of three experiments.
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Figure 5.5: Co-localisation of versican and HA.
Confluent monolayers of HK-2 cells were growth-arrested for 48 h prior to fixation 
with methanol. HA was detected by addition of biotinylated HABP and fluorescent 
Avidin-D (A), and versican detected by addition of monoclonal antibody to versican 
2-B-l and secondary Texas red-conjugated antibody (B). Co-localisation of HA and 
versican was examined by merging of individual images (C) (magnification x 100).
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Figure 5.6: Effect of anti-versican antibody on HA cable formation and 
monocytes binding.
HK-2 cells were grown in the presence of 10% FCS and then serum-deprived for 48 h 
prior to the addition serum-free medium as control (A) or serum-free medium 
containing anti-versican (dilution 1/100) antibody for 24 h (B ). Cells were then fixed 
by 100% ice-cold methanol and labelled with HABP for HA detection (magnification 
x 100).
In (C), confluent HK-2 cells were serum-deprived for 48 h prior to the addition of 
serum-free medium as control, or serum-free medium containing anti-versican 
antibody (dilution 1/100) for 24 h. Subsequently, the monolayer was washed with 
PBS prior to addition of 1 x 106 51Cr-labelledU937 cells under serum-free conditions 
for 1 h at 37°C. Quantification of bound radioactivity was carried out as described in 
chapter two. Data represent mean ± SD of three experiments.
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5,2.2 HAS3 over-expression
5.2.2.1 Confirmation o f HAS3 over-expression in transfected HK-2 cells
After cloning of HAS3 ORF into pcDNA4/TO and generation of zeocin- 
resistant clones (detailed in chapter two), the next step was to confirm more HAS3 
activity in these transfected cells. Several HK-2 clones were scanned for HA 
production in the supernatant by ELISA and one clone that showed a significant 
increase in HA production (figure 5.7C) was picked for further analysis. All mock- 
transfected cells showed similar HA profiles and, therefore, one clone was selected as 
a control cell line.
Over-expression of HAS3 mRNA in the selected stable cell line was 
confirmed by RT-PCR. The specificity of HAS3 mRNA expression was demonstrated 
by examining the expression of HAS2 mRNA in both mock- and HAS3-transfected 
cells (figure 5.7A). By scanning densitometry, there was 25% increase in HAS3:actin 
mRNA ratio in the stable HAS3 cell line compared to the mock-transfected cell line, 
with insignificant reduction in HAS2:actin mRNA ratio compared to the mock- 
transfected cell line (figure 5.7B).
HA generation by the selected cell line was examined both by ELISA of the 
cell culture supernatant and by 3H-glucosamine labelling of HA. Confluent 
monolayers of HAS3- or mock-transfected cells were serum-deprived for 48 h. Fresh 
serum-free medium was subsequently added for a further 24 h prior to collection and 
quantification of HA by ELISA (figure 5.7C). HA concentration in the culture 
supernatant was significantly greater in the HAS3 expressing cell line. This 
represented a 32% increase in the HA over the mock-transfected cells (p=0.004).
Analysis on Sephacryl S-500 of the 3H-glucosamine-labelled HA samples 
from both the HAS3- and the mock-transfected HK-2 cells demonstrated that the 
majority of the labelled HA appeared near the void volume and therefore was 
considered to be of high molecular mass (figure 5.8). In addition, there was a marked 
increase in the generation of medium and low molecular weight HA in the CM and 
the TE of the HAS3 over-expressing cells as compared to the mock-transfected cells.
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An unexpected reduction (57%) in the CA radiolabelled HA was seen in the HAS3- 
transfected cells compared to the mock-transfected cells. This reduction was seen in 
all the molecular weight fractions (high, medium and low). Of note also is that there 
were smaller HA fragments in the CA fraction of the HAS3 sample which is 
suggestive of increased HA degradative activity (figure 5.8 CA).
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Figure 5.7: HAS2/HAS3 expression and HA production in transfected HK-2 
cells.
(A) Total mRNA was extracted from confluent, transfected monolayers after 48 h of 
serum deprivation. Ethidium bromide stained PCR products were separated on a 3% 
agarose gel. Three representative PCR reactions are shown.
In (B), densitometry data of the gel bands are plotted normalised to their respective 
actin bands.
In parallel experiments, supernatant samples were collected from confluent serum- 
deprived cells exposed to serum-free medium for 24 h after growth-arrest. HA was 
then quantified by ELISA (C). Data represent mean ± SD of four separate 
experiments.
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Figure 5.8: Analysis of HA in transfected HK-2 cells.
Confluent serum-deprived monolayers of HAS3- or mock-transfected cells were 
exposed to serum-free conditions for 24 h in the presence of 20 pCi/ml 3H- 
glucosamine. Subsequently, conditioned medium (CM), trypsin extract (TE) and cell- 
associated (CA) HA fractions were prepared and analysed as described in chapter 
two. The bars labelled as High, Medium and Low represent molecular weight ranges 
(High MW > 106 Da, Low MW < 105 Da). The graphs on the right represent the 
percentage of different MW HA in each fraction.
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S.2.2.2 Visualisation o f HA in transfected HK-2
HA was visualised as described earlier in both mock-transfected and HAS3- 
transfected cells. Confocal images demonstrate a marked increase in extracellular HA, 
both in pericellular coats and also in HA cables in the HAS3-transfected cells 
compared to the mock-transfected cells (figure 5.9).
Before isolating a stable HAS3-transfected cell line, visualisation of HA was 
done in HK-2 cells transiently transfected with HAS3/pcDNA4 vector or empty 
pcDNA4/TO vector (as mock transfection) for 24 h before fixation and staining for 
HA. HAS3-transfected cells showed more HA, in both forms: coats and cables, 
compared to mock-transfected cells (figure 5.10). Although it was not possible to 
confirm that these cable-producing cells are the positive HAS-3 transfected cells, the 
data generated from both stable- and transiently-transfected cells strongly suggest that 
HAS3-over-expression is associated with increase in HA cables.
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Figure 5.9: Visualisation of HA in stable-transfected cells.
Confluent monolayers of mock- (A) and HAS3- (B) transfected cells were serum- 
deprived for 48 h prior to fixation with methanol and detection of HA by addition of 
b-HABP. Sections were imaged by confocal microscopy (magnification x 200).
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Figure 5.10: Visualisation of HA in transiently-transfected cells.
Sub-confluent HK-2 cells were serum-deprived for 48 h prior to mock- (A) or HAS3-
(B) transfection. 24 h later, fixation was done with methanol and HA detected by 
addition of b-HABP. Sections were imaged by fluorescence microscopy 
(magnification x 200). Cell nuclei are visualised by DAPI staining (blue).
5.2.23 CD44 expression in HAS3-over-expressing cells
The increased HA in the trypsin extract fraction, in HAS 3-transfected cell 
(figure 5.8 TE), is suggestive of increased CD44 expression or other HA cell-surface 
receptors. In chapter four, data have shown reduced expression of CD44 in a HAS2 
over-expressing cell line. In contrast, in the HAS3-transfected cells there was an 
increase in the cell surface CD44 as assessed by FACS analysis (figure 5.11C). The 
state of CD44 expression was also investigated using confocal imaging and again 
HAS3-transfected cells showed stronger CD44 staining than mock-transfected cells 
(figure 5.1 ID and E).
5.2.2.4 Expression o f relevant HA regulators/structural components after HAS3- 
overexpression: Hyaluronidases and Pod
Data from both chapters three and four pointed to a role of hyaluronidases in 
HA cable formation. Also, in HAS2-transfected cells (where less cables were seen), 
there was a marked reduction in HC3 of Pal. RT-PCR was done to investigate the 
expression of HYALs (HYAL1 and HYAL2) and P al (bikunin and HC3) mRNA in 
mock- and HAS3-transfected cells. Both HYAL1 and HYAL2 were up-regulated in 
the HAS3-transfected cells (figure 5.12). Densitometry data showed that the increase 
was about 250% in HYALl/actin ratio (p=0.0006) and about 200% in HYAL2/actin 
ratio (p=0.0011).
In addition, there was up-regulation of both components of the Pal: bikunin 
and to a lesser extent HC3. The increase was about 150% in bikunin/actin ratio 
(p=0.0481) and about 15% in HC3/actin ratio (p=n/s).
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Figure 5.11: CD44 expression in control and transfected HK-2 cells.
Confluent growth-arrested HK-2 cells were analysed by flow cytometry using anti- 
CD44 Ab. (A) Shows untransfected HK-2 cells with two controls: Cl is unlabelled 
cells while C2 is cells labelled with secondary FITC-conjugated Ab only. (B) Shows a 
comparison between untransfected (green line) and mock-transfected (violet area) 
HK-2 cells and (C) between mock- (green line) and HAS3- (violet area) transfected 
cells.
CD44 expression is shown by immunocytochemistry in growth-arrested mock- (D) or 
HAS3- (E) transfected HK-2 cells (magnification x 200).
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Figure 5.12: mRNA expression of HYAL1/2 and P a l components (Bikunin and 
HC3).
Total mRNA was extracted from confluent monolayers of mock- and HAS3- 
transfected cells after 48 h of serum deprivation. PCR performed for various cycles as 
detailed in chapter two. Ethidium bromide-stained PCR products were separated on a 
3% agarose gel. Three representative PCR reactions are shown. Densitometric ratios 
of the gene of interest compared to the house-keeping gene p-actin of 3 individual 
experiments are shown with the data representing mean ± SD.
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5.2.2.6 Cell migration after HAS3-overexpression
Cell migration was assessed in mock- and HAS3-transfected cell lines as 
described in chapter two. Confluent monolayers of cells were serum-deprived for 48 h 
prior to generation of an intersecting area of denuded cells by scraping with sterile 
1000 pi pipette tip. Closure of the denuded area was then monitored at different times. 
Cell migration was increased in HAS3-transfected cells compared mock-transfected 
cells and this increase was significant 48 h after scratching and all the time points that 
followed (figure 5.14).
p=0.03
600 -
400 -
200 -
p=0.003
p=0.001 T
p=0.01n
T
24
“ I —
48
Time (h)
72 96 120
■  Mock transfection 
□  HAS3 transfection
Figure 5.14: Quantification of cell migration.
Confluent serum-deprived monolayers of mock- or HAS3-transfected cells were 
scratched to produce an intersecting area of denuded cells. Subsequently, following 
washing of the monolayer to remove detached cells, the rate of cell migration of each 
of the two cell lines was assessed by directly counting the number of cells migrating 
into the intersecting denuded area at each of the time points indicated. The data are 
expressed as the number of cells per denuded area. Data represent the mean ± of four 
individual experiments.
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5.2.2.7 Enhanced cell migration after HAS3-transfection is independent o f cellular 
proliferation
Cellular proliferation in the transfected cells was assessed by alamar blue as 
described in chapter two. The rationale for doing proliferation measurement was to 
check whether the increased migratory rate in the HAS3-transfected cells is caused by 
increased proliferation rate. Following 96 h of serum-starvation, there was no 
significant difference between mock- and HAS3-transfected cells (figure 5.15).
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Figure 5.15: Growth profile in mock- and HAS3-transfected cells.
Transfected cells were seeded at low density with 10% FCS for 24 h. Later, medium 
was replaced with serum-free medium containing 10% alamar blue and a fluorescence 
measurement was taken after 1 h. After washing with PBS, cells were re-incubated 
with serum-free medium until the next alamar blue measurement (at day 4 post- 
seeding).
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5.3 Discussion
Data from chapter three have shown that in addition to pericellular HA coats, 
PTCs form HA in cable-like structures which support interactions with monocytes, 
via their cell surface CD44 receptors. The monocyte-HA interaction prevents 
monocytes-PTCs direct interaction which drive ICAM-dependent TGF-pl generation 
[135, 363]. This suggests that synthesis of HA cables may limit renal injury. 
Consistent with this hypothesis is our observation that cable formation is stimulated 
by BMP-7. Chronic renal failure has been postulated to be a state of BMP-7 
deficiency and its administration has been shown limit injury in numerous models of 
renal disease [104, 109-111].
The mechanism(s) of HA cable synthesis is still unclear. As mentioned earlier, 
Majors et al. hypothesised that a dormant HAS isoform is located on the endoplasmic 
reticulum that can be activated when the cells are stressed [170], although this theory 
stands against all previous reports that showed localization of HAS proteins in the 
cellular membrane. The hyaladherins reported in these cable structures include: Ial 
[170, 258], versican [170], although to date only Ial has been shown to be crucial to 
cable formation [258]. All these reports studied HA-cables in the colonic smooth 
muscle cells. There are no studies, to date, analysing the components of these 
structures in the kidney. In this chapter, the nature and structure of HA cables 
produced by PTCs was characterized in detail.
An important observation from the data in this chapter is the incorporation of 
components of the Ial family of proteins into the HA cables and the demonstration of 
their importance in cable assembly. Both cable assembly and HA-dependent 
monocyte binding to PTCs was inhibited by an antibody to Ial/Pal. Another 
observation is that in PTCs, HA cables are formed in the absence of serum unlike 
colonic smooth muscle cell in which HA cables were first described only in the 
presence of serum. However, addition of serum enhanced HA cable formation by 
PTCs and caused more monocyte adhesion. The Ial family includes four plasma 
proteins; these are free bikunin, Ial, Pal and IaLI. Although the components o f the 
Ial family are synthesised predominantly in hepatocytes, PTCs generate the Pal
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variant of the Ial family [343]. This may therefore explain the generation of cables 
by PTC in the absence of serum, which is the source of Ial family protein 
components for colonic smooth muscle cells. This hypothesis is further supported by 
the demonstration of HA cables in the HAS3 over-expressing cell line. This is in 
contrast to the reduction in HA cables seen in a HAS2 over-expressing (data from 
chapter four). One difference between the two cell lines is the expression of HC3 
mRNA which is markedly down-regulated in the HAS2 cell line while abundantly 
expressed in the HAS3 cell line. Future work in the department is aimed at clarifying 
the role of endogenous P al in the assembly of pericellular HA by PTCs. This can be 
investigated by inhibition of protein synthesis using siRNA technology.
TSG-6 is an inflammation-associated secreted protein composed of contiguous 
Link and CUB domains (detailed in chapter one). It may bind to HA directly through 
its link module [428], and has also been demonstrated to play an important role in the 
transfer of HCs from Ia l onto HA [278, 438]. This reaction can be visualised in a 
cell-free system utilising purified Ial, HA and TSG-6 in the absence of serum [315]. 
TSG-6 role in transfer of HC3 from Pal is less well understood. In an in vitro assay in 
the absence of serum TSG-6 does not support the transfer of HC3 from Pal to HA 
(Day AJ -  unpublished observation), although studies in the TSG-6'7" mouse do 
suggest that TSG-6 in vivo may be involved in HC3 transfer [315]. Data from chapter 
four demonstrated that the transfer of HCs of Ial/Pal to HA by TSG-6 is involved in 
the formation of pericellular HA coats. In contrast, the data presented in this chapter 
suggest that TSG-6 is not such a key event in the incorporation of Ial/Pal 
components into HA cables. This observation that TSG-6 is not a critical factor in the 
formation of HA cables is also consistent with previous work which demonstrated that 
IL-ip stimulates PTC TSG-6 synthesis [343], decreases formation of HA cables and 
HA-dependent monocyte binding (chapter three), despite being a potent stimulus of 
PTC HA generation [175]. Taken together these data suggest that up-regulation of 
TSG-6 during inflammation may represent a harmful effect as it enhances the build­
up of HA coats by facilitating the transfer of Ial/Pal into pericellular HA coats 
which: (/) negatively affect HA cable formation that may suppress the impact of 
infiltrating inflammatory cells, and (if) stimulates a migratory phenotype in the PTC 
that is shown to be associated with epithelial transdifferentiation and renal fibrosis.
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Another hyaladherin that was identified as a component of HA cables is the 
large chondroitin sulphate proteoglycan, versican. Data generated using colonic 
smooth muscle cells suggest that versican is important in binding leukocytes to HA 
cables, although the counter-receptor on the leukocyte has not been fully characterised 
[258]. The Ab used for versican detection (monoclonal AB, clone 2B1) reacts with 
the intact molecule of the proteoglycan and the chondroitinase ABC-treated core 
molecule [439]. Experiments by the Cleveland group have shown that this anti- 
versican Ab reacts with the G3 domain of the proteoglycan and not with the G1 
domain, which can bind to HA and CD44 [440](De La Motte, CA -  unpublished 
observation). In the light of the above observation, our results (figure 5.5B) can be 
explained but also fails to confirm whether versican is essential to cable formation or 
not.
IL-ip, which abrogates PTC cable formation, is a known inhibitor of versican 
synthesis [441] in other cell systems. Interestingly chondroitin sulphate competes 
efficiently with immobilized HA for the binding of full length TSG-6 at physiological 
pH [442]. In addition, overlapping sites in the G1 domain of versican bind HA and 
TSG-6 link module [443] whilst overlapping sites on the link module of TSG-6 
mediate binding to HA and chondroitin-4-sulphate [314]. Versican has been shown to 
bind HCs of the Ial family and also has been demonstrated to support the transfer of 
HCs onto HA [444]. This raises the possibility that TSG-6/Versican counter- 
regulatory mechanisms exist which modulate HA assembly altering the balance 
between HA coat and cable formation. In addition to its structural role in HA cables, 
it is therefore interesting to speculate that induction of versican may result in 
abrogation of TSG-6 HCs transfer activity thus hampering coat formation and 
favouring cable assembly. This role for versican, in the assembly of HA cables, is also 
consistent with studies demonstrating an anti-inflammatory effect, as versican can 
bind specific chemokines and this binding tends to down-regulate chemokines 
function [445].
BMP-7 stimulation leads to an increase in HA cable formation (data from 
chapter three). This observation was associated with down-regulation of 
hyaluronidase expression (HYAL1 and 2). Furthermore, decreased HA cable
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formation in HAS2 over-expressing cells was associated with an increase in 
hyaluronidase expression. This led us to postulate that hyaluronidase expression may 
be causally related to HA cable formation, and that down-regulation of hyaluronidase 
activity may help HA to remain associated with its synthesizing enzyme, and that HA 
extruded through the cell membrane is anchored to HAS isoforms and associates with 
similarly anchored HA from neighbouring cell thus forming cables. The data in this 
chapter, however, would suggest that this is not the case as increased HA cable 
formation in the HAS3 over-expressing cells occurred despite an increase in 
hyaluronidase activity. This suggests that the increase in hyaluronidase expression in 
both the HAS2 and HAS3 over-expressing cells represents a feedback response of the 
cell when it encounters a huge excess of HA and is therefore not causally related to 
the absence of cables in HAS2 over-expressing cells.
An alternative explanation put forward to explain the absence of cables in 
HAS2 cells is related to organisation of HAS2, and that competition for the UDP- 
sugar substrates between cable forming and non-cable forming HAS may limit cable 
formation. Cable forming HAS may, therefore, have specific membrane organisation 
which require additional structural components not present in the transfected cells 
which therefore limit cable formation in these cells. The ability of HAS3 transfected 
cells to form cables would, however, suggest that the expression of the specific 
isoforms of the HAS enzyme is the critical issue in HA cable formation.
PTCs express two of the three known HAS isoforms [175], HAS2 and HAS3, 
as mentioned earlier, although HAS2 represents the main HA synthase as more 
mRNA copies are expressed by PTCs compared to HAS3. Research done by others 
have shown that HAS3 can be up-regulated by different stimuli along with or 
independent of other HAS isoforms, and in different cell types such as skin fibroblasts 
[181], embryonic chondrocytes [186], keratinocytes [302, 446], and periodontal 
ligament cells [180]. HAS3 is also up-regulated in metastatic colon carcinoma cells 
[447], where its inhibition by anti-sense HAS3 transfection leads to a reduction of 
tumour growth. HAS3. HAS3 expression has also been linked to prostate cancer cell 
growth [191], but not to their metastatic ability. The HA produced by the HAS3 
isoform is of smaller molecular weight compared to that produced by HAS2 [448, 
449], however, it is still in the range of high molecular weight HA (between 2 x 105-2
x 106) and, as other HAS isoforms, participate in the formation of the pericellular 
matrix.
Over-expression of HAS3 lead also to an increase in pericellular HA coats and 
PTC wound re-epithelialization (migration). Although, the effect on cell migration 
was significant 48 h after wounding and thereafter, the enhanced migration was less 
prominent than that seen in the HAS2-transfected cells. The reason behind this 
variation could be the difference in the arrangement of pericellular HA in the cell 
lines but also could be due to more complex factors such as differences in HA profile 
(molecular weight and distribution) and the expression of HA receptors involved in 
the migratory process as CD44 (which is increased in HAS3-transfected cell), and 
RHAMM. It would be interesting to investigate the role of RHAMM in PTCs 
migration as it is still an unexplored issue.
In summary, the data suggest that regulation of hyaladherins in the face of 
constitutive HA generation, may be the key to cable assembly rather than induction of 
HA synthesis per se. Also, the data points toward differences between HAS3 and 
HAS2 isoforms in many aspects such as the quality and distribution of HA produced, 
effects on important biological functions, all of which could be due to different 
enzyme localization.
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Chapter VI 
General discussion
When HA was discovered about 70 years ago, it was viewed as an inert 
viscoelastic structure involved in soft tissue lubrication and tissue hydration. The view 
of HA has been modified as it is now known that HA participates in a wide range of 
biological events in both normal and disease status. Although very simple in structure 
as a glycoaminoglycan, the diverse role of HA in matrix biology stems partially from 
this simple structure as it allows HA to interact with a wide range of molecules. Work 
presented in this thesis and from other groups have shown that different hyaladherins 
are involved in different extracellular HA structures (TSG6 in pericellular coats, 
versican in cables and Ial in both) and these HA structures differ in their impact on 
their environment.
It is now clear that pericellular/cell-associated HA differs from soluble 
extracellular HA which binds to cell surface HA receptors inducing a wide range of 
biological activities which is partially due to the wide range of HA molecular weight 
(from 5000 to 30000 disaccharide units). Several workers have reported that HA- 
oligosaccharides may stimulate gene expression and protein synthesis of chemokines 
[450] and interstitial collagens [451]. In contrast, high MW HA inhibits the “bio­
activity” of TGF-|3 and stimulates the secretion of tissue inhibitors of 
metalloproteinases [452, 453]. Furthermore, high molecular weight HA reduced T- 
cell-mediated liver injury by reducing pro-inflammatory cytokines such as TNF-a and 
IF-y, an effect that was not produced by low MW HA [454]. These observations, 
therefore, suggest that high molecular weight HA may be “anti-fibrotic” whereas, if 
unabated, the generation of low MW HA fragments may disrupt the normal balance 
between cells and matrix and contribute to the pathophysiology of chronic tissue 
inflammation and fibrosis.
The work outlined in this thesis focused mainly on extracellular HA structures, 
their regulation by PTCs and their function. In chapter three, the discovery of HA 
cable formation by unstimulated PTCs represented a novel finding in two aspects as 
no reports had investigated the potential for HA cable production by epithelial cells 
(all studies were done in cells of mesenchymal origin like smooth muscle cells and 
mesangial cells), and HA cables (in other systems) were noted only in disease- 
mimicking conditions (like diabetes mellitus and inflammatory bowel disease) and
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also were formed only in the presence of serum (which is a rich source of 
hyaladherins). Because PTCs have the ability to produce HA cables in resting 
conditions, this suggested that their function is possibly different from those produced 
in disease-mimicking conditions. This hypothesis is supported by work which was 
performed by a fellow researcher during my studies (discussed below).
In the context of PTC pathophysiology, HA cables seem to play an anti­
inflammatory, anti-fibrotic role in that the presence of HA cables around PTCs 
reduces the generation of TGF-pi by these cells when exposed to monocytes [135]. 
Zhang et al. have illustrated that monocytes can interact with ICAM on PTCs. This 
direct interaction between monocytes and PTCs results in PTC “activation” and 
stimulates TGF-pl generation by PTCs. In the presence of HA cables, however, 
monocyte access to ICAM receptors is minimized and so less ICAM-dependant TGF- 
pl generation is seen.
BMP-7 has emerged recently as a new therapeutic agent for renal pathologies. 
It is well-established now that chronic renal diseases represent a state of BMP-7 
deficiency, and many animal studies have shown a recovery response from the injured 
kidney after BMP-7 administration. Many studies have been done to elucidate the real 
mechanism through which BMP-7 exerts its healing effect. Most notably, Zeisberg et 
al. have shown that BMP-7 counteracts TGF-pl-induced epithelial-to-mesenchymal 
differentiation [109]. A second mechanism was suggested by Gould et al. as they 
showed that BMP-7 stimulation of epithelial cells decreases mRNA expression for 
endothelin-2 (ET-2; a vasoconstrictor), and increases mRNA expression for heme 
oxygenase (HO-1; a vasodilator) [106], this effect is beneficial to the kidney in the 
post-injury phase as it helps in increasing blood supply to the damaged tissue. The 
previous study also showed that BMP-7 stimulation resulted in decreased basal and 
TNF-a-stimulated expression of some pro-inflammatory cytokines such as IL-lp and 
IL-6. Another mechanism for mode of action of BMP-7 was suggested by the 
candidate (date from chapter three) and this mechanism was related to the BMP-7 
effect on HA regulation. Again this concept was supported by work done at the 
Institute by Zhang XL (discussed below).
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The relationship between HA and BMP-7 was first reported by Nishida et al. 
in 2000 [179]. In that report, BMP-7 stimulation of chondrocytes led to induction of 
HAS2 mRNA together with up-regulation of CD44 and aggrecan (a member of the 
hyaladherins) mRNA resulting in an increase in the size of the pericellular matrices in 
these cells. Further work done by the same group has revealed that this matrix- 
regaining effect (via HAS2 and aggrecan up-regulation) of BMP-7 is beneficial in the 
HA hexasaccharide-induced matrix-depletion model of osteoarthritis [275]. 
Interestingly, IL -la stimulation of chondrocytes led to a decrease in pericellular 
matrix although it enhanced HAS2 mRNA expression. This is thought to be caused by 
both CD44 mRNA up-regulation (which increases HA internalization) and inhibition 
of aggrecan expression (which might promote the stability of extracellular HA 
structures)[178].
In chapter three, BMP-7 was shown to increase HA cable generation by 
PTCs. This increase in HA cables was associated with an increase in HAS2 mRNA 
and down-regulation of both HYAL1 and 2 mRNA. Further work by Zhang et al. has 
illustrated clearly that the BMP-7-mediated increase in cable generation is important 
in down-regulating the impact of incoming monocytes i.e. decreased PTC TGF-pl 
generation [363]. The same work also showed that the effect of increased ICAM-1 
expression (through TNF-a stimulation) can be masked by HA cables as BMP-7 
treatment reduced PTCs-monocyte direct interaction (and subsequent TGF-pl 
generation). This effect of BMP-7 on HA cables and how it may mask PTCs surface- 
receptors is illustrated in figure 6.1. Thus, in normal physiological conditions the 
presence of BMP-7 will lessen the impact of any tissue macrophages, while in renal 
pathology the reduction in BMP-7 levels may translate into a reduction of HA cables 
and hence an increase in the inflammatory potential of the incoming monocytes.
In contrast to the view presented in this thesis, HA cables are also viewed as 
pro-inflammatory, pro-fibrotic structures. Work done on colonic smooth muscle cells 
[170, 258] and mesangial cells [282] showed that various stimuli (such as high 
glucose and viral infections) can induce the formation of HA cables in these systems 
and these HA cables are suggested to be important in initiating/maintaining the 
inflammatory reaction associated with inflammatory diseases like ulcerative colitis
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and diabetic nephropathy. Further work done at the Institute of Nephrology, however, 
would support the hypothesis that HA deposits do not drive inflammation in diabetic 
nephropathy (Lewis, A -  M.D. thesis 2006). In that study, renal biopsies from human 
patients with/without DN showed that although HA was increased in DN, HA could 
not be established as a predictor of outcome and no correlation was found between 
HA and the extent of inflammatory infiltrate (monocytes and macrophages).
The above hypothesis is further supported by data generated following 
examination of IL-ip effect on HA structures (chapter three) which highlighted the 
specificity of HA cables as IL-lp is a potent stimulus of HA production. Previous 
work in the department showed that IL-ip not only increases HAS2 mRNA 
expression [175] but also increased TSG-6 mRNA expression [343], however, IL-ip 
does not alter the expression of Ia l in PTCs. In addition, IL-lp was shown to 
increase the expression of functionally active CD44 [219] and increase HA/CD44 
interaction. The increase in CD44 functionality was not the result of increased CD44 
mRNA expression but the result of increased post-translational O-glycosylation of 
CD44. This increase in CD44 activity could be attributed to conformational changes 
mediated by carbohydrates which might restrict cell surface mobility of CD44 or 
cause charge repulsion between neighbouring CD44 molecules thus preventing the 
formation of functional multivalent aggregated receptors. The increase in pericellular 
HA coats (figure 3.14) in PTCs after IL-lp stimulation can, therefore, be the result of 
the above mentioned changes i.e. increased HAS2 mRNA (increase in crude HA), 
increased CD44 functionality (increase in pericellular HA assembly) and increased 
TSG-6 expression (which is crucial in stabilising pericellular HA coats), moreover, 
these factors could be preferentially increasing HA coats at the expense of HA cable 
formation. The increased pericellular HA, as shown in chapter four, induces epithelial 
cell migration and therefore can be viewed as an inflammatory response.
IL-lp treatment of PTCs resulted in increased ICAM-1 mRNA expression 
which led to increased monocyte binding that was mostly ICAM-1 dependent (data 
from chapter three). Direct cell-to-cell contact is thought to be an important feature of 
a variety of biological processes. De novo tubular expression of ICAM-1 and 
increased expression by interstitial cells occurs in various human renal diseases and in
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general, the intensity of ICAM staining correlates with disease activity [455]. 
Furthermore, administration of antibody to ICAM-1 has been proposed as a possible 
therapeutic option to preserve renal function, at least in a model of ischaemic renal 
injury [456]. Work done by Zhang et al. has demonstrated that in PTCs, the 
interaction of ICAM-1 with leukocytes plays a key role in the subsequent pathological 
events. The direct interaction between leukocytes and PTCs through ICAM-1 leads to 
increased TGF-pl generation by PTCs and the effect of this interaction (on TGF-pl 
generation) was reduced when this ICAM-1 dependent cell-to-cell interaction was 
inhibited (by blocking leukocyte ICAM-1 receptor via either CD1 la/CD18 Ab or by 
soluble ICAM-1 receptors), moreover blocking monocyte-HA cable interactions (via 
CD44 Ab) resulted in increased TGF-pi generation, possibly by increasing direct 
cell-to-cell contact (Zhang, XL -  M.D. thesis 2005).
i
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Tubular lumen
Figure 6.1: Schematic diagram depicting the proposed mechanism by which IL-ip or BMP-7 might affect the interaction of monocytes with adhesion 
molecules expressed by PTCs.
(A) Under normal physiological conditions, few monocytes are present in the renal interstitium. With an intact basement membrane and the presence o f  HA cables, 
very few monocytes might interact directly with PTCs ICAM-1 receptors.
(B) Although ICAM-1 is known to be expressed predominantly on the luminal aspect o f  PTCs, under pro-inflammatory conditions (represented by IL-1(3 
stimulation in this study) it may also be expressed and up-regulated on the basal aspect o f  the cell (Zhang, XL -  M.D. thesis 2005). Under such conditions, which 
are usually associated with damage to the basement membrane, infiltrating monocytes gain access to cell surface ICAM-1, which subsequently triggers the 
generation o f  a pro-fibrotic response, by stimulating TGF-f31 generation.
M onocytes bound to
HA cables via their ^ '
*
Tubular lumen
M onocytes bound to 
ICAM -1 receptors via 
their CD 11 a/CD 18
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(C) In contrast, following stimulation by BMP-7, PTCs generate HA cable structures which preferentially bind infiltrating monocytes by engagement o f  monocyte 
CD44. This interaction subsequently prevents/retards migration o f  monocytes onto the PTC cell surface, thus preventing their interaction with PTC ICAM-1.
Data from this thesis have confirmed the concept that HA cable formation is 
not single factor-dependent; like increased synthesis or decreased degradation. 
Initially, a potential role for hyaluronidases was thought to be an important factor in 
HA cable regulation. This was supported by data from BMP-7 experiments (which 
showed a concomitant increase in HA cables with a reduction in HYAL1 and HYAL2 
mRNA expression) and data from HAS2-transfections (which showed a concomitant 
decrease in HA cables with an increment in HYAL1 and HYAL2 mRNA expression). 
Data from HAS3-transfections, however, showed increased HA cables along with an 
increment in HYAL1 and 2 mRNA expressions. Also, increases in mRNA 
expressions do not necessarily translate into more protein activity and currently, there 
is no direct evidence to support cell surface degradation of HA in PTCs. This meant 
that factors, other than hyaluronidase activity, could be more crucial to HA cable 
formation.
The degradation of HA has been proposed to occur via receptor-mediated 
endocytosis and subsequent degradation within lysosomes and generally, HA 
degradation is considered as an intracellular process. Initially, extracellular high 
molecular weight HA is bound to plasma membrane via CD44 or RHAMM. The 
degradation of HA is initiated by HYAL2, however, it is unclear whether degradation 
begins at the cell-surface or following receptor-mediated endocytosis. The 
degradation products of HYAL2 are then transferred via endosomes into lysosomes 
and degraded into small oligosaccharides by the co-ordinated action of HYAL1 and 
two p-exoglycosidases. This proposed mechanism is supported by recent work done 
in the department on smooth muscle cells (Jenkins RH -  Ph.D. thesis 2005). 
Immunofluorescence experiments showed that HYAL2 is localised to the inner 
surface of the cell membrane and to intracellular compartments, while HYAL1 is 
localised only to intracellular compartments. Interestingly, there was no co­
localisation between CD44 and HYAL2 in the cell membrane of smooth muscle cells 
(CD44 being on the outer side and HYAL2 on the inner side). There are, however, 
reports that propose an extracellular mechanism for HA degradation. Mechanisms 
suggested include limited activity of HYAL2 in sub-optimal pH of 7.4 which binds 
and degrades HA at the cell surface before subsequent internalisation and further 
degradation [457]. Also, the presence of acidic extracellular microenvironments for
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HA degradation was suggested [458]. For all that, more work is needed to establish 
the role of HYALs in HA cable formation. This could be achieved, for example, by 
using a pure hyaluronidase inhibitor (yet to be identified) in 
control/stimulated/transfected cells. Indomethacin (a non-steroidal anti-inflammatory 
agent), which is considered as a HYAL inhibitor [459], could be used in initial 
experiments. Also, transfecting cells with vectors containing HYAL1 or HYAL2 
constructs (cloned successfully in the Institute of Nephrology) would be another 
useful approach to elucidate the role of HYALs.
Although HAS3 was initially viewed as the constitutive generator of HA by 
PTCs [175], HAS3 over-expression was associated with increased HA cables which, 
in turn, increased monocyte adherence. Similar findings i.e. HA cable induction after 
HAS3 over-expression were reported in other laboratories (Tammi, M -  unpublished 
data) although the potential of these HA structures to bind monocytes was not tested. 
The reduction in HA cables seen after HAS2 over-expression supports the concept 
that HA cables are HAS3-dependent. Several points should be considered to better 
understand the mechanism of formation of extracellular HA structures, including: (/') 
Substrate competition between different HAS isoforms: over-expression of HAS2 
might lead to substrate deficiency for the cable-producing HAS3. (//) Differences in 
enzyme localisation: HAS activity has been linked to its plasma membrane 
localisation [460]. This work by the Finland group shows that latent HAS2 and HAS3 
are present in the ER-Golgi pathway and this pool can be rapidly mobilized and 
activated by insertion in the plasma membrane. Furthermore, it shows that substrate 
starvation of HAS can result in its exclusion from the plasma membrane and finally 
its inactivation, (iii) Differences in Pal (and other hyaladherins) expression (discussed 
below)
Ial has been identified to be an important component of HA cables and its 
expression is now known to be a crucial factor in HA cable formation. In others’ work 
as well as data from this thesis, blockade of Ia l resulted in severe truncation of HA 
cables and reduced monocyte-HA interaction. One of the main differences noted 
between the HAS2 and HAS3 over-expressing cells was their Pal expression. In the 
HAS2-transfected cells, HC3 expression was decreased while it is unchanged or
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slightly increased in the HAS3-transfected cells. The down-regulation of HC3 mRNA 
in HAS2-transfected HK-2 cells is intriguing but one can speculate that because 
HAS2 over-expression resulted in increased cell-associated HA, the cells, attempting 
to clear intracellular HA, try to down-regulate hyaladherins to facilitate HA 
degradation and/or expulsion. This explanation is supported by western blot 
experiments that showed positive intracellular HA-Ial interaction (data from chapter 
four). It is also supported by data from HAS3 over-expression where cell-associated 
HA was decreased and Ial mRNA levels were unchanged (data from chapter five).
Mia et a l [459] suggested that the circulating HYAL inhibitor is a member of 
the Ial family, with the Pal as the most likely candidate as observed from reverse 
HA-substrate gel zymography experiments. The circulating inhibitor, yet to be 
properly identified, is ineffective against Streptomyces hyaluronidase which suggests 
that protection of HA substrate is not the entire mechanism of action of the 
hyaluronidase inhibition. Data from this thesis supports this HA-protective ability of 
Pal: (/) Ial/Pal Ab (which is reported to reverse the Pal HYAL inhibitory effect) in 
chapter five resulted in dramatic decrease in HA cable formation, (if) Reduction in 
HC3 expression in HAS2-transfected cells was associated with decreased cable 
formation, although overall HA content was increased. While the stable expression of 
HC3 following HAS3 over-expression was associated with increased cable formation 
although HYAL1 and 2 mRNA expression increased. This role of Ial in PTCs 
represents an interesting area to investigate. This could be done for example by using 
inhibitory methods like siRNA or antisense transfection after stimulating cable 
formation (with BMP-7 stimulation or HAS3 transfection).
TSG-6 has been shown to be crucial in stabilising pericellular HA coats via 
catalysing the transfer of Ial/Pal HCs onto HA chains (data from chapter four). 
However, the role of TSG-6 as the major catalyst of HC-HA cable interaction is not 
well-established as Ab blocking experiments failed to inhibit HA cable formation and 
did not alter HA-dependent monocyte binding. Concurring with this are the data 
obtained from TSG_/" mouse mesenchymal cells which showed that, upon stimulation, 
these knock-out cells produce monocyte-binding HA cables as effectively as cells 
isolated from wild-type mice (De La Motte, CA — Ph.D. thesis 2004). Taken together,
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these data strongly suggest that TSG-6 is not crucial to HA cable formation nor to 
HA-dependent monocyte binding.
The role of versican in the formation of HA cables was investigated in chapter 
three and the results showed positive co-localisation of extracellular HA and versican. 
How crucial versican is for the formation of these cables is still a question without a 
clear answer. However, work from the Cleveland group has shown, in addition to HA- 
versican co-localisation, that using L-selectin blocking Ab (which interacts with the 
G3 domain of versican [330]) to treat stimulated smooth muscle cells (with higher HA 
cables content) caused a 70% reduction in monocyte binding (De La Motte, CA -  
Ph.D. thesis 2004). Interestingly, smooth muscle cells cultured in sulphate-free 
medium were shown to produce HA cables that do not bind monocytes. These HA 
cables showed positive Ia l incorporation in them, however their versican content was 
reduced (De La Motte, CA -  personal communication). From these observations it is 
proposed that: (/) Resting monocytes adhere first via their L-selectin receptors before 
interacting with HA via their CD44 receptors, (if) Versican incorporation into HA 
cables is crucial to their function (monocyte adherence) but not to its formation, 
although much work is still needed in this regard to prove these concepts and to 
establish the importance of versican in HA cables.
Data from this thesis suggest that HA cables and pericellular coats are 
different in at least two respects: differences in sub-cellular origins (perinuclear for 
HA cables while HA coats are closely related to plasma membrane) and differences in 
their physiological impact; with HA cables representing an anti-inflammatory 
response while HA coats have a role in enhancing cell migration which can be viewed 
either as a pro-fibrotic role (facilitating epithelial-to-mesenchymal transformation in 
the interstitium) or as a healing role (facilitating the replacement of damaged tubular 
cells).
Finally, the work presented here gives detailed insights into the metabolism of 
HA in the PTCs. A new mechanism of action is suggested for the renal-protective 
agent BMP-7. A new form of extracellular HA was examined in detail along with its 
main regulators: HAS2 and HAS3. The potential role of different hyaladherins in the
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extracellular HA structures was examined. Ultimately, this work addressed an 
important matrix molecule in renal pathophysiology that still requires more research 
to understand its full potential.
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